In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Optical Imaging in Neurosurgery Meeting is a gathering of optical imaging experts and neurosurgeons who share a common goal of improving visualization in surgery. This event aims to function both as a showcase of cutting-edge optical imaging technologies and a forum for addressing unmet clinical needs that could potentially be solved by optics-based methods. Through presentation and organized discussion, this meeting seeks to bridge the gap between technological advancement and clinical requirements.
Danielle Harper, PhD - Course Co-Director Instructor, Wellman Center for Photomedicine at Massachusetts General Hospital
Pablo Valdes, MD, PhD - Course Co-Director Assistant Professor, Department of Neurosurgery, University of Texas Medical Branch
Brett Bouma, PhD Wellman Center for Photomedicine at Massachusetts General Hospital
Alexandra Golby, MD Brigham and Women's Hospital
Michael Mooney, MD Brigham and Women's Hospital
Maxina Sheft Wellman Center for Photomedicine at Massachusetts General Hospital
Benjamin Vakoc, PhD Wellman Center for Photomedicine at Massachusetts General Hospital
Martin Villiger, PhD Wellman Center for Photomedicine at Massachusetts General Hospital
Faculty
Daniel Côté, PhD Professor, CERVO Brain Research Center
Emily Gibson, PhD Associate Professor, University of Colorado - Denver
Sylvain Gioux, PhD Director of Imaging Research, Intuitive Surgical
Costas Hadjipanayis MD, PhD Executive Vice Chair, Neurological Surgery, University of Pittsburgh
Kevin Huang, MD Neurosurgeon, Department of Neurosurgery, Brigham & Women's Hospital Assistant Professor of Neurosurgery, Harvard Medical School
Peter Kan, MD, MPH Professor, Department of Neurosurgery, University of Texas Medical Branch
Anand Kumar, PhD Director, Mike Toth Head and Neck Cancer Research Center, Mass Eye and Ear
Frédéric Leblond, PhD Professor, Department of Engineering Physics, Polytechnique Montreal
John YK Lee, MD Professor, Department of Neurosurgery, University of Pennsylvania
Anita Mahadevan-Jansen, PhD Professor, Biophotonics Center, Vanderbilt University
Laura Marcu, PhD Professor, Department of Biomedical Engineering, UC Davis
Michael Mooney, MD Neurosurgeon, Department of Neurosurgery, Brigham & Women's Hospital Assistant Professor of Neurosurgery, Harvard Medical School
Brian Pogue, PhD Department Chair, Department of Medical Physics, University of Wisconsin Madison
John Rolston, MD, PhD Neurosurgeon, Department of Neurosurgery, Brigham & Women's Hospital Associate Professor of Neurosurgery, Harvard Medical School
Timothy Smith, MD, PhD, MPH Neurosurgeon, Department of Neurosurgery, Brigham & Women's Hospital Associate Professor of Neurosurgery, Harvard Medical School
Bryan Spring, PhD Associate Professor, Department of Physics, Northeastern University
Shriya Srinivasan, PhD Assistant Professor, School of Engineering and Applied Sciences, Harvard University
Eric Suero-Molina, Priv.-Doz. Dr. med Senior Physician, Department of Neurosurgery, Münster University Hospital
Martin Villiger, PhD Assistant Professor, Wellman Center for Photomedicine at Massachusetts General Hospital
Lei Wang, PhD Assistant Professor, School of Medicine, Oregon Health & Science University
We can assist you with any special needs (i.e., physical, dietary, parking, etc). Please contact Danielle Harper prior to the live event at djharper@mgh.harvard.edu to make arrangements.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Value-based health care focuses on improving patient health outcomes while reducing health care costs over time. Value-based care benefits all stakeholders in health care: first and foremost, patients, but also providers, healthcare systems, payors, and society at large. However, achieving value-based health outcomes for patients remain low and stagnating at unacceptable levels and all stakeholders remain frustrated.
This lecture series presented by the Massachusetts General Hospital, Department of Neurology’s Center for Value-Based Health Care and Science will inform how well-established frameworks (implementation science and quality improvement) can address unsolved healthcare problems. Additionally, it will serve as a first step for health care providers to learn about these methods and how they can help improve their practice. As a desired result of this educational activity, providers and teams will be able to design and implement value-based healthcare projects and enhance patient reported outcomes across multiple conditions and care settings.
This course consists of 10 weekly lectures from October 2022 to January 2023. Seminars will feature lectures and interactive activities lead by experts with extensive experience in value-based health care and/or sciences. These leaders in the field will share what they have learned and their own methods for overcoming barriers in traditional health care systems to develop successful health care delivery models. Special emphasis will be places on utilizing these methods to tackle and prevent health inequities.
Lidia Moura, MD, PhD, MPH - Course Director Associate Professor of Neurology, Harvard Medical School; Co-director, Center for Value-based Health Care and Sciences, Principal Investigator, NeuroValue Laboratory, Massachusetts General Hospital; Chief Health Informatics Officer, Epilepsy Foundation of America
Sahar Zafar, MD, MSc - Course Director Assistant Professor of Neurology, Harvard Medical School; Co-director, Center for Value-based Health Care and Sciences, Associate Medical Director, MGH Neuroscience Intensive Care Unit, Massachusetts General Hospital; Director, Mass General Brigham Neurocritical Care Fellowship, Mass General Brigham
Amanda Guidon, MD, MPH - Course Director Assistant Professor of Neurology, Harvard Medical School; Education & Dissemination Lead, Center for Value-based Health Care and Sciences, Director, Myasthenia Gravis Clinic, MGH, Massachusetts General Hospital; Director, Neuromuscular Medicine Fellowship, Mass General Brigham
Upon completion of this activity, participants will be able to:
Define important value-based healthcare and/or sciences terminology.
Contrast the differences, similarities, and applications of quality improvement and implementation frameworks in healthcare.
Recognize how each participant’s unique role in their teams can utilize quality improvement methods and techniques.
Extrapolate implementation, change management, and quality improvement methods to participants’ own practices and as it relates to their role in their teams
Construct and organize a value-based healthcare and/or research team
Reflect and study value-based initiatives and use those insights to plan future advancements
Identify how to use value-based health care methods to address health inequalities related to:
Telemedicine
Racial, Ethnic, and Language Minority patient populations
Part A: Introduction to Value-Based Science Concepts and Methods
Parts A and B will overview what value-based science methods are, the use of different frameworks and methods in healthcare.
October 31, 2022 12:00-1:00PM
Lecture 1: Introduction to Value-Based Health Care (Value-Based Healthcare 101)
The first lecture will provide an overview of value-based health care, including a definition and goals of value-based healthcare. Different value-based health care frameworks will be introduced, for detailed discussion in future lectures. Measures of successful implementation of these frameworks, and a broad overview of future directions in value-based care will be provided.
November 9, 2022 4:00-5:00PM
Lecture 2: Learning Healthcare Systems and Implementation Science
These systems utilize continuous implementation strategies to improve care over shorter timeframes compared to traditional research methods. Through real-time patient reported outcome data, provider feedback, and improved decision-making tools, these systems can significantly benefit patients and their communities.
November 16, 2022 4:00-5:00PM
Lecture 3: Quality Improvement (QI) Science
QI methods utilize PDSA (Plan, Do, Study, Act) cycles to rapidly identify and improve systems.
Part B: Applying Value-Based Science (Concept to Reality)
November 30, 2022 4:00-5:00PM
Lecture 4: Value-based Neurology Care
Identifying value-based health metrics of interest
Real-life Example: Post-Acute Symptomatic Seizure Investigation and Outcomes Network
December 7, 2022 4:00-5:00PM
Lecture 5: Growth and Maintenance of a Learning Healthcare System
Challenges and Solutions for continued innovation of an established system
Real-life Example: Epilepsy Learning Healthcare System
December 13, 2022 12:00-1:00PM
Lecture 6: Creating a Quality Improvement Ecosystem in Your Organization
Reflection on the current status quo for neurology care and research
Emphasis on how value-based healthcare can be utilized to advance these areas.
Part C: Using Value-based Methods to Address Health Inequities
A special focus will be placed in this program on methods to assess and address care disparities.
January 4, 2023 4:00-5:00PM
Lecture 7: Virtual Care & Patients with Limited English Proficiency
Identify ways of utilizing value-based healthcare methods in virtual or telehealth care environments.
Real-world examples from the Massachusetts General Hospital Center of TeleHealth and Virtual Care division.
January 11, 2023 12:00-1:00PM
Lecture 8: Optimizing Care Across Patients’ Race, Ethnicity, and Language
Recognize value-based healthcare methods for optimizing care of patients from different racial, ethnic, and language backgrounds.
Real-world examples from the Massachusetts General Hospital Department for Community Health Improvement and Community Health, Diversity, and Inclusion.
January 18, 2023 4:00-5:00PM
Lecture 9: Strategies to Identify and Address Neurodisparaties in Sexual and Gender Minority Individuals
Audiences will be shown value-based healthcare strategies for addressing Neurodisparities as they relate to sexual and gender minority individuals.
January 25, 2023 4:00-5:00PM
Lecture 10: Recruitment Strategies to Improve Diversity in Research and Care
Help audiences recognize value-based healthcare strategies for creating equity in clinical trials and promoting diversity in research and care through recruitment initiatives.
This activity is intended for healthcare professionals and staff including providers (faculty, residents, fellows, and advanced practice providers), nurses, and research staff with involvement or interest in improving health care systems.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Hospital Cancer Center Grand Rounds 2024-2025 September 19, 2024 - May 22, 2025
Back again the 2024-2025 Cancer Center Grand Rounds are available to the public to attend virtually LIVE via paid subscription. (Please note: This subscription does not include in-person attendance)
The theme of the series is "Early Detection" and kicks off Thursday September 19, 2024 at 12:00 PM EDT. The series will cover a comprehensive array of disease areas and topics, attendees will be provided with a robust selection of sessions to bring them up to speed on the most cutting-edge research and therapies in oncology.
The subscription will provide access to BOTH the live webinar AND the recording; however, if claiming credit, you may only claim credit for attending one or the other per date.
Colin D. Weekes, MD, PhD - Course Director Director, Medical Oncology Research for Pancreatic Cancer, Director, Cancer Center Grand Rounds Program Massachusetts General Hospital
Douglas Micalizzi, MD, PhD Clinical Director, Cancer Early Detection and Diagnostics Clinic, Massachusetts General Hospital Cancer Center
Lecia Sequist, MD, MPH Program Director, Cancer Early Detection and Diagnostics Clinic, Massachusetts General Hospital Cancer Center; Landry Family Professor of Medicine Harvard Medical School
This activity is intended for research and clinical staff who need to be educated on cutting edge information on advances and perspectives on cancer research and treatment across the full spectrum of cancer specialization.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This multidisciplinary continuing medical education program targets the practicing musculoskeletal provider or clinician seeking to polish their hands-on, diagnostic, and procedural skills in musculoskeletal ultrasound performed at the point-of-care through guided instruction by expert physicians at Massachusetts General Hospital and Spaulding Rehabilitation Center. Specialties such as orthopedics, sports medicine, rheumatology, physical medicine and rehabilitation, emergency medicine, internal medicine, primary care, family medicine, and radiology can benefit from this basic to intermediate course.
Minna Kohler, MD, RhMSUS Director, Rheumatology Musculoskeletal Ultrasound Program, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
David Robinson, MD Sports Medicine Physiatrist, Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital
Speakers
Marwa Ahmed, MD, MS Clinical Instructor, Sports Medicine Department of PM&R, Harvard Medical School Medical Director Boston Landing - Spaulding Outpatient Center Brighton Massachusetts General Hospital & Spaulding Rehabilitation
Jemima Albayda, MD, RhMSUS Associate Professor of Medicine, Director, Rheumatology Fellowship, Program Director, Musculoskeletal Ultrasound and Injection Clinic, Johns Hopkins Medicine
Nour Al Jalbout, MD Co Director, Harvard Emergency Ultrasound Fellowship, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital
Ashwin Babu, MD President of Medical Staff: Spaulding Rehabilitation Team Physician: New England Revolution, USA Paralympic Soccer; Consultant: New England Patriots, Boston Bruins, Harvard University, Curry College, Suffolk University Associate Program Director: Spaulding/Harvard Physical Medicine and Rehabilitation Residency Training Program
Joanne Borg-Stein, MD Chief, Newton Wellesley Hospital Division of Sports and Musculoskeletal Rehabilitation Associate Director, Harvard/Spaulding Sports Medicine Fellowship Department of Physical Medicine and Rehabilitation, Harvard Medical School
Haylee Borgstrom, MD Sports Medicine PM&R Physician; Associate Program Director, Spaulding/Harvard Physical Medicine and Rehabilitation Residency Training Program; Instructor, Physical Medicine & Rehabilitation, Harvard Medical School
Lauren Elson, MD Instructor in Physical Medicine and Rehabilitation, Harvard Medical School; Director of Dance Medicine, Spaulding Rehabilitation Hospital
Calvin Huang, MD, MPH Director, Ultrasound Education, Harvard Medical School; Emergency Ultrasound, Department of Emergency Medicine, Massachusetts General Hospital
Eugene Kissin, MD, RhMSUS Rheumatologist, Boston Medical Center; Clinical Professor of Medicine , Program Director, Rheumatology Fellowship Program, Boston University, Chobanian & Avedisian School of Medicine
Mark Matza, MD, MBA, RhMSUS Co-Clinical Director, Rheumatology, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Anthony Reginato, MD, PhD Associate Professor Director, Division of Rheumatology, Brown University, Alpert Medical School, Department of Medicine
Craig Rovito, MD Brain Injury Medicine, Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital; Program Director, Spaulding/Harvard Physical Medicine and Rehabilitation Residency Training Program
Hamid Shokoohi, MD, MPH, FAEMUS Director, MGH Emergency Ultrasound Program, Director, Emergency Ultrasound Research, Massachusetts General Hospital; Associate Professor of Emergency Medicine, Harvard Medical School
Zachary Stewart, MD Musculoskeletal Radiologist, Director of Musculoskeletal Ultrasound, Massachusetts General Hospital; Clinical Instructor of Radiology, Harvard Medical School
Janeth Yinh, MD, RhMSUS Rheumatology, Massachusetts General Hospital
Instructors
Christopher D. Estes, NP, RhMSUS Nurse Practitioner, Rheumatology Musculoskeletal Ultrasound Program, Division of Rheumatology, Allergy, and immunology, Massachusetts General Hospital
Nicole Katz, MD Resident Physician (PGY-4) Spaulding/Harvard Physical Medicine and Rehabilitation Residency Training Program
David Lee, MD Attending Physician, Bedside Procedure Service Academic Hospitalist, Department of Medicine Brigham and Women's Hospital
Room Blocks: There are limited room blocks for attendees of the course at the Kimpton Marlowe Hotel (venue) and Wyndham Hotel Beacon Hill (5-minute drive from venue). For instructions on booking at the preferred rate in either room block, please contact davodea@mgh.harvard.edu.
Other Lodging Options:
Holiday Inn Express & Suites Boston - Cambridge (10-minute walk)
Hampton Inn Boston/Cambridge (10-minute walk)
Fairfield Inn & Suites Boston Cambridge (10-minute walk)
The Kendall Hotel (15-minute walk)
The Boxer Boston (5-minute drive)
citizenM Boston North Station hotel (5-minute drive)
Upon completion of this activity, participants will be able to:
Recognize basic musculoskeletal sonoanatomy and sonopathology.
Develop interprofessional team and individual strategies to utilize musculoskeletal ultrasound at the point-of-care.
Demonstrate mastery of procedural techniques and scanning protocols for musculoskeletal ultrasound.
Develop the practicing clinician’s skills in the use of MSUS for evaluation and treatment for a variety of musculoskeletal conditions and diseases by bridging older and newer practices with clinical research.
Apply the use of diagnostic ultrasound and ultrasound-guided procedures to enhance their clinical knowledge, skill set, and judgement in practice.
Please reach out to David O'Dea (davodea@mgh.harvard.edu) with proof of membership to receive a discount code for tuition.
NOTE: Standard tuition applies to all MD, DO, chiropractors and other established providers attending the course.
Registration Type
Tuition Fee
Standard
$1,250.00
Fellow/Resident/Medical Student
$900.00
Non-Physician/APPs
$1,000.00
Industry
$1,500.00
Cancellation Policy: Registrations cancelled on or before March 15, 2025 will be refunded, less a $150 administrative fee. Registrations cancelled after March 15, 2025 will not be refunded.
Contact mgbcpd@mgb.org if you require assistance in cancelling your online registration.
This activity is intended for Physicians, Advance Practice Providers (APPs), Nurses and other members of the healthcare team. Specialties such as orthopedics, sports medicine, rheumatology, physical medicine and rehabilitation, emergency medicine, internal medicine, primary care, family medicine, and radiology can benefit from this basic to intermediate course.
In support of improving patient care, this activity has been planned and implemented by Mass General Brigham and Cabo Verdean American Medical Society. Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 7.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Psychology
7.00 Continuing Education (CE) credits are awarded.
Social Work As a Jointly Accredited Organization, Mass General Brigham is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Mass General Brigham maintains responsibility for this course. Social workers completing this course receive 7.00 continuing education credit.
Lifelong Learning Maintenance of Certification (MOC) Program
MOC RECOGNITION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Participants will gain an understanding of the healthcare delivery system and the social and economic factors affecting the health of Cabo Verdeans. Through interactive presentations and discussions by CVAMS members, the audience will learn about various topics in surgery, cardiology, preventative care, oncology, palliative care, mental health and education. In a concurrent mental health symposium participants will gain an understanding of trauma informed care. Attendees will be able to formulate goals to help improve health outcomes in Cabo Verde and the diaspora.
Doreen Defaria Yeh, MD Associate Director, MGH Adult Congenital Heart Disease Program Co-Director, MGH Cardiovascular Disease and Pregnancy Program Program Director, Cardiovascular Disease Fellowship, Massachusetts General Hospital
Madelaine Tully, MD Family Physician, Progressive Community Health Center Milwaukee, Wisconsin
Planning Committee
Julio Teixeira, MD, FACS President of CVAMS Director of Minimally Invasive Surgery, Northwell Health New York
Patricia Andrade, MD Physician, General Surgeon Taunton and Fall River, MA
Elizabeth Gomes, DO Physician, Jenks Park Pediatrics Women and Infant's Hospital through Care - New England Central Falls, RI | Providence, RI
Maria Fatima Barros, RN, MSN (Retired) Volunteer many communities’ health & advisory committees, RI Department of Health Advisory Boards Providence, RI
Rosilda James, PsyD Clinical Psychologist, Alves Psychotherapy Walnut Creek, CA
Samora Miguel Cardoso Lopes Clinical Research Sub-investigator, Department of Anesthesia, Critical Care And Pain Medicine Harvard Medical Faculty Physicians Beth Israel Deaconess Medical Center Boston, MA
Maya Spencer, MD Pediatrician, Atrius Health Braintree, MA
Susan Weinberg, MD, FACR Founder, Mary Jo Cropper Family Center for Breast Care Past Director of Trihealth Radiology, Cincinnati Rad Partners—SEAL Team
Lyla Blake, MD, MPH Physician, Community Health Center of Cape Cod Falmouth, MA
Kimberly Coto, LICSW, MSW Clinical Social Work/Therapist New Bedford, MA
Faculty
Patrice Alves, MD Internal Medicine Physician, Christus Health San Antonio, TX
Paulo Pina, MD Network Pediatric Medical Director, Family Health Centers at NYU Langone Brooklyn, NY
Maritsa Barros, EdD, MS University Lecturer, Tufts University Owner, Senavision
Carla Barbosa, MD National Program Coordinator for Oncology Ministry of Health, Cabo Verde
Adriano Cabral, MEd, CAGS CEO, Inclusion Family Center, Inc. Brockton, MA
Samantha DeAndrade, MD, MPH Fellow in Urogynecology, Harbor-UCLA Medical Center Los Angeles, CA
Luis Manuel Dias Andrade, MD Physician, Agostinho Neto University Hospital Praia, Cabo Verde
David Earle, MD, FACS Director, New England Hernia Center Associate Professor of Surgery, Tufts University – School of Medicine Medical Advisor, Western Mass Region of the National Ski Patrol
Oyere K. Onuma, MD Director, Global Cardiovascular Health Program at Massachusetts General Hospital – Cardiology Division & Corrigan Minehan Heart Center Assistant Professor of Medicine, Harvard Medical School Associate Director, Health Equity in Cardiology (MGH)
E. Isabel Lopes, MD Physician, Mad River Community Hospital, Open Door Community Health Center & Providence Redwood Memorial Hospital California, USA
Antonio Mendes, MD Medical Director, Mendes Medical Associates Norwood, MA
Robert M. Teixeira, MD Assistant Professor of Surgery, University of Utah Salt Lake City, UT
Danielson Pereira Barreto da Veiga, MD President, Order of Physicians, Cabo Verde Chair of Surgery, Agostinho Neto University Hospital
Nicholas Tawa, MD Assistant Professor of Surgery, Harvard Medical School Associate Director of Nutrition Support Service, Beth Israel Deaconess Medical Center
Nivia Vieira, MSc Assistant Director of Healthcare Partnership, Project Bread East Boston, MA
Idalina S. Afopa, FNP-BC Family Nurse Practitioner, Veterans Health Administration Medical Center, Manhattan, New York, NY
Valéria Semedo, MD Physician, Agostinho Neto University Hospital Coordinator, HAN – Palliative Care Member, African Association of Palliative Care Lecturer, University of Cape Verde Nursing Chair, Disability Verification Commission of the National Social Security Institute Cabo Verde
Jason Sherer, MD, MPH Physician, Cardiology - St. Francis Heart Center Rockville Centre, NY
Darlene Spencer Program Officer/Board President, Carney Family Charitable Foundation Cape Verdean Association in New Bedford
Joseph Gomes, DO Emergency Medicine Physician, Memorial Hospital West Pembroke, FL
Merrian Brooks, MD Attending Pediatrician/Adolescent Medicine Specialist, Craig Dalsimer Division of Adolescent Medicine, Children's Hospital of Philadelphia Philadelphia, PA
Anibal Melo, MD Physician, Saint Luke’s Hospital – Department of Nephrology St. Louis, MO
Djanira Fernandes, MD PGY1 Resident, Beth Israel Deaconess Medical Center
Tim Johnson, MD Orthopedic Surgeon, Johns Hopkins School of Medicine Assistant Professor of Sports Medicine, Shoulder & Elbow Surgery, Johns Hopkins School of Medicine
Elisa Cabral, MS Inclusion Family Center
Claudia Fontes, MD Pediatric Emergency Medicine Fresno, CA
Roberto Pineda, MD Thomas Y. & Clara W. Butler Chair of Ophthalmology, Massachusetts Eye & Ear Associate Professor of Ophthalmology, Harvard Medical School
Gabriella Spinola Chief Marketing Officer, CMO WeCare 365 AFC
Upon completion of this activity, participants will be able to:
Recognize the unique causes of morbidity and mortality in Cabo Verde and the diaspora.
List specific challenges identified by the CVAMS teams in the areas of cardiology, preventive medicine, surgery, and mental health.
Use the experiences and data from the recent scientific exchange to identify opportunities for future collaborations and enhance public health priorities and building sustainable infrastructure.
Acquire tools to practice trauma informed care in a clinical setting. Realize the importance of client-provider relationship building to support healing.
Identify the signs of burn-out and accumulative stress in one’s self and others. Create a self-care plan through an interactive workshop.
Identify implicit bias and build awareness as they relate to delivering trauma informed care.
Recognize the significance of colonial trauma, immigration, assimilation, colorism, family separation and classism.
Cancellation Policy: Registrations cancelled on or before September 22, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after September 22, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for physicians, nurses, nurse practitioners, psychologists, physician assistants, social workers, other members of the healthcare team, and community members.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Hospital Cancer Center Grand Rounds 2023-2024 September 7, 2023 - May 30, 2024
For the first time ever, the 2023-2024 Cancer Center Grand Rounds are available to the public to attend virtually LIVE via paid subscription. (Please note: This subscription does not include in-person attendance)
The theme of the series is "Women in Cancer: and kicks off Thursday September 7, 2023 at 12:00 PM EDT. with the annual "Chabner Pioneers in Oncology Lectureship". The series will cover a comprehensive array of disease areas and topics, attendees will be provided with a robust selection of sessions to bring them up to speed on the most cutting-edge research and therapies in oncology.
The subscription will provide access to BOTH the live webinar AND the recording; however, if claiming credit, you may only claim credit for attending one or the other per date.
Colin D. Weekes, MD, PhD - Course Director Director, Medical Oncology Research for Pancreatic Cancer, Director, Cancer Center Grand Rounds Program Massachusetts General Hospital
Upon completion of this activity, participants will be able to:
Evaluate recent advances or controversies in hematology/oncology treatment, clinical research and/or basic science investigation presented in this series
Assess opportunities to integrate information, tools or practices presented in this conference into how you deliver or support research and patient care
Apply new information or perspectives from this conference into specific aspects of your responsibilities in patient care, research or the system in which you work.
Recognize evolving landscape of cancer care worldwide
Sessions will be held weekly on Thursday from September 7, 2021 to May 30, 2022 from 12:00 to 1:00 PM.
September 7, 2023 The Chabner Pioneers in Oncology Lectureship – Precision Medicine for Primary and Metastatic Brain Tumors: From Bench to Bedside (and Back to Bench) Priscilla Brastianos, MD Mass General Cancer Center
September 28, 2023 (This session will be available to view LIVE ONLY. There will be no recording for this session.) Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Cancer Cigall Kadoch, PhD Dana-Farber Cancer Institute
October 5, 2023 Talk Title Novel Therapeutics in Gynecologic Cancers Roisin O’Cearbhaill, MD Memorial Sloan-Kettering Cancer Center
October 12, 2023 Women in Cancer: Navigating the Glass Ceiling Lisa Butterfield, PhD University of California San Francisco Kornelia Polyak, MD, PhD Dana-Farber Cancer Institute Noopur Raje, MD Mass General Cancer Center
November 9, 2023 Achieving Success as A Square Peg in the Round Hole of Academic Medicine Jennifer Temel, MD Mass General Cancer Center
November 30, 2023 Female Participant Engagement in Cancer Research: Sample Programs from the Field to a Pandemic Lourdes Baezconde-Garbanati, PhD University of Southern California
December 7, 2023 The Dobbs Decision: Implications for Women’s Health and Cancer Care Lisa Barroilhet, MD University of Wisconsin School of Medicine and Public Health
December 14, 2023 Targeted Therapy for Premenopausal Early Breast Cancer: A 100 Year Old Strategy Sandra Swain, MD Georgetown University Medical Center Spring 2024 Grand Rounds Schedule
January 11, 2024 Integrating Clinical and Laboratory Research to Identify Mechanisms of Response and Resistance to Immune Checkpoint Therapy Padmanee Sharma, MD, PhD MD Anderson Cancer Center
January 18, 2024 From the Ether Dome to Seldin Plaza: My Path in Renal Cell Carcinoma Tian Zhang, MD UT Southwestern Medical Center
January 25, 2024 Can’t Stop, Won’t Stop: The Development of New Therapies, and New Trialists, Toward a Future of Cure Janice Mehnert, MD NYU Langone Health
February 8, 2024 Advocacy in Oncology: Connecting What Matters with Our Science and Care Pamela Kunz, MD Yale School of Medicine
February 29, 2024 Brain Metastases of Breast Cancer Patricia Steeg, PhD National Institutes of Health
March 14, 2024 Rethinking Radiation Oncology Using HPV Driven Oropharyngeal Carcinoma as a Model Nancy Lee, MD, FASTRO Memorial Sloan Kettering Cancer Center
March 21, 2024 Bridging the GAP While Shattering Ceiling Rachna Shroff, MD, MS, FASCO University of Arizona Cancer Center
March 28, 2024 Porphyria: New Therapies and Research Rebecca Karp, MD Massachusetts General Hospital Amy Dickey, MD, MSc Massachusetts General Hospital
April 25, 2024 Treating AML in 2024 : Individualizing Treatment Approaches with Novel Therapies Courtney DiNardo, MD, MSCE MD Anderson Cancer Center
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
This activity is intended for research and clinical staff who need to be educated on cutting edge information on advances and perspectives on cancer research and treatment across the full spectrum of cancer specialization.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 11.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
MOC COMPLETION CRITERIA
Participant completion for MOC points will be reported to the boards at the conclusion of the course.
Please have your ABIM ID available when completing the evaluation at the end of the course.
Instructions: Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program
Upon successful completion of this activity, if you wish to receive MOC Part 2 points you will need to enter your ABIM ID number in the post-course evaluation. The Mass General Brigham Office of Continuing Professional Development will verify completion of your activity and report to the ABIM. Diplomates must check their ABIM Portfolio for confirmation of your MOC Part 2 points.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 11.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
5C: Concepts in Contemporary Critical Care Cardiology is a novel offering of the MGH Heart Center designed to educate practicing clinicians about current topics at the forefront of cardiac intensive care – such as ECMO and mechanical circulatory support - and provide clinicians with a robust evidence base of medical knowledge to be able to provide comprehensive care to modern cardiac intensive care patients.
Instructor in Medicine, Harvard Medical School; Cardiologist, Massachusetts General Hospital
Faculty
Aaron Aguirre, MD, PhD Assistant Professor of Medicine, Harvard Medical School; Critical Care Cardiologist, Massachusetts General Hospital
Aranya Bagchi, MBBS Assistant Professor of Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care and Pain Medicine, Massachusetts General Hospital
Lisa Bebell, MD, MSc Instructor of Medicine, Harvard Medical School; Critical Care Medicine and Infectious Diseases, Massachusetts General Hospital
Marvin Chang, MD, PhD Assistant Professor of Anesthesia, Harvard Medical School; Anesthesiologist, Massachusetts General Hospital
Ryan Chung, MD Massachusetts General Hospital
David Convissar, MD Instructor in Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care and Pain Medicine, Massachusetts General Hospital
Jerome Crowley, MD, MPH Instructor in Anesthesia, Harvard Medical School; Cardiothoracic Anesthesiologist, Critical Care Medicine, Massachusetts General Hospital
Kyle Devins, MD Massachusetts General Hospital
Danielle Doucette, RRT Massachusetts General Hospital
Mike Fitzsimons, MD Associate Professor of Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care and Pain Medicine, Massachusetts General Hospital
Kathryn Hibbert, MD Assistant Professor of Medicine, Harvard Medical School; Critical Care Cardiologist, Massachusetts General Hospital
Sohah Iqbal, MD Chief of Interventional Cardiology, Massachusetts General Hospital - Salem
Eric Isselbacher, MD Associate Professor of Medicine, Harvard Medical School; Co-Director, Thoracic Aortic Center, Massachusetts General Hospital
Yvonne Lai, MD Assistant Professor of Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care Medicine, Massachusetts General Hospital
Dennis Lu, MD
Ina Ly, MD Massachusetts General Hospital
Jona Ludmir, MD Assistant Professor of Medicine, Harvard Medical School; Critical Care Cardiologist, Massachusetts General Hospital
Rajeev Malhotra, MD, MS Assistant Professor of Medicine, Harvard Medicine School; Cardiologist, Massachusetts General Hospital
Ioannis Mastoris, MD Advanced Heart Failure and Transplant Cardiologist, Mass General Brigham; Instructor of Medicine, Harvard Medical School
Eriberto Michel, MD Assistant Professor of Surgery, Harvard Medical School; Cardio-Thoracic Surgeon, Massachusetts General Hospital
Jahan Mohebali, MD, MPH Assistant Professor of Surgery, Harvard Medical School; Cardio-Thoracic Surgeon, Massachusetts General Hospital
Christopher Newton-Cheh, MD, MPH Massachusetts General Hospital
Philip Podrid, MD Cardiac Electrophysiology, Boston Medical Center
Malavika Prabhu, MD Massachusetts General Hospital
Jill Rackliffe, CNP Massachusetts General Hospital
Jonah Rubin, MD Massachusetts General Hospital
Marc Sabatine, MD, MPH Professor of Medicine, Harvard Medical School; Cardiologist, Massachusetts General Hospital
Kenneth Shelton, MD Assistant Professor of Anesthesia, Harvard Medical School; Chief, Division of Critical Care, Massachusetts General Hospital
Michael Silverman, MD, MPH Assistant Professor of Medicine, Harvard Medical School; Cardiac Critical Care Cardiologist, Massachusetts General Hospital
Edmond Solomon, RPh Massachusetts General Hospital
Kelly Tankard, MD Instructor of Medicine, Harvard Medical School; Critical Care Anesthesiologist, Massachusetts General Hospital
Lana Tsao, MD Instructor of Medicine, Harvard Medical School; Heart Failure Cardiologist, Massachusetts General Hospital
Van-Khue Ton, MD, PhD Assistant Professor of Medicine, Harvard Medical School; Advanced Heart Failure & Transplantation Cardiologist, Massachusetts General Hospital
Mary Norine Walsh, MD St. Vincent Heart Center
Alison Witkin, MD Assistant Professor of Medicine, Harvard Medical School; Associate Director of Pulmonary Hypertension and Thromboendarterectomy, Massachusetts General Hospital
Man Piu (Mark) Wong, MD Instructor of Anesthesia, Harvard Medical School; Anesthesiologist, Massachusetts General Hospital
Evin Yucel, MD Instructor of Medicine, Harvard Medical School; Cardiologist Specializing in Echocardiography, Massachusetts General Hospital
Upon completion of this activity, participants will be able to:
Compare available strategies for urgent univentricular and biventricular mechanical support.
Choose vasoactive medications based on an algorithmic approach to shock phenotypes.
Practice consensus-based selection criteria for choosing ECMO and mechanical circulatory support strategies.
Select strategies for optimal care of the post-arrest patient.
Manage refractory hypoxemia with improved understanding of ventilator parameters and mechanics in cardiac patients, and acknowledge heart-lung interaction and impact on physiology and treatment.
Evaluate contributions of right ventricular dysfunction and ventricular interdependence in acute cardiopulmonary dysfunction.
Demonstrate appropriate systems-based practice in modern cardiac critical care by employing care bundles and evidence-based practice with nutrition and physical therapy.
Recognize signs and causes of delirium in critically ill patients and implement appropriate neuropharmacologic treatment plan.
Cardiogenic Shock: Hub-and-Spoke Network Perspective and Optimal Practice for Transfers | Sohah Iqbal, MD
2:00
Percutaneous VAD and MCS: Overview and Indications | Ivana Nikolic, MD
2:15
Heart Transplant: Indications, Evaluation, and Surgery | Lana Tsao, MD
2:30
Critical Care of the Immediate post-VAD and post-Transplant Patient | Eriberto Michel, MD & Van-Khue Ton, MD, PhD
2:45
Alarm! MCS Device Emergencies | David Convissar, MD
3:00
Panel Discussion: Acute and Chronic Cardiac Failure; Heart Replacement Therapies Denis Lu, MD; Ivana Nikolic, MD; Lana Tsao, MD; Eriberto Michel, MD; David Convissar, MD; Sohah Iqbal, MD
3:20
BREAK
Section V: Case Records of the MGH Heart Center ICU Moderator: David Dudzinski, MD
3:30
Clinicopathologic Conference: Case Records of the MGH Heart Center ICU | David M. Dudzinski, MD; Mary Norine Walsh, MD; Christopher Newton-Cheh, MD, MPH; Malavika Prabhu, MD; Kyle Devins; Ina Ly, MD; Ryan Chung, MD
4:30pm
Adjourn
Saturday, April 29, 2023 | 7:50am - 12:15pm
7:50
Welcome Back – Day 2 | David Dudzinski, JD, MD & Ivana Nikolic, MD
Section VI: Cardiovascular Comorbidities in the Cardiac Critical Care Units Moderators: Ivana Nikolic, MD & David Convissar, MD
8:00
Tachyarrhythmia and Bradyarrhythmia in Cardiac Critical Care | Rajeev Malhotra, MD
8:20
Acute Aortic Syndromes: Diagnosis and Management | Eric Isselbacher, MD
Panel Discussion: Cardiovascular Comorbidities in the Cardiac Critical Care Units Rajeev Malhotra, MD; Eric Isselbacher, MD; Jahan Mohebali, MD; David Convissar, MD; Ivana Nikolic, MD
9:20
BREAK
Section VII: Non- Cardiovascular Comorbidities in the Cardiac Critical Care Units Moderators: Jill Rackliffe, NP & Amit Bardia, MD
9:30
Sepsis and ICU Infection Update | Lisa Bebell, MD
9:45
Acute Kidney Injury and Renal Replacement Therapy | Man Piu (Mark) Wong, MD
10:00
Rational Approaches to Sedation and Neurologic Management in Cardiac Critical Care | Kenneth Shelton, MD
10:15
Rapid Evidence Review on ICU Prophylaxis and Quality in the ICU | Amit Bardia, MD
10:30
Panel Discussion: Optimizing Care of Non-Cardiac Comorbidities in Cardiac Critical Care Amit Bardia, MD; Kenneth Shelton, MD; Mark Wong, MD; Lisa Bebell, MD; Ivana Nikolic, MD; Edmond Solomon, RPh
10:50
BREAK
Section VIII: Literature Update and Clinical Cases Moderators: David M. Dudzinski, MD & Kelly Tankard, MD
11:00
Top 3 Papers from 2022-2023 in Cardiac Critical Care Literature | Kelly Tankard, MD
11:15
Challenging Cases from the MGH Cardiac Critical Care Units | David Dudzinski, JD, MD; Van-Khue Ton, MD, PhD; Jerome Crowley, MD; Eriberto Michel, MD, Emily Zern, MD
12:05pm
Conclusion | David Dudzinski, JD, MD; Ivana Nikolic, MD; Jill Rackliffe, NP
Cancellation Policy: Registrations cancelled on or before April 14, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after April 14, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for physicians, nurses, pharmacists, physician assistants, and other members of the healthcare team. This activity is intended for providers in the specialties of Anesthesiology, Cardiac Electrophysiology, Cardiac Surgery, Cardiology, Critical Care, Emergency Medicine, Geriatric Medicine, Internal Medicine, Interventional Cardiology, Pulmonary Disease, Thoracic Surgery, and Vascular Surgery.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 7.25 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer. This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI), MRI-ultrasound fusion biopsy, including transperineal biopsy, PSMA PET imaging, focal therapy treatment options, and other recent advances in imaging technology and diagnostics/therapeutics for prostate cancer. The course is designed to provide a focused, yet comprehensive advanced clinical review for practicing urologists, radiologists, medical oncologists, and radiation oncologists, as well as advanced practice providers. Participant learning and interaction will be encouraged through case reviews, question-and-answer sessions, and interaction with the course faculty.
Cancellation Policy: Registrations cancelled on or before October 18, 2024 will be refunded, less a $35 administrative fee. Registrations cancelled after October 18, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 6.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation
Lifelong Learning Maintenance of Certification (MOC) Program
MOC RECOGNITION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
This all-day event will promote the collaboration and interprofessional discussion regarding current innovative techniques and treatments. It will address the current debate surrounding approaches to the mitral valve: catheter-based procedures vs. open heart surgery. While there is some resistance to the use of catheter-based procedures in the treatment of mitral valve disease, this is mostly due to an existing stigma that assumes the old way is the best way. Historically, mitral valvuloplasty has been primarily treated with open heart surgery, but advancements in technology over the last century have allowed us to apply new techniques for disease treatment. The ongoing debate of which treatment is better (surgery or catheter based) is present in both fields. By the end of the event, attendees will be able to distinguish between the different approaches to the management of mitral valve disease and utilize procedures from both cardiac surgery and cardiology to better their practice in the future.
Please note that there are varying tuition prices:
Mark J. Cunningham, M.D. - Course Director Cardiac Surgery Interim Chief, Cardiac Surgery Brigham and Women’s Hospital
Robert S.D. Higgins, M.D., M.S.H.A. Cardiac Surgery President, Brigham and Women’s Hospital Executive Vice President, Mass General Brigham
Thoralf Sundt, III., M.D. Cardiac Surgery Director, Cardiac Surgery Service Line Mass General Brigham
Patrick T. O’Gara, M.D. Cardiovascular Medicine Watkins Family Distinguished Chair in Cardiology Brigham & Women’s Hospital
Pinak Bipin Shah, M.D. Cardiovascular Medicine Director, Cardiac Catheterization Laboratory Brigham and Women’s Hospital
Eugene Braunwald, M.D. Cardiovascular Medicine Distinguished Hersey Professor of Medicine, Harvard Medical School Chairman Emeritus, Department of Medicine, Brigham and Women’s Hospital
Tirone David M.D., F.R.C.S.C. Cardiac Surgery Chief of Cardiac Surgery, University of Toronto Melanie Munk Chair of Cardiovascular Surgery, Peter Munk Cardiac Centre
Stanton K. Shernan, M.D., F.A.H.A., F.A.S.E. Cardiovascular Medicine Benjamin G. Covino Professor of Anaesthesia Brigham and Women’s Hospital
Tommaso Danesi, M.D. Cardiac Surgery Vice-Chief of Cardiac Surgery AULSS 8, San Bortolo Hospital
Richard J. Shemin, M.D. Cardiac Surgery Robert & Kelly Day Chair in Cardiothoracic Surgery University of California, Los Angeles
Gerard M. Doherty, M.D. Surgeon-in-Chief Crowley Family Distinguished Chair, Brigham and Women’s Hospital
Cancellation Policy: Registrations cancelled on or before October 6, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after October 6, 2023 will not be refunded.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 22.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 22.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
MOC COMPLETION CRITERIA
Participant completion for MOC points will be reported to the boards at the conclusion of the course.
Please have your ABIM ID available when completing the evaluation at the end of the course.
Instructions: Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program
Upon successful completion of this activity, if you wish to receive MOC Part 2 points you will need to enter your ABIM ID number in the post-course evaluation. The Mass General Brigham Office of Continuing Professional Development will verify completion of your activity and report to the ABIM. Diplomates must check their ABIM Portfolio for confirmation of your MOC Part 2 points.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 22.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Live Stream or In-Person options Fairmont Copley Hotel, Boston, MA
OCTOBER 11-13, 2023
Registration Type
Early Bird Rate (Before September 1, 2023)
Standard Rate (After September 1, 2023)
Physicians
$795.00
$895.00
Allied Health Care Professionals
$695.00
$795.00
Residents/Fellows
$600.00
$600.00
This course provides a comprehensive review of state-of-the-art practices to diagnose and treat patients with cardiovascular conditions. Led by the leading clinical faculty of Harvard Medical School and the Massachusetts General Hospital (MGH) Corrigan Minehan Heart Center, Update in Clinical Cardiology ensures attendees are current with recent advances in clinical cardiology and the best ways to incorporate them into daily practice to optimize patient outcomes.
The 2023 program offers you the opportunity to learn:
Important medical and procedural advances for the management of common clinical problems such as coronary artery disease and heart failure (including heart failure with preserved ejection fraction)
The latest transcatheter options
Best practices to treat patients with severe valvular disease
Important techniques for managing heart disease in pregnancy
The new paradigms for care of specialized populations, such as adults with congenital heart disease, cardiac patients with cancer, and athletic individuals
The latest concepts of diagnosis, decision-making, pharmacology, and therapy in the areas of ischemic heart disease, cardiac arrhythmias, and congestive heart failure
Associate Professor of Medicine, Harvard Medical School; Cardiologist specializing in Echocardiography and Cardiovascular Performance, Massachusetts General Hospital
Instructor in Medicine, Harvard Medical School; Director, Hormones & Cardiovascular Disease Clinic, Massachusetts General Hospital
Nurse Planner
Susan McDermott MSN ANP-BC
Director of Advance Practice Providers Cardiology Division, Massachusetts General Hospital
Keynote Speaker
Patrick O'Gara, MD Professor of Medicine, Harvard Medical School; Director of Strategic Planning for the Cardiovascular Division, Brigham & Women's Hospital
Faculty
Erin Coglianese, MD Assistant Professor of Medicine, Harvard Medical School; Medical Director, Mechanical Cardiac Support Program, Massachusetts General Hospital
Douglas E. Drachman, MD Assistant Professor of Medicine, Harvard Medical School; Director of Education and Interventional Cardiology Fellowship Program, Massachusetts General Hospital
David Dudzinksi, MD Assistant Professor of Medicine, Harvard Medical School; Director of Cardiac Intensive Care Unit, Massachusetts General Hospital
Akl Fahed, MD, MPH Instructor in Medicine, Harvard Medical School; Interventional Cardiologist, Massachusetts General Hospital
J. Sawalla Guseh, MD Instructor of Medicine, Harvard Medical School; Director of Cardiovascular Performance Fellowship Program, Massachusetts General Hospital
Kevin Heist, MD, PhD Associate Professor of Medicine, Harvard Medical School; Cardiac Electrophysiologist, Massachusetts General Hospital
Eric Isselbacher, MD Associate Professor of Medicine, Harvard Medical School; Co-Director, Thoracic Aortic Center, Massachusetts General Hospital
Farouc Jaffer, MD, PhD Associate Professor of Medicine, Harvard Medical School; Director, Coronary Intervention; Director, MGH CTO Percutaneous Coronary Intervention Program, Massachusetts General Hospital
James Januzzi, MD Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School; Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Massachusetts General Hospital
Christopher Learn, MD Instructor in Medicine, Harvard Medical School; Cardiologist, Adult Congenital Heart Disease Specialist, Massachusetts General Hospital
Gregory Lewis, MD Associate Professor of Medicine, Harvard Medical School; Medical Director, Cardiac Transplantation Program, Director, Cardiopulmonary Exercise Testing Laboratory, Massachusetts General Hospital
Moussa Mansour, MD Associate Professor in Medicine, Harvard Medical School; Director, Atrial Fibrillation Program, Massachusetts General Hospital
Theofanie Mela, MD Associate Professor of Medicine, Harvard Medical School; Director, Lead Management Program, Cardiac Electrophysiologist, Massachusetts General Hospital
Pradeep Natarajan, MD Associate Professor of Medicine, Harvard Medical School; Director of Preventive Cardiology, Massachusetts General Hospital
Tomas Neilan, MD, MPH Associate Professor of Medicine, Harvard Medical School; Director, Cardio-Oncology Program, Massachusetts General Hospital
Michelle O'Donoghue, MD, MPH Associate Professor of Medicine, Harvard Medical School; Cardiologist, Brigham and Women's Hospital
Jonathan Passeri, MD Assistant Professor of Medicine, Harvard Medical School; Co-Director of Heart Valve Program & Director of Interventional Echocardiography, Massachusetts General Hospital
Nilay Patel, MD Instructor in Medicine, Harvard Medical School; Interventional Cardiologist, Massachusetts General Hospital
Marc Sabatine, MD, MPH Professor of Medicine, Harvard Medical School; Cardiologist, Massachusetts General Hospital
Rahul Sakhuja, MD, MPP Instructor in Medicine, Harvard Medical School; Interventional Cardiologist, Massachusetts General Hospital
Nandita Scott, MD Assistant Professor of Medicine, Harvard Medical School; Co-Director Corrigan Women's Heart Health Program, Director, Cardiovascular Medicine Section, Massachusetts General Hospital
Jagmeet Singh, MD, PhD Professor of Medicine, Harvard Medical School; Founding Director, Resynchronization and Advanced Cardiac Therapeutics Program, Massachusetts General Hospital
Albree Tower-Rader, MD Instructor in Medicine, Harvard Medical School; Cardiologist, Cardiac Radiologist, Massachusetts General Hospital
Ido Weinberg, MD Associate Professor of Medicine, Harvard Medical School; Director, Vascular Medicine Fellowship, Massachusetts General Hospital
Daniel Zlotoff, MD, PhD Instructor in Medicine, Harvard Medical School; Heart Failure & Transplant Cardiologist, Massachusetts General Hospital
Upon completion of this activity, participants will be able to:
Apply newly acquired knowledge of cardiovascular disease in the care of cardiac patients.
Incorporate the principles of proper evaluation for cardiovascular disease into practice.
Determine the goals to be achieved in the care of cardiovascular patients and implement tools to achieve these goals.
Use diagnostic and therapeutic tools to treat patients with cardiovascular disease appropriately.
Demonstrate active information sharing amongst participants and speakers so that the entire healthcare team in attendance obtains information that can be utilized to improve clinical practice and patient care.
FAIRMONT COPLEY PLAZA 138 ST. JAMES AVENUE BOSTON, MA 02116
PHONE: 617-267-5300
MUST SPECIFY ATTENDING THE UPDATE IN CLINICAL CARDIOLOGY COURSE TO OBTAIN THESE RATES WHEN BOOKING
Single Rate
Double Rate
Moderate & Fairmont Room (One Queen Bed)
$399.00
$399.00
Deluxe Room (One King Bed or Two Double Beds)
$439.00
$439.00
Room assignment is based on guest preferences and availability at the time of request.
Registration Type
Early Bird Rate (Before September 1, 2023)
Standard Rate (After September 1, 2023)
Physicians
$795.00
$895.00
Allied Health Care Professionals
$695.00
$795.00
Residents/Fellows
$600.00
$600.00
Cancellation Policy: Registrations cancelled on or before September 28, 2023 will be refunded, less a $100 administrative fee. Registrations cancelled after September 28, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for Physicians, Nurses, Physician Assistants in the following specialties Cardiology, Critical Care, Emergency Medicine, General Practice, Geriatric Medicine, Hematology/Oncology, Internal Medicine, Interventional Cardiology, Obstetrics/Gynecology, Peripheral Vascular Disease, Primary Care, Pulmonary Disease, and Sports Medicine.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 5.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy This activity provides 5.5 contact hours (5.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-009-L99-P
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 5.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The MGH Pericardial Disease Symposium will be a one-day live virtual course dedicated to providing a contemporary overview of common pericardial diseases, specifically highlighting the presentation, diagnosis, and management of acute pericarditis, recurrent pericarditis, and constrictive pericarditis. The course will feature evidence-based educational strategies including case presentations, didactic lectures, patient perspectives, and complex case round-table discussions to foster an interactive, collaborative, and multi-disciplinary learning environment.
Assistant Inpatient Education Director, Cardiology Division, Associate Program Director for Elective and Subspecialty Training, Internal Medicine Residency Program, Massachusetts General Hospital; Instructor, Harvard Medical School
Chief, Division of Cardiac Surgery, Co-Director of the Corrigan Minehan Heart Center, Massachusetts General Hospital; Professor of Surgery, Harvard Medical School
Cardiac Surgeon, Massachusetts General Hospital; Assistant Professor of Surgery, Harvard Medical School
Faculty
George Blees Patient
Jonathan Hausmann, MD Rheumatologist, Boston Children's Hospital and Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School
Emily Lau, MD, MPH Instructor in Medicine, Harvard Medical School; Director, Hormones & Cardiovascular Disease Clinic, Massachusetts General Hospital
Leonard Lilly, MD Cardiology Section Chief, Brigham and Women's Hospital; Professor, Harvard Medical School
Tomas Neilan, MD, MPH Director, Cardio-Oncology Program, Co-Director, Cardiac MR PET CT Program, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
Michael Picard, MD Cardiologist, Massachusetts General Hospital; Professor, Harvard Medical School
Baileigh Rolfe Patient
Ada Stefanescu, MD Interventional Cardiologist, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Albree Tower-Rader, MD Cardiologist, Massachusetts General Hospital; Instructor of Medicine, Harvard Medical School
Brittany Weber, MD, PhD Director of Cardio-Rheumatology Clinic, Brigham and Women's Hospital; Instructor of Medicine, Harvard Medical School
Session 1: Acute Pericarditis: Upon completion of this activity, participants will be able to:
Identify optimal treatment strategies for acute pericarditis.
Compare different approaches to pericardiocentesis and identify benefits/limitations to each approach.
Recognize signs of connective tissue disease in patients with acute pericarditis and identify common rheumatologic conditions associated with acute pericarditis.
Session 2: Recurrent Pericarditis: Upon completion of this activity, participants will be able to:
Identify hallmark features of recurrent and constrictive pericarditis on advanced cardiac imaging.
Describe the mechanisms of auto-inflammation associated with recurrent pericarditis and identify novel treatment strategies that intercede on these pathways.
Summarize the treatment algorithm for recurrent pericarditis and identify emerging indications for the use of IL-1 inhibitors.
Session 3: Constrictive Pericarditis: Upon completion of this activity, participants will be able to:
Describe the pathophysiology and hemodynamics of constrictive pericarditis.
Recognize echocardiographic manifestations of constrictive pericarditis.
Identify indications for pericardiectomy and compare approaches to surgical treatment
Cancellation Policy: Registrations cancelled on or before February 22, 2024 will be refunded, less a $15 administrative fee. Registrations cancelled after February 22, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for Physicians, Nurses, Physician Assistants in the following specialties Cardiology, Critical Care, Emergency Medicine, General Practice, Geriatric Medicine, Hematology/Oncology, Internal Medicine, Interventional Cardiology, Obstetrics/Gynecology, Peripheral Vascular Disease, Primary Care, Pulmonary Disease, and Sports Medicine.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this enduring material for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Summary of Relevant Financial Relationships
INELIGIBLE COMPANIES Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:
Advertising, marketing, or communication firms whose clients are ineligible companies
Bio-medical startups that have begun a governmental regulatory approval process
Compounding pharmacies that manufacture proprietary compounds
Device manufacturers or distributors
Diagnostic labs that sell proprietary products
Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
MITIGATION STRATEGIES Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners have reported no relevant financial relationship with an ineligible company:
Women with spinal cord injury (SCI) face barriers to health care that may lead to medical conditions going unrecognized or untreated due to attitudinal, environmental, economic, and informational barriers as they navigate the health care system. This educational course will help providers who serve women with SCI build capacity to provide optimal care for women with SCI by reviewing important aspects of primary and specialty care for women with SCI, including:
Health maintenance, well-being, and accessibility
General medical issues related to SCI
Sexual and reproductive health
Pregnancy and peripartum care
Target Audience
This activity is intended for physicians from multiple disciplines.
Learning Objectives
Upon completion of this activity, participants will be able to:
Review elements of effective interprofessional care teams providing comprehensive carefor women with SCI.
Identify relevant components of prenatal care women with SCI.
Describe the importance of facility accessibility for providing care for women with SCI.
Formulate a plan for appropriate health maintenance measures and preventive healthscreening for a woman with SCI based on her age and personal and family history.
Format
This course uses an innovative adaptive learning platform that presents content customized to each learner depending on their baseline level of expertise.
Associate Director of Quality, Spaulding Rehabilitation Network, Mass General Brigham Assistant Professor of Physical Medicine and Rehabilitation, Harvard Medical School Director of Health Policy, Harvard Medical School Department of Physical Medicine and Rehabilitation
This course uses an innovative adaptive learning platform that presents content customized to each learner depending on their baseline level of expertise.
This activity consists of 4 modules. This course uses an innovative adaptive learning platform that presents content customized to each learner depending on their baseline level of expertise.
You may complete the modules in any order. After you have completed each module, return to this page to access the next module.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequities. The goal of the Colloquium is to bring together individuals from healthcare, academia, private/public business sector, and the public at large to develop unique approaches to tackling these inequities. We know that impactful initiatives to promote cancer equity require the skills and experiences of individuals from all these sectors of society. The speakers will reflect a similar mixture of backgrounds. Attendees will have the opportunity to engage with each other and the Cancer Equity Colloquium faculty to potentially develop novel partnerships.
Colin D. Weekes, MD, PhD, FASCO Christopher D. Horner Endowed Chair in Pancreatic Cancer, Director, Pancreatic Cancer Research, Director, Cancer Center Grand Rounds, Director, Equity, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Brenda Lormil-Raymond, MSN, FNP-C Equity Nurse Practitioner, Phase I Research (Termeer Center), Massachusetts General Hospital Cancer Center; Founder, Haitian American Medical Association (HAMA)
FACULTY
Brendan Abel, JD Healthcare Policy & Advocacy Director, Johnson & Johnson; Teaching Faculty, Harvard Medical School Center for Bioethics
Natasha Archer, MD Physician, Dana Farber/Boston Children's Cancer and Blood Disorders Center; Assistant Professor of Pediatrics, Harvard Medical School
Sharl Azar, MD Medical Director, Comprehensive Sickle Cell Disease Treatment Center, Robert K. Kraft Chair in Diversity, Equity, and Inclusion, Massachusetts General Hospital Cancer Center
Lourdes Baezconde-Garbanati, PhD, MPH Associate Dean of Community Initiatives, KSOM USC Distinguished Professor of Population and Public Health Sciences Dept. of Population and Public Health Sciences Associate Director of Community Outreach and Engagement, USC NCCC Director, Center for Health Equity in the Americas (CenHealth) Norris Comprehensive Cancer Center (USC NCCC) Keck School of Medicine (KSOM) University of Southern California (USC)
Aditya Bardia, MD, MPH, FASCO Professor of Medicine, Geffen School of Medicine at UCLA, Director, Breast Oncology Program, Assistant Chief (Translational Research), Division of Medical Oncology, Director of Translational Research Integration UCLA Health Jonsson Comprehensive Cancer Center
Farrah A. Belizaire Founder, LiteWork Events, LLC Diversity Officer, MIT Brain & Cognitive Sciences
Regina Jeanise Brown, MD Senior Medical Director, Clinical Research Physician Early Development, Oncology J&J Innovative Medicine Johnson & Johnson
Taneshia Camillo-Sheffey Consultant, Founder & Director, The Haute House Design Studio MadelNcubator, Inc
Melissa B. Davis, PhD Director, Institute of Translational Genomic Medicine (ITGM) Professor, Department of Microbiology, Biochemistry, and Immunology Morehouse School of Medicine Georgia Research Alliance Distinguished Investigator
Yves M. Duroseau, MD, MPH Chair, Emergency Medicine, Lenox Hill Hospital President, Medical Board, Lenox Hill Hospital Vice President, Western Region Emergency Medicine Service Line, Northwell Health
Fena Fenelon CEO & Founder, Sofenomenal Agency Group, Public Speaker, Cancer Survivor (Colorectal)
Marvella E. Ford, PhD Professor and Vice Chair of Inclusive Excellence, Department of Public Health Sciences Associate Director of Population Science and Community Outreach and Engagement, Hollings Cancer Center Medical University of South Carolina SmartState Endowed Chair, Cancer Disparities Research, South Carolina State University
Richard J. Lee, MD, PhD Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Assistant Physician, Department of Medicine Massachusetts General Hospital Cancer Center
Lisa Lewis, MPH Graduate Student, Harvard Medical School, Center for Bioethics Harvard Medical School, Department of Global Health and Social Medicine
Lady Katlyne D. Louis Founder of Chosen Women of God & Rèspire Retreat & Restoration
Kanisha Louis Jean, MSN, FNP-BC Nurse Practitioner, Family Medicine, CCI Health Services Mentor, Dotson Bridge & Mentorship Program, Simmons University; Founder & President, MelanIN Medicine, Inc.
Luckson Mathieu, MD Senior Clinical Reviewer FDA Division of Oncology 2
Olorunseun O. Ogunwobi, MD, PhD Barnett Rosenberg Professor of Biochemistry and Molecular Biology, Chairperson, Department of Biochemistry and Molecular Biology, Michigan State University
Kenley Preval MD/PhD Student, UMass Medical School; Founder, Improving Academic Medicine Underrepresentation (IAMU)
Sana Raoof, MD, PhD Resident Physician, Memorial Sloan-Kettering Cancer Center
Kerry Reynolds, MD Assistant Professor, Harvard Medical School; Associate Physician, Massachusetts General Hospital Cancer Center Clinical Director, Inpatient Oncology Director, Severe Immunotherapy Complications Service
Veronica Sandoval, PhD, JD Principal, Patient Inclusion & Health Equity Chief Diversity Office, Genentech, A Member of the Roche Group
Lecia Sequist, MD, MPH Director, Cancer Early Detection and Diagnostics Program Massachusetts General Hospital Cancer Center; Landry Family Professor of Medicine, Harvard Medical School
Cardinale Smith, MD, PhD Chief Medical Officer, Tisch Cancer Hospital, The Mount Sinai Hospital Vice President and Chief Quality Officer, Tisch Cancer Center, Mount Sinai Health System Associate Director, Community Outreach and Engagement, Tisch Cancer Institute Professor of Medicine, Division of Hematology/Medical Oncology and Brookdale Department of Geriatrics and Palliative Medicine
Ryan Sullivan, MD Associate Professor, Harvard Medical School; Peter and Ann Lambertus Endowed Chair in Cancer, Director, Center for Melanoma, Massachusetts General Hospital Cancer Center
Erica Stringer-Reasor, MD Associate Professor, Division of Hematology Oncology, Vice Chair for Diversity, Equity, and Inclusion DOM, Director, Breast Cancer Program, O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham
J. Kevin Tucker, MD Vice President, Education, Mass General Brigham Assistant Professor of Medicine, Harvard Medical School
Katia Vincent Spoken Word Artist Sickle Cell Thriver
Clayton C. Yates, PhD John R. Lewis Professor of Pathology, Professor of Pathology, Oncology, Urologic-Oncology, Director for Translational Health Disparities and Global Health Equity Research, Program Co-Leader for Cancer Genetics and Epigenetics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
A limited number of rooms have been blocked at the following nearby hotels for the nights of June 13, 14, and 15. Please see below for booking information.
The meeting venue is accessible via the Assembly Row stop on the Orange Line and MBTA Route 90 Bus from Davis Square. Additionally, there are transportation resources available through Assembly Connect. Assembly Connect programs are free for residents, employees, and visitors to the Assembly Square District of Somerville, MA.
If you choose to drive and park at the MGB Assembly Row parking garage where the event is being held, the parking fees are as follows:
Introduction | Colin D. Weekes, MD, PhD & Brenda Lormil-Raymond, MSN, FNP-C
8:10
Keynote Address | Wayne Frederick, MD, MBA
8:45
Clinical Trial Diversification| Moderator: Colin D. Weekes, MD, PhD Panelists:Luckson Mathieu, MD; Regina Jeanise Brown, MD; Erica Stringer-Reasor, MD
9:45
Intentional Engagement Session
10:00
BREAK*
10:05
The Evolving Therapeutic Paradigm for Sickle Cell Disease: Food for Thought Moderator: Katia Vincent Panelists: Natasha Archer, MD; Sharl Azar, MD; Yves M. Duroseau, MD, MPH
10:55
Cancer From My Lens Moderator: Taneisha Camillo-Sheffy Panelists: Chuck Christian;Fena Fenelon; Natalie Sabga; J. Kevin Tucker, MD
11:55
LUNCH*
12:30pm
Cancer Immunotherapy Moderator: Richard J. Lee, MD, PhD Panelists: Ryan Sullivan, MD & Kerry Reynolds, MD
1:30
Cancer Screening Redefined | Sana Raoof, MD, PhD
2:00
BREAK*
2:15
Disease-Specific Breakout Sessions: Breast | Aditya Bardia, MD, MPH, FASCO & Melissa B. Davis, PhD Colon | Jacquelyne Gaddy, MD, MSc, MSCR & Olorunseun O. Ogunwobi, MD, PhD Prostate | Richard J. Lee, MD, PhD & Clayton Yates, PhD Lung | Lecia Sequist, MD, MPH & Cardinale Smith, MD, PhD
4:00
Intentional Engagement Session
4:15
A Year in Review Moderator: Pastor Cesar Depaz Panelists: Rev. Jean J.M. Louis & Lady Katlyne D. Louis
4:45
Wrap-Up
5:00pm
Adjourn
5:00 - 7:00pm – Welcome Reception
*The exhibit hall will be open during breakfast, breaks, and lunch
Saturday, June 15, 2024 | 8:30am - 4:00pm
8:30am
Breakfast*
9:00
Welcome | Colin D. Weekes, MD, PhD & Brenda Lormil-Raymond, MSN, FNP-C
9:05
Leadership: Catalysts for Transformation | Aithan Shapira, PhD, MFA
9:40
Unique Scientific Approaches to Cancer Genomics | Melissa B. Davis, PhD & Clayton Yates, PhD
10:30
Intentional Engagement Session
10:45
The Power of Community Networking | Moderator: James Hills Panelists: Farrah A. Belizaire; Duclas M. Charles, PharmD; James Hills; Kanisha Louis Jean, MSN, FNP-BC
11:45
Cultivating the Next Generation | Kenley M. Preval
12:10
LUNCH* & Fireside Chat | Wayne Frederick, MD, MBA & Colin D. Weekes, MD, PhD
1:00
Innovative Approaches to Building Community & Academic Partnerships | Moderator: Aditya Bardia, MD, MPH, FASCO Panelists: Lourdes Baezconde-Garbanati, PhD, MPH; Marvella E. Ford, PhD; Cardinale Smith, MD, PhD
2:00
BREAK*
2:10
Activating Advocacy Through Policy Moderator: Lisa Lewis, MPH Panelists: Veronica Sandoval, PhD, JD; Brenda Abel, JD; Geoffrey A. Gallo
3:10
Fireside Chat | Aithan Shapira, PhD, MFA & Colin D. Weekes, MD, PhD
3:55
Closing Remarks
4:00pm
Adjourn
*The exhibit hall will be open during breakfast, breaks, and lunch
Cancellation Policy: Registrations cancelled on or before May 31, 2024 will be refunded, less a $20 administrative fee. Registrations cancelled after May 31, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
ACCOMODATIONS/TRAVEL
A limited number of rooms have been blocked at the following nearby hotels for the nights of June 13, 14, and 15. Please see below for booking information.
The meeting venue is accessible via the Assembly Row stop on the Orange Line and MBTA Route 90 Bus from Davis Square. Additionally, there are transportation resources available through Assembly Connect. Assembly Connect programs are free for residents, employees, and visitors to the Assembly Square District of Somerville, MA.
If you choose to drive and park at the MGB Assembly Row parking garage where the event is being held, the parking fees are as follows:
This activity is intended for Physicians, Nurses, Pharmacists, Psychologists, Physician Assistants, Social Workers, Other members of the healthcare team, General Public, and Patients & Caregivers.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 14.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The care of injured and critically ill patients is complex and challenging. The goal for the Trauma and Acute Care Surgery Symposium at Massachusetts General Hospital, aims to give clear guidelines to practicing clinicians who manage such patients. This symposium offers an ideal mix of the traditional standard-of-care principles with new, cutting-edge information. It explores issues in several areas including resuscitation, surgical techniques, bleeding control, inflammation and infection, respiratory care, nutrition, prehospital care, rehabilitation, and ethics. Multiple learning modalities will be incorporated into the course to engage the learner in the educational process and help them develop new strategies they can apply in their own practice setting.
George Velmahos, MD Division Chief of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital; John F. Burke Professor of Surgery, Harvard Medical School
Faculty
Aalok Agarwala, MD Division Chief, General Surgery Anesthesia, Associate Director, Anesthesia Quality and Safety, Massachusetts General Hospital
Katherine Albutt, MD Department of Surgery, Massachusetts General Hospital
Suzanne Algeri, RN Associate Chief Nurse, Surgical, Orthopedics and Neurosciences, Massachusetts General Hospital
Reza Askari, MD Assistant Professor, Harvard Medical School; Trauma, Burn and Surgical Critical Care, Brigham and Women's Hospital
Matthew Bartek, MD General Surgeon, Critical Care Physician, Palliative Care Physician, Massachusetts General Hospital Salem Hospital
Kristina Bermas, MD Medical Director, Acute Care Surgery and Trauma, Wentworth-Douglass Hospital Surgical Director, Critical Care Unit, Wentworth-Douglass Hospital Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital
Gabriel Brat, MD Assistant Professor of Surgery, Beth Israel Deaconess Medical Center; Assistant Professor of Biomedical Informatics, Harvard Medical School (Secondary)
Gary Brenner, MD, PhD Director, MGH Pain Medicine Fellowship, Massachusetts General Hospital
Christopher Burns, MD Division of Trauma, Burn and Surgical Critical Care, Brigham and Women's Hospital
Jason Cohen, MD Chief Medical Officer, Boston MedFlight
Charles Cook, MD Associate Professor of Surgery, Harvard Medical School; Chief of Acute Care Surgery, Trauma, and Surgical Critical Care, Beth Israel Deaconess Medical Center
Amory de Roulet, MD General Surgeon, Massachusetts General Hospital
Matthew Elson, MD General Surgery, Massachusetts General Hospital
Adam Field, MD Clinical Fellow in Surgery, Brigham and Women's Hospital
Karim Fikry, MD Anesthesiology, Surgical Critical Care, Lahey Hospital & Medical Center
Jonathan Gates, MD Chief, Surgery, Hartford Hospital
Denise Gee, MD Vice Chair, Clinical Operations, Department of Surgery, Surgical Director, Mass General Weight Center Section Head, Swallowing, Heartburn and Esophageal Disease Program, Massachusetts General Hospital
Petrut Gogalniceanu, MD Guy's and St Thomas NHS Trust, King's College, United Kingdom
Robert Goldstone, MD Colorectal Surgeon, Newton-Wellesley Hospital; Staff Surgeon, Massachusetts General Hospital
Jeremy Goverman, MD Burns Service, Surgery, Massachusetts General Hospital
Peter Hedberg, MD General Surgeon, Massachusetts General Hospital Martha's Vineyard Hospital
Nir Hus, MD Trauma Surgeon, Delray Beach Medical Center; Assistant Professor of Surgery, Schmidt College of Medicine, Florida Atlantic University
Shams Iqbal, MBBS Interventional Radiologist, Massachusetts General Hospital
Megan Janeway, MD Surgeon, Acute Care and Trauma Surgery/Surgical Critical Care, Boston Medical Center (BMC); Assistant Professor of Surgery, Boston University Chobanian & Avedisian School of Medicine (CASM)
Haytham Kaafarani, MD Professor of Surgery, Harvard Medical School; Medical Director, Hospital Quality & Safety, Medical Director, Trauma Center, Massachusetts General Hospital
Jane Keating, MD Acute Care Surgery, Hartford Hospital
Edward Kelly, MD Chief, Division of Trauma, Acute Care Surgery & Surgery Critical Care, Baystate Health
David King, MD Trauma and Acute Care Surgeon, Massachusetts General Hospital
David Lawlor, MD Pediatric Surgery, Mass General for Children
Michael Llwellyn, PA-C Lead Physician Assistant for Robotic Surgery, Department of Surgery, Massachusetts General Hospital
Casey Luckhurst, MD Pancreatic and General Surgeon Inpatient Director, Pancreatitis Treatment Center, Massachusetts General Hospital
Adrian Maung, MD Associate Professor of Surgery (General, Trauma & Surgical Critical Care), Trauma Medical Director, Surgery, Surgical Director, Perioperative Services, Surgery Yale School of Medicine
Fred Millham, MD Chief of Surgery, South Shore Hospital
Lauren Nentwich, MD Emergency Medicine Physician, Boston Medical Center (BMC)
Josh Ng-Kamstra, MD Surgeon, Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital
Jonathan Parks, MD General Surgery, Surgical Critical Care, Massachusetts General Hospital Martha's Vineyard Hospital
Erika Rangel, MD Acute Care and General Surgeon Associate Program Director, Surgical Residency Program, Massachusetts General Hospital
Ali Salim, MD Division Chief, Trauma, Burn and Surgical Critical Care, BWH Distinguished Chair in Surgery, Brigham and Women's Hospital Professor of Surgery, Harvard Medical School
Sabrina Sanchez , MD Associate Professor of Surgery Associate Chair for Faculty Development and Diversity, Boston University, Chobanian & Avedisian School of Medicie
Kevin Schuster, MD Professor of Surgery (General, Trauma & Surgical Critical Care), Section Chief, General Surgery, Trauma & Surgical Critical Care, Yale School of Medicine
Sarah Stokes, MD Department of Surgery, Beth Israel Deaconess Medical Center
Crisanto Torres, MD Trauma Surgeon, Boston Medical Center (BMC); Assistant Professor of Surgery, Boston University Chobanian & Avedisian School of Medicine (CASM)
Robert Winchell, MD G. Thomas Shires II Professor of Surgery, Professor of Medical Ethics in Medicine, Chief, Division of Trauma, Burns, Acute and Critical Care, Weill Cornell Medicine
Sara Zhao, MD Interventional Radiologist, Associate Program Director, Interventional Radiology Residency Program, Massachusetts General Hospital Instructor, Harvard Medical School
Upon completion of the activity, participants will be able to:
Apply treatment plans for trauma and acute surgery patients.
Describe indications for operative versus non-operative management after complex emergency surgical problems.
Evaluate challenges related to systems of, and leadership in, patient care.
Create systems to improve quality of trauma care in their own institutions.
Organize multidisciplinary teams to provide well-coordinated care.
Maintenance of Certification (MOC)
American Board of Surgery (ABS) MOC Recognition Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Zero Preventable Deaths: Truly Zero? | Robert Winchell, MD
2:40
Rescue Before The Rescue | Aalok Agarwala, MD
2:50
Discussion
Session X: MODERN TRENDS IN.. Moderator: Ali Salim, MD
3:00
Soft Tissue Reconstruction | Nir Hus, MD
3:15
Hemostatic Agents | David King, MD
3:30
Discussion
Session XI: THE SURVIVOR GAME Moderator: George Velmahos, MD
3:40
A Game of Mystery, Trauma Expertise, and Audience-Seducing Skills | Kevin Schuster, MD; Kristina Bermas, MD; Jane Keating, MD; Megan Janeway, MD; Nir Hus, MD
4:40pm
Adjourn
Tuesday, November 12, 2024 | 7:30am - 4:00pm
Acute Care Surgery
Session XII: WHAT'S NEW IN…. Moderator: Casey Luckhurst, MD
7:30am
Perforated Diverticulitis | Robert Goldstone, MD
7:40
Necrotizing Pancreatitis | Casey Luckhurst, MD
7:50
Non-Operative Cholecystitis | Shams Iqbal, MBBS
8:00
Discussion
Session XII: MESH OR NO MESH OR WHAT MESH? Moderator: Jonathan Parks, MD
8:15
Small Umbilical Hernia: Elective or Strangulated | Reza Askari, MD
8:30
Contaminated/Infected Ventral Hernia | Jonathan Parks, MD
8:45
Parastomal Hernia: Elective or Strangulated | Josh Ng-Kamstra, MD
9:00
Discussion
Session XIII: THE ONE QUESTION THAT MATTERS Moderator: Reza Askari, MD
9:15
Enteral or Parenteral Nutrition? | Edward Kelly, MD
9:25
Which Wound Dressing? | Jeremy Goverman, MD
9:35
How to Come Off Anesthesia Without Coughing? | Jamie Sparling, MD
9:45
When to Give Anticoagulation Reversal? | Karim Fikry, MD
9:55
Discussion
10:00
BREAK
Session XIV: THE MAGIC INTERVENTION IS… Moderator: Edward Kelly, MD
10:30
…Robotic Acute Care Surgery | Michael Llwellyn, PA-C
10:40
…Prediction/Prescription Through AI | Gabriel Brat, MD
10:50
…Surgical Palliative Care | Matthew Bartek, MD
11:00
…Home Hospital | Denise Gee, MD
11:10
Discussion
Session XV: KEYNOTE LECTURE
11:25
Introduction of the Keynote Lecturer | George Velmahos, MD
11:30
Memento Mori | Robert Winchell, MD
12:00pm
LUNCH
Session XVI: THE MAGIC DRUG IS… Moderator: Erika Rangel, MD
1:00
…Controls Persistent Pain | Gary Brenner, MD, PhD
1:15
…Controls Persistent Bleeding | Jonathan Gates, MD
Early Bird Tuition Fees (until September 18, 2024)
Regular Tuition Fees (after September 18, 2024)
Physician (MD/DO)
$800.00
$850.00
Nurse (RN/APRN)
$650.00
$700.00
Resident/Fellow
$550.00
$600.00
Allied Health Professional / Other
$650.00
$700.00
Cancellation Policy: Registrations cancelled on or before October 28, 2024 will be refunded, less a $90 administrative fee. Registrations cancelled after October 28, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for Physicians, Nurses, Nurse Practitioners, Physician Assistants, and other members of the healthcare team who focus on critical care, emergency medicine, general surgery and trauma/acute surgery.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 8 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
MOC COMPLETION CRITERIA
Participant completion for MOC points will be reported to the boards at the conclusion of the course.
Please have your ABIM ID available when completing the evaluation at the end of the course.
Instructions: Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program
Upon successful completion of this activity, if you wish to receive MOC Part 2 points you will need to enter your ABIM ID number in the post-course evaluation. The Mass General Brigham Office of Continuing Professional Development will verify completion of your activity and report to the ABIM. Diplomates must check their ABIM Portfolio for confirmation of your MOC Part 2 points.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 8 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This course provides interactive didactic lectures and video demonstration of management approaches in the multidisciplinary care of patients with acute heart and lung failure. While there are other CME courses offered at regional academic centers, no center offers an integrated course on heart and lung support.
Our Short-term MCS course brings together a uniquely multidisciplinary panel of speakers, not only including cardiologists, cardiothoracic surgeons and pulmonologists, but also respiratory therapists, nurses and palliative care physicians. The course faculty reflects the complexity of care for patients with acute heart and lung failure and illustrates how a team of diverse providers work together to address challenges to improve quality of care.
Assistant Professor of Medicine, Harvard Medical School; Critical Care Cardiologist, Massachusetts General Hospital
Faculty
Erin Coglianese, MD Assistant Professor of Anesthesia, Harvard Medical School; Medical Director, Mechanical Cardiac Support, Massachusetts General Hospital
David Convissar, MD Instructor in Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care and Pain Medicine, Massachusetts General Hospital
Gaston Cudemus, MD Chief, Cardiac Anesthesiology and Medical Director of ECMO Program, NCH Heart Institute
David D'Alessandro, MD Associate Professor of Surgery, Harvard Medical School; Surgical Director, Heart Transplantation and Ventricular Assist Devices, Massachusetts General Hospital
David Dudzinksi, MD Assistant Professor of Medicine, Harvard Medical School; Director of Cardiac Intensive Care Unit, Massachusetts General Hospital
Navin Kapur, MD, FAHA, FACC, FSCAI Associate Professor, Tufts University School of Medicine; Director, Acute Mechanical Circulatory Support Program, Tufts University School of Medicine
Yvonne Lai, MD Assistant Professor of Anesthesia, Harvard Medical School; Anesthesiologist, Critical Care Medicine, Massachusetts General Hospital
Christine McCarthy, CNP Nurse Practitioner, Palliative Care and Geriatric Medicine, Massachusetts General Hospital
Kamal Medlej, MD Instructor in Emergency Medicine, Harvard Medical School; Emergency Medicine Specialist, Critical Care Physician, Massachusetts General Hospital
Ivana Nikoli, MD Instructor in Medicine, Harvard Medical School; Cardiologist, Massachusetts General Hospital
Ali Pitti, CCP, LP, MS Senior Perfusionist, Massachusetts General Hospital
Emily Rubin, MD Instructor in Medicine, Harvard Medical School; Pulmonary and Critical Care Physician, Massachusetts General Hospital
Jonah Rubin, MD Instructor in Medicine, Harvard Medical School; Critical Care Physician and Pulmonologist, Massachusetts General Hospital
Kenneth Shelton, MD Assistant Professor of Anesthesia, Harvard Medical School; Chief, Division of Critical Care, Massachusetts General Hospital
Alyssa Taubert, OT, OTD, OTR, CBIS Doctor of Occupational Therapy, Massachusetts General Hospital
Mauricio Villavicencio, MD Associate Professor of Surgery, Mayo Clinic College of Medicine; Surgical Director of Heart & Lung Transplantation and Mechanical Circulatory Support, Mayo Clinic
Alison Witkin, MD Assistant Professor of Medicine, Harvard Medical School; Associate Director of Pulmonary Hypertension and Thromboendarterectomy, Massachusetts General Hospital
Sarah D. Wright, PT Board Certified Cardiovascular and Pulmonary Clinical Specialist, Doctor of Physical Therapy, Massachusetts General Hospital
Adil Yunis, MD Cardiology Clinical Fellow, Harvard Medical School; Cardiology Division, Massachusetts General Hospital
Upon completion of this activity, participants will be able to:
Describe an Extracorporeal membrane oxygenation (ECMO) circuit including pumps, filters, tubing, safety monitors, oxygenators, heating and cooling elements, and different variations in the set up.
Recognize and explain the different types of cannulae and cannulation strategies for ECMO.
Recognize and manage cardiogenic shock.
Identify and manage acute lung failure.
Recognize the indications for TCS devices (heart pumps, cannula devices, and ECMO).
Diagnose and manage common complications associated with ECMO and other TCS devices.
Interpret hemodynamic data for patients with short-term support.
Evaluate and manage weaning from ECMO and other short term support.
Demonstrate the importance of involving Palliative Care and Ethics in the management of acute heart and lung failure.
Describe the steps in building a multidisciplinary team.
Describe physical therapy strategies to mobilize and “pre-hab” patients on short term support while waiting for heart and lung transplant.
Describe the role of heart transplant and durable mechanical circulatory support in the care of patients with cardiogenic shock.
Determine the latest development of heart and lung support devices in the pipeline.
3 Case Study Presentations with Q&A and Polling |Presented by Fellows; Moderated by Van-Khue Ton, MD, PhD; Jerome Crowley, MD, MPH; Eriberto Michel, MD; Jona Ludmir, MD
10:15
BREAK
Act 2: All of the Bridges
10:25
How and When to Wean Temporary MCS | Jona Ludmir, MD
10:40
Transition from Temporary to Durable MCS | Erin Coglianese, MD
11:10
When You Can't Wean | Christine McCarthy, MD & Emily Rubin, MD
11:25
Panel Q & A
11:40
LUNCH BREAK
PART 2 (Afternoon): Take My Hand, We’ll Make It I Swear Multidisciplinary Care of Patients with Acute Heart/Lung Failure
12:20pm
Welcome Back! | Van-Khue Ton, MD, PhD; Jerome Crowley, MD, MPH; Eriberto Michel, MD; Jona Ludmir, MD
Act 1: Lungs
12:25
Severe ARDS: Considerations for Veno-venous ECMO | Alison Witkin, MD
12:40
Non-ARDS indications for VV ECMO | Jonah Rubin, MD
12:55
Massive PE: Considerations for ECMO | Ivana Nikolic, MD
1:10
Transitioning From Short-Term Support to Lung Transplant | Eriberto Michel, MD
1:25
Panel Q&A
1:40
BREAK
1:45
3 Case Study Presentations with Q&A and Polling | Presented by Fellows; Moderated by Van-Khue Ton, MD, PhD; Jerome Crowley, MD, MPH; Eriberto Michel, MD; Jona Ludmir, MD
2:30
BREAK
Act 2: Advanced Clinical Management
2:35
ECMO 102: Beyond the Basics | Jerome Crowley, MD
2:50
Post-Cardiotomy Shock | Yvonne Lai, MD
3:05
Innovative Approaches to “Pre-Habbing” Patients on Temporary Support | Sarah Wright, PT DPT CCS & Alyssa Taubert, OT, OTD, OTR, CBIS
3:20
Panel Q&A
3:35
BREAK
Act 3: Moving Forward - Future of Temporary Heart/Lung Support
3:40
Building a Multidisciplinary Team (combined talk) | Kamal Medlej, MD & Gaston Cudemus, MD
3:55
Medicolegal Risks of Temporary Support | David Dudzinski, MD, JD
4:10
Over the Horizon: Temporary Heart/Lung Support in the Pipeline | Mauricio Villavicencio, MD
4:25
Panel Q&A
4:35
Complex Case Presentation (ECMO CPC) | Adil Yunis, MD; Kenneth Shelton, MD; Van-Khue Ton, MD, PhD; Jerome Crowley, MD, MPH; Eriberto Michel, MD; Jona Ludmir, MD
4:55
Closing Remarks | Van-Khue Ton, MD, PhD; Jerome Crowley, MD, MPH; Eriberto Michel, MD; Jona Ludmir, MD
Cancellation Policy: Registrations cancelled on or before February 27, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after February 27, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for physicians, nurses, and physician assistants in Anesthesiology, Cardiac Surgery, Cardiology, Critical Care, Hospice and Palliative Care, Internal Medicine, Interventional Cardiology, Pulmonary Disease.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This conference is free of charge thanks to the support of the American Institute for Neuro Integrative Development (AIND), the Genesis Foundation for Children
THIS IS A VIRTUAL COURSE
You will receive the Zoom link upon registering.
More than 10,000 rare diseases are estimated to impact over 30 million Americans. Unfortunately, many individuals remain undiagnosed, leading to prolonged and challenging journeys in pursuit of understanding and proper care. These often place significant burdens on families and strain our medical system. Rapid advancements in genetics have significantly enhanced our diagnostic capabilities and care recommendations, with targeted therapies emerging for select disorders. However, navigating the complex landscape of evaluation and testing options for diagnosis remains a challenge for both families and medical professionals. This program is designed to provide patients, families, and healthcare providers (including both primary and specialty physicians) with the latest insights into a genetic evaluation. Featuring six expert MGH/HMS genetics providers and families of patients, the course covers clinically relevant fundamentals of human genetics, genetic counseling, and the latest technological advancements in diagnostics and therapies.Through engaging lectures and real-life patient perspectives, participants will enhance their understanding of the intricacies surrounding rare genetic disorders. Whether you are a family facing the challenges of diagnosis, a medical provider, or someone with a general interest in the field, this program aims to empower attendees with knowledge to advocate for those affected by these unique conditions.
David Sweetser, MD, PhD - Course Director Clinical Geneticist, Research Scientist, Chief of Medical Genetics and Metabolism, MGH Site Director Undiagnosed Diseases Network, Co-Director Pitt Hopkins Clinic, Massachusetts General Hospital
Frances High, MD, PhD Clinical Geneticist, Research Scientist, Co-Director Klinefelter Syndrome Clinic, Director of Reproductive Endocrinology and Infertility Genetics, Massachusetts General Hospital for Children
Angela Lin, MD Clinical Geneticist, Co-Director Turner Syndrome and Myhre Syndrome Clinics, Director Pediatric Hereditary Hemorrhagic Telangiectasia Center, MassGeneral for Children
Catherine Nowak, MD Clinical Geneticist, Clinical Director, Division of Medical Genetics and Metabolism, Massachusetts General Hospital for Children
Melissa Walker, MD, PhD Neurologist, Research Scientist, Director Neuro-Pediatric Mitochondrial Disorders Clinic, Massachusetts General Hospital for Children
Ashley Wong, MS, LCGC Genetic Counselor, Massachusetts General Hospital for Children Assistant Professor, MGH Institute of Health Professions
Upon completion of this activity, participants will be able to:
Recognize the value as well as strengths, limitations, and pitfalls of genetic testing.
Identify the common diagnostic genetic tests used and gain familiarity with test result interpretation.
Recognize the value of multidisciplinary coordinated care for individuals with rare genetic syndromes.
Recognize genetic disorders currently amenable to targeted therapies and new therapeutic possibilities on the horizon.
ABP MOC RECOGNITION STATEMENT Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 6 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
ABIM MOC RECOGNITION STATEMENT Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 6 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity is intended for Physicians, Nurses, Nurse Practitioners, Dentists, Dieticians, Psychologists, Physician Assistants, and Social Workers across the country, as well as General Public, and Patients & Caregivers.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PLEASE NOTE: The Vasculitis Ultrasound Workshop is an optional add-on
A comprehensive update on vasculitis and polymyalgia rheumatica (PMR), with an optional hands-on vasculitis ultrasound workshop. Sessions will discuss the diagnosis and treatment of vasculitis and PMR. The course will feature high-yield talks from world-renowned physician-investigators conducting research on vasculitis and related conditions including giant cell arteritis (GCA), PMR, Takayasu’s arteritis (TAK), and ANCA-associated vasculitis (granulomatosis with polyangiitis [GPA], microscopic polyangiitis [MPA] and eosinophilic granulomatosis with polyangiitis [EGPA]). This course targets the practicing rheumatologist, rheumatology trainee, and allied health professional including nephrologists, pulmonologists, otorhinolaryngologists, neurologists and others interested in learning about important advances in the field of vasculitis and PMR in recent years.
Sebastian H. Unizony, MD Co-Director, Rheumatology Vasculitis Program, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School
Rheumatology Vasculitis Program. Dr Unizony’s main academic interests include the use of clinical and translational research methods to advance the treatment in systemic vasculitides and related disorders including giant cell arteritis and polymyalgia rheumatica. He is a member of the Pan American League of Associations for Rheumatology (PANLAR) vasculitis group that has published treatment guidelines for giant cell arteritis, Takayasu’s arteritis and ANCA-associated vasculitis. A list of his publications can be found in the following link: https://pubmed.ncbi.nlm.nih.gov/?term=Unizony+S&sort=date
Mark A. Matza, MD, MBA, RhMSUS Clinical Director, Rheumatology, Medical Director, Medical Infusion Center Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Dr. Mark A. Matza is a board-certified rheumatologist at the Massachusetts General Hospital in Boston, Massachusetts where he serves as the Clinical Director of Rheumatology and the Medical Director of the Medical Infusion Center. He received his undergraduate degree from Yale University and both MD and MBA degrees from Georgetown University. He completed internal medicine training at the Mount Sinai Hospital in New York City and rheumatology fellowship at the Massachusetts General Hospital. He is certified in musculoskeletal ultrasound through the American College of Rheumatology (RhMSUS). Dr. Matza has clinical and research interests in giant cell arteritis and started the GCA Fast Track Program at MGH in 2019, providing urgent ultrasound and clinical evaluation of patients suspected of having GCA. He has lectured and instructed on the use of ultrasound at both USSONAR and ACR.
Minna J. Kohler, MD, RhMSUS (Vasculitis Ultrasound Workshop Co-Director) Director, Rheumatology Musculoskeletal Ultrasound Program, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Minna Kohler, M.D. RhMSUS is the founder and Director of the Rheumatology Musculoskeletal Ultrasound (MSKUS) Program at MGH. She completed a clinical/research rheumatology fellowship at Yale University School of Medicine. Prior training includes 3 years of general surgery residency, 2 years of the NIH-sponsored fellowship in Image-Guided Therapy in the Department of Radiology at Brigham and Women's Hospital, and internal medicine residency at Lahey Clinic. Dr. Kohler received diagnostic/ interventional MSKUS training in the Yale MSKUS program for surgeons in the Department of Orthopaedics/Rehabilitation. She developed the MGH rheum ultrasound training curriculum and actively teaches MSKUS to MGH Rheumatology, IM, & Emergency Departments, Spaulding PM&R residents, and Harvard medical students. Dr. Kohler serves as key faculty for MGH rheumatology and the Spaulding PM&R residency programs (rotation director for rheumatology and ultrasound). She also serves as adjunct faculty to the MGH CURE (Center for Ultrasound Research Education) in the Department of Emergency Medicine. Dr. Kohler is a graduate of the USSONAR (Ultrasound School of North American Rheumatologists) program and serves as a faculty mentor for training ultrasound to rheumatologists nationally. She is the director of the MGB MSKUS at the POC CME course and has been a pioneer in promoting ultrasound training through the American College of Rheumatology (ACR). She has been an invited speaker and instructor for numerous courses nationally and internationally. Dr. Kohler has educational/research interests in point-of-care ultrasound related to arthritis, tendinitis, bursitis, vasculitis, and other rheumatic diseases. Other clinical and research interests include osteoarthritis, crystal arthritis (gout, pseudogout), psoriatic arthritis, seronegative spondyloarthropathies, rheumatoid arthritis, and immunotherapy related or cancer-related inflammatory arthritis.
Faculty
John Stone, MD, MPH Professor of Medicine, Harvard Medical School; The Edward A. Fox Chair in Medicine, Massachusetts General Hospital; Executive Chairman, The IgG4ward! Foundation
Research: I co-founded the Vasculitis Center at Johns Hopkins University and directed a multi-center, randomized clinical trial in Wegener's granulomatosis. The results of this trial were published in The New England Journal of Medicine (2005). I am currently the Co-PI of a second multi-center clinical trial in ANCA-associated vasculitis: Rituximab in ANCA-Associated Vasculitis HRAVe). The primary results of this trial were recently published in The New England Journal of Medicine (2010).
My most current research interest pertains to an emerging disease known as IgG4-related systemic disease (IgG4-RSD). My research group at the MGH made the seminal observation that rituximab therapy leads to the targeted reduction of the IgG4 subclass of immunoglobulins in this disorder.
Teaching: I gave the Sir James Cameron Lecture at the Royal College of Physicians (Edinburgh) in 2003. I delivered the Dunlop-Dottridge Lecture at the Canadian Rheumatology Association (2007) and gave the Woodbury Lecture at Dalhousie University in 2010. I have written and edited a textbook entitled A Clinician’s Pearls & Myths in Rheumatology (Springer). Two editions of this book have been published, most recently in 2023.
Peter Merkel, MD, MPH Chief, Division of Rheumatology Professor of Medicine and Epidemiology, University of Pennsylvania
Dr. Merkel is the Chief of Rheumatology and a Professor of Medicine and Epidemiology at the University of Pennsylvania. Dr. Merkel is an internationally recognized research and clinical expert in vasculitis, scleroderma, and other systemic autoimmune diseases, and is an author on over 400 scientific publications. He is the Principal Investigator of the Vasculitis Clinical Research Consortium (VCRC) and the Vasculitis Patient-Powered Research Network (VPPRN), two leading international research infrastructures for clinical investigation in vasculitis. Dr. Merkel’s research focuses on clinical trial design and conduct, outcome measure development, clinical epidemiology, genetic epidemiology, and biomarker discovery.
Dr. Merkel received his MD from Yale University, his MPH from Harvard University, completed his residency training at the Hospital of the University of Pennsylvania and his fellowship at the Massachusetts General Hospital/Harvard Medical School. He has been a faculty member at Harvard Medical School, Boston University School of Medicine, and now the University of Pennsylvania School of Medicine. Dr. Merkel has received the majority of his research support from the National Institutes of Health, the US Food and Drug Administration, the Patient-Centered Outcomes Research Institute, with additional funding from industry sources and private foundations.
Michael E Wechsler, MD, MMSc Professor of Medicine, National Jewish Health Director, NJH Cohen Family Asthma Institute, Associate Vice President, Innovation & Industry Relations in the Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA
Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at NJH in Denver, Director of the National Jewish Health (NJH)/Cohen Family Asthma Institute and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Professor Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, tezepelumab and depemokimab. He has published more than 325 manuscripts relating to asthma, EGPA and eosinophilic lung diseases and has been an investigator in over 60 clinical trials. He was a member of the Steering Committee and site Principal Investigator of the NIH-sponsored Asthma Clinical Research Network (ACRN/AsthmaNet), a multicentre asthma clinical trials consortium, and currently serves as the PI of the Denver site of the Precision Intervention in Severe/Exacerbating Asthma (PRECISE) network. A member of the American Society of Clinical Investigation and the Association of American Physicians, he has participated in many different task forces related to the study of eosinophilic lung diseases that were sponsored by the NIH, the FDA, the European Respiratory Society and the International Eosinophil Society. He is currently Associate Editor of the journal Chest and has served as Associate Editor of the journal Allergy and on the editorial board of the European Journal of Clinical Investigation.
Tanaz A Kermani, MD Division of Rheumatology, University of California Los Angeles; Clinical Professor of Medicine, Founder and Director, Multi-Disciplinary Vasculitis Program, UCLA
Dr. Tanaz Kermani is the Founder and Director of the multi-disciplinary Vasculitis Program at UCLA. She completed her residency and rheumatology fellowship at the Mayo Clinic followed by an additional 2 years of training in vasculitis as part of the NIH-sponsored Vasculitis Clinical Research Consortium. She joined the UCLA Health's Division of Rheumatology in 2012 where she is a full-time clinician. She is an active researcher with projects that include international collaborative efforts in vasculitis. Her primary research interest is in large-vessel vasculitis where she has published extensively.
Kaitlin A. Quinn, MD Staff Clinician, Vasculitis Translational Research Program, Associate Director, Rheumatology Fellowship Training Program, National Institutes of Health (NIH)
Kaitlin Quinn M.D. received her medical degree from New York Medical College. She completed her internal medicine residency training and rheumatology fellowship training at Georgetown University Hospital. She subsequently completed a two-year Vasculitis Clinical Research Consortium - Vasculitis Foundation Fellowship within the NIAMS Vasculitis Translational Research Program where she focused on vasculitis from a clinical and research perspective. Dr. Quinn is board certified in Internal Medicine and Rheumatology.
Dr. Quinn’s research interests include clinical research in many different types of vasculitis. Primarily, her research has focused on imaging in large-vessel vasculitis, including giant cell arteritis and Takayasu’s arteritis. She has also conducted studies in ANCA-associated vasculitis and has an interest in the development of outcome measures in vasculitis. She is involved in the OMERACT Vasculitis Working Group.
Eli Miloslavsky, MD Rheumatology, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
Dr. Miloslavsky specializes in the diagnosis and treatment of vasculitis and other systemic diseases such as inflammatory myopathy and sarcoidosis among others. His research has focused on outcomes and treatment of ANCA-Associated Vasculitis and glucocorticoid toxicity.
Dr. Miloslavsky also has a strong interest in medical education. He currently teaches at MGH and Harvard Medical School where he holds several leadership roles. Within medical education his research has focused on simulation, consultative medicine, science education and peer teaching.
Dr. Miloslavsky graduated from the Icahn School of Medicine at Mount Sinai and completed his internal medicine residency and rheumatology fellowship at MGH.
Naomi Patel, MD, MPH Rheumatology, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Naomi Patel is a practicing adult rheumatologist and clinical researcher. Dr. Patel is a graduate of the David Geffen School of Medicine at the University of California, Los Angeles. She completed her Internal Medicine internship, residency, and chief resident year at Stanford and then completed her rheumatology fellowship at Massachusetts General Hospital and pursued a Master of Public Health degree through the Harvard T. H. Chan School of Public Health. She enjoys seeing and working with patients in the Rheumatology Clinic with a variety of rheumatic diseases, with a specialization in vasculitis. With >60 peer-reviewed publications in the medical literature, Dr. Patel receives grant funding to conduct research in quantifying and assessing the impact of glucocorticoids in rheumatic diseases. She has also served as an investigator in multiple clinical trials and conducts clinical epidemiologic research evaluating the impact of rheumatic diseases and immunosuppressive medications on the outcomes of COVID-19 infection and post-acute sequelae of COVID-19. She is an active member and participant in the American College of Rheumatology and its subcommittees.
Belen Arevalo, MD Rheumatology, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Dr. Belen Arevalo is a board-certified rheumatologist. She received her medical degree from the University of Azuay Medical School in Ecuador and completed her medicine residency at Mount Sinai Morningside/West in New York where she served as chief resident for an additional year. She completed her rheumatology fellowship at The University of Chicago and following her fellowship she joined the Rheumatology Department at Massachusetts General Hospital. In addition to seeing patients with general rheumatologic conditions, Dr. Arevalo’s clinical interest includes vasculitis which stems from significant exposure to patients with various vasculitides and having been involved in research projects studying the cardiovascular risk in different rheumatic conditions including vasculitis. She is part of the Vasculitis Program at MGH.
Guy Katz, MD Rheumatologist, Division of Rheumatology, Allergy, & Immunology, Department of Medicine, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School
Dr. Guy Katz is a rheumatologist and clinician-investigator in the Division of Rheumatology, Allergy, & Immunology at the Massachusetts General Hospital (MGH). He is a member of the MGH IgG4-Related Disease Center, Rheumatology Vasculitis Program, and Rheumatology and Allergy Clinical Epidemiology Research Center. He received his medical degree from the Icahn School of Medicine at Mount Sinai and completed a residency in internal medicine at the Thomas Jefferson University Hospital followed by a fellowship in rheumatology at the Massachusetts General Hospital. Dr. Katz specializes in the treatment of systemic immune-mediated diseases including IgG4-related disease and systemic vasculitis. He conducts clinical epidemiology and translational research on IgG4-related disease and ANCA-associated vasculitis, with particular interests in mechanisms leading to organ damage, long-term disease outcomes, and management strategies that balance disease control and treatment-associated harm. He has serves as a principal investigator and sub-investigator on clinical trials in multiple diseases, including IgG4-related disease, ANCA-associated vasculitis, and systemic lupus erythematosus. In addition to research and clinical care, Dr. Katz has been actively involved in the American College of Rheumatology, previously serving on the Fellows-in-Training Subcommittee of the Committee on Training and Workforce, the Annual Meeting Planning Committee, and the Committee on Ethics and Conflicts of Interest.
Instructors
Hamid Shokoohi, MD, MPH Director, Emergency Ultrasound Fellowship, Director, Emergency Ultrasound Research, Massachusetts General Hospital; Associate Professor of Emergency Medicine, Harvard Medical School
Myma Albayda, MD, MPH Associate Professor of Medicine, Director, Rheumatology Fellowship Program, Director, Musculoskeletal Ultrasound and Injection Clinic, Johns Hopkins University
Room Blocks: There are limited room blocks for attendees of the course at the Kimpton Marlowe Hotel (venue) and Wyndham Hotel Beacon Hill (5-minute drive from venue). For instructions on booking at the preferred rate in either room block, please contact davodea@mgh.harvard.edu.
Other Lodging Options:
Holiday Inn Express & Suites Boston - Cambridge (10-minute walk)
Hampton Inn Boston/Cambridge (10-minute walk)
Fairfield Inn & Suites Boston Cambridge (10-minute walk)
The Kendall Hotel (15-minute walk)
The Boxer Boston (5-minute drive)
citizenM Boston North Station hotel (5-minute drive)
Upon completion of this activity, participants will be able to:
Become confident in the use of the various imaging modalities available for the diagnosis and longitudinal monitoring of patients with large vessel vasculitis (e.g., vascular ultrasound, advanced vascular imaging [CTA, MRI/MRA, PET]) while understanding strengths, limitations and performance of each modality.
Employ the ability to create a comprehensive management plan for patients with large vessel vasculitis and PMR including immunomodulation, prevention of treatment-related side-effects, and longitudinal monitoring for disease relapse and disease-related vascular damage.
Understand the indications of tocilizumab for patients with GCA, recognizing its limitations and current knowledge gaps (e.g., treatment duration) while identifying alternatives for patients failing tocilizumab treatment.
Understand the role of sarilumab for patients with PMR
Employ the ability to create a comprehensive management plan for patients with small vessel vasculitis including immunomodulation, prevention of treatment-related side-effects, and longitudinal monitoring for disease relapse and disease-related damage.
Understand when and how to use avacopan for the treatment of GPA and MPA
Understand the role of plasma exchange for patients with AAV
Understand when and how to use IL-5 blockade therapy for patients with EGPA
Hands-On Ultrasound Workshop:
Upon completion of this activity, participants will be able to:
Illustrate the role of ultrasound in the diagnosis of GCA.
Describe the scanning protocol for large vessel vasculitis and review key considerations.
Assess sonographic findings in vasculitis.
Demonstrate how fast-track clinics can improve the care for patients with GCA.
Perform hands-on vasculitis ultrasound training in small groups under expert faculty supervision.
Current Treatment of Giant Cell Arteritis: IL-6 Blockade and Beyond | John H. Stone, MD, MPH
11:40
What is the Role of Biologics and Other Glucocorticoid-Sparing Agents in the Treatment of Polymyalgia Rheumatica | Sebastian Unizony, MD
12:20pm
Lunch Break
1:50
Standard of Care and Future Perspective for Takayasu’s Arteritis | Tanaz A. Kermani, MD
2:30
Towards No Glucocorticoid Use for ANCA-Associated Vasculitis: Avacopan and Other Treatments in the Pipeline | Peter Merkel, MD, MPH
3:10
To PLEX or not to PLEX? What is the Current Role for Plasma Exchange in ANCA-Associated Vasculitis | Guy Katz, MD
3:40
Afternoon Break
4:00
When and How to Use Eosinophil-targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis | Michael Wechsler, MD, MMSc
4:40
Not Everything is Immunosuppression in Vasculitis. Adjunctive Treatments (glucocorticoid-induced osteoporosis prevention, immunizations, cardiovascular disease prevention) | Naomi Patel, MD, MPH
5:20
Panel: Vasculitis Treatment Q&A | Peter Merkel, MD, MPH Guy Katz, MD Michael Wechsler, MD, MMSc Naomi Patel, MD, MPH Tanaz A Kermani, MD Sebastian Unizony, MD
5:50
Conclusion Remarks
6:00pm
Adjourn
*Please Note: Agendas Are Subject To Change
Vascular Ultrasound Workshop
Saturday, March 29, 2025 | 7:30am - 11:30am
7:30am
Welcome and Introduction to Vasculitis Ultrasound | Mark A. Matza, MD, MBA, RhMSUS & Minna J. Kohler, MD, RhMSUS
7:35
Basics of Vasculitis Ultrasound: Machine & Doppler Settings, and Protocol | Mark A. Matza, MD, MBA, RhMSUS
8:05
Live Demonstration: Temporal and Axillary Artery | Mark A. Matza, MD, MBA, RhMSUS
8:15
Hands on Vasculitis Ultrasound Scanning: Temporal Arteries | Mark A. Matza, MD, MBA, RhMSUS Minna J. Kohler, MD, RhMSUS Hamid Shokoohi, MD, MPH Myma Albayda, MD
9:15
Morning Break
9:30
Pitfalls, Tips, and Tricks in Vasculitis Ultrasound | Mark A. Matza, MD, MBA, RhMSUS & Minna J. Kohler, MD, RhMSUS
9:45
Clinical Cases in Vasculitis Ultrasound | Mark A Matza, MD, MBA, RhMSUS
10:00
Hands on Vasculitis Ultrasound Scanning: Axillary and Temporal Arteries | Mark A. Matza, MD, MBA, RhMSUS Minna J. Kohler, MD, RhMSUS Hamid Shokoohi, MD, MPH Myma Albayda, MD
Cancellation Policy: Registrations cancelled on or before March 14, 2025 will be refunded, less a $40 administrative fee. Registrations cancelled after March 14, 2025 will not be refunded.
Contact mgbcpd@mgb.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 9.50 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ABA MOC Statement
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
ABS MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
ABOHNS MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose.
In the United States, almost 40% of all inpatient procedures are performed on patients aged 65 and older; at MGB trauma centers over 50% of injured patients are older adults, the majority of whom are frail. To prepare our healthcare system to care for growing numbers of older adults who have increasing medical and psychosocial complexity, front line clinicians including Advanced Practice Providers (APPs), surgical trainees, nurses, and surgical attendings urgently need more training in geriatric syndromes and the 5 pillars of Age-Friendly care (Medication, Mobility, what Matters, Mentation and Multicomplexity). This training will address the needs of the growing number of geriatric patients, and avoid hazards of hospitalization such as delirium, falls, infections, and loss of function, and reduce caregiver strain. These issues are particularly relevant in surgery and trauma where mortality, complications, and other adverse outcomes are consistently higher for older patients than their younger counterparts. Moreover, national stakeholders including CMS and the American College of Surgeons are setting standards for geriatric surgical care that clinicians must be prepared to meet. Evidence suggests that geriatric-focused clinical pathways can reduce delirium, ICU stays, length of stay, and readmissions in older surgical patients. Clinicians will benefit from in depth training in geriatric care to enable the implementation of structures and processes to improve outcomes.
Zara Cooper, MD, MSc Michele and Howard J. Kessler Distinguished Chair of Surgery and Public Health Kessler Director, Center for Surgery and Public Health Director, Center for Geriatric Surgery, Brigham and Women’s Hospital Professor of Surgery, Harvard Medical School
Rachelle Bernacki, MD, MS Director of Care Transformation and Postoperative Services, Center for Geriatric Surgery, Brigham and Women’s Hospital Director of Quality Initiatives, Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School
Julia Loewenthal, MD Geriatrician, Division of Aging, Brigham and Women’s Hospital Assistant Program Director, Internal Medicine Residency Program, Brigham and Women’s Hospital Instructor in Medicine, Harvard Medical School
Andrea Wershof Schwartz, MD, MPH Geriatrician, Division of Aging, Brigham and Women’s Hospital Associate Professor of Medicine, Harvard Medical School Associate Director, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System
Course Planners
Amy Bulger, RN, MPH, GERO-BC, CPHQ Director of Geriatrics Operations, Center for Geriatric Surgery and Department of Nursing, Brigham and Women’s Hospital
Lynne O'Mara, MPAS, PA-C Clinical Program Manager, Center for Geriatric Surgery, Brigham and Women’s Hospital Senior Administrator of Inpatient Operations, Brigham and Women’s Hospital
Course Speakers
Roman Belenkiy, PharmD, BCGP Transitions of Care Pharmacist, Brigham and Women’s Hospital
Christy Cauley, MD, MPH Colorectal and Gastrointestinal Surgeon, Massachusetts General Hospital Director of Research, MGH Colorectal Surgery Assistant Professor, Harvard Medical School
Sevdenur Cizginer, MD, MPH, AGSF Assistant Professor of Medicine, Harvard Medical School Geriatrician, Massachusetts General Hospital
Stacie Deiner, MD, MS LeRoy Garth Professor and Vice Chair for Research, Department of Anesthesiology, Dartmouth Hitchcock Medical Center
Laura Frain, MD, MPH Geriatrician, Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital Instructor in Medicine, Harvard Medical School
Esteban Franco Garcia, MD, AGSF Instructor in Medicine, Harvard Medical School Program Director, Geriatric Medicine Fellowship, Massachusetts General Hospital Director, Geriatric Inpatient Fracture and Trauma Service, Massachusetts General Hospital
Tamryn Fowler Gray, PhD, RN, MPH Clinical Specialist, Department of Medical Oncology, Division of Stem Cell Transplantation and Cellular Therapies Research Scientist, Phyllis F. Cantor Center for Research in Nursing and Patient Services, Dana-Farber Cancer Institute Instructor in Medicine, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School
Masaya Higuchi, MD, MPH, CMD, AGSF Medical Director, MGH Perioperative Optimization of Senior Health Program (POSH) Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital Instructor in Medicine, Harvard Medical School
Houman Javedan, MD Clinical Director, Division of Aging, Brigham and Women’s Hospital Assistant Professor of Medicine, Harvard Medical School
Nancy Latham, PhD, PT Clinical Research Director, Research Division of Men’s Health, Aging and Metabolism, Brigham and Women’s Hospital Lecturer in Medicine, Harvard Medical School
Deborah Lee, MD Geriatrician, Massachusetts General Hospital Instructor in Medicine, Harvard Medical School
Sharon Levine, MD Section Head, Geriatric Medicine, Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital Professor of Medicine, Director of Geriatrics Education Innovation, Boston University School of Medicine
Elizabeth Lilley, MD, MPH Surgical Oncologist, Brigham and Women’s Hospital Affiliate Faculty, Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute Associate Program Director, Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship, Harvard Medical School
Ariela Orkaby, MD, MPH Geriatrician, Director of Frailty Research, Division of Aging, Brigham and Women’s Hospital Associate Director for Research Training, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System Assistant Professor of Medicine, Harvard Medical School
Cancellation Policy: Registrations cancelled on or before February 29, 2024 will be refunded, less a $45 administrative fee. Registrations cancelled after February 29, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Please note: up to 13.5 credits will be awarded if you attend both the symposium AND Immunotherapy Toxicities optional session.
If you attend the symposium only, you will be awarded up to 11.5 credits. If you attend the Immunotherapy Toxicities optional session only, you will be awarded up to 2 credits.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 13.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please note: up to 13.5 MOC points will be awarded if you attend both the symposium AND Immunotherapy Toxicities optional session.
If you attend the symposium only, you will be awarded up to 11.5 MOC points. If you attend the Immunotherapy Toxicities optional session only, you will be awarded up to 2 MOC points.
Please Note: This course has two components you can register for. You can either register for the symposium only, Immunotherapy Toxicities session only, or both
Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. For clinicians trying to keep current with advancing immuno-oncology principles and research, the pace of these developments has brought new challenges. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field.
This year we have added an optional session on Immunotherapy Toxicities, focusing on the identification and management of common and uncommon toxicities from immune-checkpoint inhibitors. Attendance at this session, entitled “Sink or Swim: Navigating the Murkey Waters of Immunotherapy Toxicities” is optional and available for an additional fee. It will take place after the close of the general session on the second day. Attendance at the Advances in Cancer Immunotherapy symposium is NOT required to attend this toxicities session, you may register to ONLY attend this part of the program.
Registration Type
Symposium Tuition Fee
Symposium AND Afternoon Toxicities Session Tuition Fee
Justin Gainor, MD Director, Center for Thoracic Cancers, Director of Targeted Immunotherapy, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Krista Rubin, MS, FNP-BC Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital Cancer Center
Ryan Sullivan, MD Physician Investigator, Cancer Center, Mass General Research Institute; Assistant In Medicine, Hematology-Oncology, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
Faculty
Steven Blum, MD Instructor in Medicine, Massachusetts General Hospital
Priscilla Brastianos, MD Associate Professor of Medicine, Harvard Medical School; Physician Investigator, Mass General Research Institute; Assistant Physician, Massachusetts General Hospital Cancer Center
Daniel P. Cahill, MD, PhD Professor of Neurosurgery, Harvard Medical School; Neurosurgical Oncologist, Department of Neurosurgery, Massachusetts General Hospital
Michael Dougan, MD, PhD Massachusetts General Hospital
Riley Fadden, MSN, RN, FNP-C Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital Cancer Center
Alexander Faje, MD Massachusetts General Hospital
Christine Freedman, RN Massachusetts General Hospital Cancer Center
Xin Gao, MD Assistant in Medicine, Massachusetts General Hospital Cancer Center; Assistant Professor, Harvard Medical School
Elizabeth Gerstner, MD Associate Professor of Neurology, Harvard Medical School; Department of Neurology, Massachusetts General Hospital
Amanda Guidon, MD, MPH Massachusetts General Hospital
Rakesh Jain, PhD Director, Steele Laboratory, Massachusetts General Hospital; A. Werk Cook Professor of Radiation Oncology, Harvard Medical School
Howard Kaufman, MD Assistant in Surgery, Surgery, Massachusetts General Hospital; Lecturer in Surgery, Harvard Medical School
Florence (Katie) Keane, MD Assistant Professor in Radiation Oncology, Massachusetts General Hospital
Meghan Mooradian, MD Instructor, Medicine, Harvard Medical School; Clinical Oncologist, Medial Oncology, Massachusetts General Hospital Cancer Center
Iman Osman, MD Rudolf L. Baer Professor of Dermatology, Ronald O. Perelman Department of Dermatology, Professor, Department of Medicine, Professor, Department of Urology, NYU Langone Health
Patrick Ott, MD, PhD Clinical Director, Melanoma Disease Center, Director, Clinical Sciences, Center for Immuno-Oncology, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School
Jong Chul Park, MD Assistant Professor of Medicine, Massachusetts General Hospital Cancer Center
Michael Parsons, PhD Associate Professor of Psychology, Harvard Medical School; Neuropsychologist, Pappas Neuro-Oncology Center, Department of Psychiatry, Massachusetts General Hospital
Laura Petrillo, MD Palliative Care Physician, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School
Kerry Reynolds, MD Clinical Director, Inpatient Oncology Units, Director, Severe Immunotherapy Complications Program, Massachusetts General Hospital Cancer Center
Sherin J. Rouhani, MD, PhD Inpatient Oncologist, Massachusetts General Hospital Cancer Center
Kurt Schalper, MD, PhD Associate Professor of Pathology, Director, Translational Immuno-oncology Laboratory, Yale School of Medicine
Arlene Sharpe, MD, PhD Kolokotrones University Professor, Chair, Department of Immunology, Harvard Medical School
Alexandra-Chloe Villani, PhD Director, Single-Cell Genomics Program, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School; Associate Scientist, Broad Institute of MIT and Harvard
Oladapo Yeku, MD, PhD, FACP Physician Investigator, Mass General Research Institute; Assistant Professor of Medicine, Harvard Medical School; Assistant in Medicine, Massachusetts General Hospital Cancer Center
A limited number of rooms have been held at the Boston Marriott Copley Place for the nights of November 13, 14, and 15 at a rate of $279.00 per night. To book a room in the block, please click HERE or call the hotel directly at 1-800-228-9290. The deadline to book is Wednesday, October 23, 2024.
Upon completion of this activity, participants will be able to:
Evaluate cancer immunotherapy principles and strategies and how they influence current treatment approaches.
Identify the emerging role of personalized cancer vaccination and other immunotherapy combinations in patients with solid tumor and hematologic malignancies.
Define currently approved and emerging predictive biomarkers for cancer immunotherapy.
Recognize and implement management strategies for immune-mediated side effects in patients treated with immunotherapy agents.
Recognize the importance of establishing a multidisciplinary approach in the immunotherapy era.
Welcome | Justin Gainor, MD; Krista Rubin, MS, FNP-BC; Ryan Sullivan, MD
8:05
Predicting Response and Toxicity to Immune Check Point Inhibition: Is There a Simple (but Not Simplistic) Way | Iman Osman, MD
8:35
Q&A
8:45
Biomarkers Debate: Blood vs. Tissue | Iman Osman, MD (Blood) vs. Kurt Schalper, MD, PhD (Tissue)
9:15
Q&A
9:25
Incorporating Biomarker Analysis into Optimal Treatment Selection | Kurt Schalper, MD, PhD
9:55
Q&A
10:05
BREAK*
10:20
Balancing the Risks & Benefits of Peri/Post-Operative Immunotherapy| Ryan Sullivan, MD
10:50
Q&A
11:00
Panel Discussion: Incorporating Checkpoint Inhibitors into Multidisciplinary Brain Metastases Care | Priscilla Brastianos, MD; Daniel Cahill, MD, PhD; Elizabeth Gerstner, MD; Katie Keane, MD; Michael Parsons, PhD
12:00 pm
RAPID FIRE!!! What’s Next in Immunotherapy?
Intralesional strategies – Jong Chul Park, MD
Personalized cancer vaccines – Patrick Ott, MD, PhD
New generation – Xin Gao, MD
12:30
Q&A
12:40
Wrap-Up Session | Justin Gainor, MD; Krista Rubin, MS, FNP-BC; Ryan Sullivan, MD
1:00 pm
Adjourn
*The exhibit hall will be open during breakfast, breaks, and lunch
Sink or Swim: Navigating the Murky Waters of Immunotherapy Toxicities Identification and management of common and uncommon toxicities from immune-checkpoint inhibitors
1:30 pm
Introduction | Krista Rubin, MS, FNP-BC
1:35
Endocrine Toxicities | Alexander Faje, MD
1:55
Q&A
2:05
Oral Toxicities| Nathaniel Treister, DMD, DMSc
2:25
Q&A
2:35
BREAK
2:45
NeuroMuscular Toxicities | Amanda Guidon, MD, MPH
3:05
Q&A
3:15
Gastrointestinal Toxicities| Michael Dougan, MD, PhD
Symposium AND Afternoon Toxicities Session Tuition Fee
Physicians
$199.00
$235.00
Fellows/Nurses/PAs/etc.
$99.00
$135.00
Industry
$499.00
$549.00
Afternoon Toxicities Session ONLY
N/A
$50.00
Cancellation Policy: Registrations cancelled on or before October 31, 2024 will be refunded, less a $35 administrative fee. Registrations cancelled after October 31, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School (HMS) faculty will be joined by renowned national and international experts from the International Society of University Colon and Rectal Surgeons (ISUCRS) to explore the latest advancements in surgical treatments for benign diseases of the colon and rectum. The program will feature hands-on cadaver courses, co-taught by Harvard faculty and distinguished leaders in the field, including Dr. Arun Rojanasakul (Thailand), Dr. Gabriela Moeseline (Germany), Dr. Mark Soliman (USA), and Dr. Stephen Goldstone (USA), who have graciously agreed to serve as guest workshop co-directors. These sessions will provide unforgettable hands-on experiences, covering topics such as anal fistula, pilonidal disease, robotic surgery, laparoscopic techniques, and HRA procedures.
The event will also include two days of live and virtual lecture sessions, featuring updates from world-class surgeons from around the globe, including Dr. Joseph Nunoo Mensah (UK), Dr. Lucia Oliveira (Brazil), Dr. Carlo Ratto (Italy), Dr. Ayca Gultekin (Turkey), Dr. Gonsalo Hagerman (Mexico), and many others. Live and virtual lectures will be enhanced with videos and interactive content, offering participants a comprehensive learning experience. Expect spirited debates and challenging case discussions, ensuring a dynamic and engaging experience for both seasoned surgeons and novice colorectal learners.
Be sure to bring your APP team to learn alongside us while enjoying the charm of Boston in the spring, right in the heart of its historic downtown. Finally, for the brave at heart, join our poster competition! Three lucky winners will have the opportunity to present their work as part of our meeting and win cash prizes.
Special Discounts: ISUCRS members are eligible for a 15% discount, while surgeons from low-income countries can receive a 30% discount on registration fees.
Liliana Bordeianou, MD Professor of Surgery, Harvard Medical School; Co-Director, MGH Pelvic Floor Disorders Center, Co-Chair, Mass General Brigham Colorectal Surgery Collaborative, Massachusetts General Hospital
Christy Cauley, MD Assistant Professor Harvard Medical School; Colorectal Surgeon, Gastrointestinal Surgeon Massachusetts General Hospital
International Faculty
Joseph Nunoo Mensah, MD, FASCRS Colorectal Surgeon at Kings College Hospital and Cleveland Clinic London,UK; Head of the Department of Colorectal Surgery; Former President of the International Society of University Colon and Rectal Surgeons (ISUCRS) from 2022-24.
Arun Rajanasakul , MD, FASCRS Emeritus Prof at the Banpakok International Hospital in Bangkok, Thailand: Honorary FASCRS (USA), PSCS (Phillipines), ACRSI (India) and SSCS (Singapore) Fellow; Past president of the Colorectal Surgery Committee of Thailand and the Coloproctology Association of Asia-Pacific; Inventor of the LIFT (Ligation Intersphincteric Fistula Tract) Procedure
Lucia Oliveira, MD Director of the Anorectal Physiology department, Cepemed, Rio de Janeiro, Brazil; Board Member of ALAPP (Latin American Pelvic Floor Society)
Carlo Ratto, MD, FASCRS Prof. Ratto is the Chief of the Unit of Proctology and Pelvic Floor Surgery at the Isola Tiberina Gemelli Hospital in Rome, Italy, and Hon FASCRS (USA)
Ayca Gultekin, MD Professor of Surgery, Zonguldak Bulent Ecevit University School of Medicine, Turkey; Editor in Chief, Turkish Journal of Colorectal Disease; Assistant Secretary, UEMS (European Union of Medical Specialists) Section of Surgery-Coloproctology; Chair of Pelvic Floor Disorders Group, Turkish Society of Colon and Rectal Surgery
Gabriela Moseline, MD Professor of Surgery and Dept. Head of the newly established Center for Hereditary Tumors at the Academic Hospital of the University of Düsseldorf Ev. BETHESDA in Duisburg, Germany; Director of InSiGHT (International Society for Hereditary Gastrointestinal Tumors) Former Secretary of ESCP (European Society for Coloproctology) from 2016 – 2020 and ESCP Program Director(2020-2024)
Gonzalo Hagerman, MD , FASCRS Professor, Universidad Panamericana, Mexico; Staff Surgeon, Department of Surgery, ABC Hospital, Mexico City; President Sandra Sucar Foundation; Past president Mexican Bord of Specialists in Diseases of Colon and Rectum
Dhatchai Charoesilavath, MD Associate Professor of Surgery, Chulalongkorn University, Bangkok, Thailand Colorectal Surgeon, Chulalongkorn Hospital Bangkok, Thailand
USA Faculty
David A. Kleiman, MD, MSc, FACS, FASCRS Staff colorectal surgeon in the Division of Colon & Rectal Surgery at Lahey Hospital & Medical Center, Assistant Professor of Surgery at Tufts University School of Medicine
Julia Saraidaridis, MD, FACS, FASCRS Staff colorectal surgeon in the Division of Colon & Rectal Surgery at Lahey Hospital & Medical Center , Assistant Professor of Surgery at Tufts University School of Medicine; National PI on the BLINQ Study and the ASCRS Anorectal QI Taskforce
Mark K. Soliman, MD, MBA Chief of Colorectal Surgery and Program Medical Director, AdventHealth Digestive Health Institute; Chair of Colorectal Surgery, AdventHealth Medical Group
Will Perry, MD, MPH Assistant Professor of Surgery at Mayo Clinic Colon and rectal surgeon at the Mayo Clinic, Rochester, MN Honorary Fellow at Oxford University Hospitals NHS Trust
Margarita Murphy, MD Associate Professor, Florida State University; Colon and Rectal Surgeon at the Orlando Health Colon and Rectal Institute Affiliated Assistant Professor, Medical University of South Carolina Medical School
Lilias Maquire, MD Assistant Professor of Surgery, Perelman School of Medicine, University of Pennsylvania Colorectal Surgeon, Corporal Michael J. Crescenz Memorial VA Medical Center Director of Colorectal Research, University of Pennsylvania
Maggie Westfal, MD Assistant Professor, Medical University of South Carolina 4th Year Medical Student Clerkship Director; Division of Colorectal Surgery Medical University of South Carolina
Stephen Goldstone, MD Assistant Clinical Professor in Surgery, Icahn School of Medicine at Mount Sinai, New York Principal Investigator of the ANCHOR Study Group
Jennifer Davids, MD Section Chief of Colorectal Surgery, Boston Medical CenterNaomi Sell Goldsmith, MD
Naomi Sell Goldsmith, MD Colon and Rectal Surgeon at Winchester Hospital, MA
Lillian Chen, MD Assistant Professor of Surgery, Tufts Medical School Colon and rectal surgeon at Tufts Medical Center
Angela Khunen, MD Assistant Professor of Surgery Tufts University School Of Medicine Colorectal Surgery Fellowship Program Director, Lahey Clinic, MA
David Kleiman, MD Staff Surgeon, Lahey Hospital and Medical Center Assistant Professor of Surgery, Tufts University School of Medicine
Julia Saraidaridis, MD Staff Surgeon, Lahey Hospital and Medical Center Assistant Professor of Surgery, Tufts University School of Medicine
Thomas Peponis, MD Assistant Professor of Surgery, Department of Surgery/Division of Colon and Rectal Surgery, UMass Chan Medical School
Jason Hall, MD, MPH Chairman and Surgeon-in-Chief, Department of Surgery, Tufts Medical Center Professor and Benjamin Andrews Chair of Surgery, Tufts University School of Medicine Interim Director, Tufts Medical Center Cancer Center
Olga Berezneva Assistant Professor of Surgery, Boston University, Chobanian and Avedisian School of Medicine; Colorectal surgeon at Boston Medical Center
Mass General Brigham and Harvard Faculty
Kyle Staller, MD Associate Professor of Medicine, Harvard Medical School Director, Gastrointestinal Motility Laboratory at Massachusetts General Hospital Member, Clinical and Translational Epidemiology Unit at Massachusetts General Hospital
Dana Fugelso, MD Instructor in Surgery, Harvard Medical School Beth Israel Deaconess Medical Center
Joel Goldberg, MD Assistant Professor of Surgery, Harvard Medical School Brigham and Women's Hospital
William Kastrinakis, MD Chief of General Surgery at the North Shore Medical Center, Salem, MA Surgical Director of the Mass General/Northshore Cancer Center
Rob Goldstone, MD Assistant Professor of Surgery, Harvard Medical School Massachusetts General Hospital
Grace Lee, MD Assistant Professor of Surgery, Harvard Medical School Colorectal Surgeon, Massachusetts General Hospital and Salem Hospital
Rich Hodin, MD Professor of Surgery, Harvard Medical School Division Chief, Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital
Ron Bleday, MD Associate Professor of Surgery, Harvard Medical School Chief, Section Colon and Rectal Surgery, Brigham and Women's Hospital Vice Chair in Surgery for Quality and Safety Co-Chair, Mass General Brigham Colorectal Surgery Collaborative
Rocco Ricciardi, MD Associate Professor of Surgery, Harvard Medical School Chief, Section Colon and Rectal Surgery, Massachusetts General Hospital
Todd Francone, MD Associate Professor of Surgery, Tufts Medical School Division Chief, Colon and Rectal Surgery, Newton Wellesley Hospital
Lieba Savitt, NP-C; WHNP-BC, MSN, MBA APP Clinical Manager Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital
Beth O'Dea, NP Nurse Practitioner, Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital
Hiroko Kunitake, MD Associate Professor of Surgery, Harvard Medical School Colorectal Surgery Fellowship Director, Massachusetts General Hospital Chair, Perioperative Senior Health Clinic, Massachusetts General Hospital
Jonathan Glickman, MD Associate Professor of Surgery, Harvard Medical School
Holly Bonnette, ANP-BC Nurse Practitioner, Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital; Lead APP, Colorectal Surgery Center and Center for Pelvic Floor Disorders
Daniel Worrall, ANP-BC Nurse Practitioner, Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital
Upon completion of this activity, participants will be able to:
Describe advances in anal fistula, pilonidal cyst, hemorrhoids, and anal fissure management.
Identify the current controversies in the management of patients with diverticulitis.
Review the current treatment pathways and appreciate the nuanced surgical options available to patients with inflammatory bowel disease.
Describe the importance of having multidisciplinary team input to manage complex pelvic floor conditions.
Discuss international differences in management of benign colorectal diseases and the importance of international exchange of ideas in surgery.
Practice new technical skills by participating in hands on workshops on a range of procedures including robotic, laparoscopic, anorectal, and high resolution anoscopy.
SUBMIT AN ABSTRACT FOR A POSTER PRESENTATION
The deadline for poster submission is March 1, 2025,
All accepted posters will be scored and judged on Thursday, April 3, 2025 or Friday April 4, 2025 by a panel and will be exhibited electronically throughout the meeting.
Prizes
1st Place
$500 + Presentation on Saturday, April 5 + Complimentary Registration for the Main Course, 2026
2nd Place
$250 + Presentation on Saturday, April 5 + Complimentary Registration for the Main Course, 2026
3rd Place
$100 + Presentation on Saturday, April 5 + Complimentary Registration for the Main Course, 2026
Submission Rules:
Abstract must be in English, their length must not exceed 3000 characters not including spaces and the headers.
Abstracts should include : Title, Background, Methods, Results, and Conclusion. The authors and affiliations do not count towards this limit.
Submission of an abstract requires a paid registration of the first author. Following registration, please email your abstract to lbordeianou@mgh.harvard.edu
Only one abstract may be submitted per first author. Once received, a confirmation will be sent to the submitting author
The submitting author is responsible for the content of the abstract and the consent to submit on behalf of all co-authors
Maintenance of Certification (MOC)
American Board of Surgery (ABS) MOC Recognition Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
ISUCRS members and Low-Income Country registrants will receive discounted tuition rates. Please use the appropriate code (listed below) at checkout:
ISUCRS Members will receive 15% off when the following code is used: ISUCRS15
Low-Income Country registrants will receive 30% off when the following code is used: LIC30
Faculty: Lucia Oliveira, MD; Carlo Ratto, MD; Maggie Westfal, MD; Joseph Nunoo Mensah, MD; Dhatchai Charoensilavath; Naomi Goldsmith, MD
An intensive course on advanced anal fistula repair and pilonidal sinus. We will cover sophisticated anal fistula and pilonidal decision-making though lectures, videos and a hands-on cadaver lab
Option IV. High Resolution Anoscopy Hands-On Workshop
Course Directors: Grace Lee, MD and Holly Bonnette, MD (Harvard, USA) Honorary Guest Course Director: Stephen Goldstone, MD (Mt Sinai, USA)
Faculty: Danna Fugelso, MD; Daniel Worral, NP; Grace Lee, MD; Holly Bonnette; Lieba Savitt, NP; Lillian Chen, MD; Beth O’Dea NP; Jonathan Glickman
Bring yourself and your APP team to improve your familiarity, comfort, and expertise with HRA through lectures, videos, and a hands-on session in a simulation model.
Main Course: Friday, April 4, 2025 | 7:00am - 5:00pm
7:00am
Registration (a light continental breakfast will be served)
7:40
Welcoming Remarks | Liliana Bordeianou, MD
7:50
What is the ISUCRS and Why Are We Here | Joseph Nunoo-Mensah, MD (Great Britain)
Morning Session I: International Anorectal Masterclass: Spotlight on Anal Fistula
Moderators: Hiroko Kunitake, MD & Joel Goldberg, MD Panelists: Rocco Ricciardi MD; Tod Francone, MD; Naomi Goldsmith, MD; Rob Goldstone MD; Jennifer Davids, MD; Gabriela Moseline, MD; Margarita Murphy, MD; Arun Rajanasakul (Thailand); Lucia Oliveira, MD (Brazil); Carlo Ratto, MD (Italy); Joseph Nunoo-Mensah, MD (Great Britain); Ayca Gultekin, MD (Turkey)
8:00am
What Did I Lean on my 4000th Fistula Surgery: Simplified anogenital anatomy and comprehensive anal fistula patterns | Arun Rajanasakul ( Thailand )
8:20
Successful Anal Fistula Surgery Benefits from Preoperative Imaging: A Case for Endoanal Ultrasound | Lucia Oliveira, MD (Brazil)
8:30
Fistulotomy With and Without Immediate Primary Repair | Carlo Ratto, MD (Italy)
8:40
Why we should stop using setons | Dhatchai Charoensilavath (Thailand)
9:00
Role and place of VAAFT, FiLAC, Fistura, OTSSC Clip and Fixcision in your Anal Fistula Surgery Arsenal: Serious Procedures or Just Hype ? | Joseph Nunoo-Mensah, MD (Great Britain)
9:10
Horseshoe Fistula: Now What? | Ayca Gultekin, MD (Turkey)
9:20
Paul Shellito, MD Lectureship Series - Advanced Anal Fistula Surgery: Partition and Intervention | Introduction by: Hiroko Kunitake, MD Speaker: Arun Rajanasakul (Thailand)
9:45
Panel Discussion
10:20
Break and Posters Walk Through
Morning Session II: International Pelvic Floor Masterclass: Spotlight on Rectal Prolapse
Moderator: Liliana Bordeianou MD Panelists: Carlo Ratto, MD (Italy); Lliana Bordeianou, MD (USA); Joseph Nunoo-Mensah, MD (Great Britain); Will Perry, MD (USA); Arun Rajanasakul, MD; Lieba Savitt, NP; Olga Berezneva, MD; Gonzalo Dhatchai Charoensilavath (Thailand);Hagerman, MD; Margarita Murphy, MD; David Kleiman, MD; Lucia Oliveira, MD; Ayca Gultkein, MD; Rob Goldstone, MD
10:30
Surgery in Patients with Visible External Rectal Prolapse and High-Grade Internal Rectal Intussusception: The European View | Carlo Ratto, MD (Italy)
10:40
Surgery in Patients with Visible External Rectal Prolapse and High-Grade Internal Rectal Intussusception: The USA View | Lliana Bordeianou, MD (USA)
10:50
Surgery in Patients with Visible External Rectal Prolapse and High-Grade Internal Rectal Intussusception: The UK View | Joseph Nunoo-Mensah, MD (Great Britain)
11:00
Recurrent Rectal Prolapse: What Now? | Will Perry, MD (USA)
11:20
Panel Discussion
11:50
Break
Morning Session III: International Anorectal Masterclass: Spotlight on Hemorrhoids, Anal Fissures and Pilonidal Disease
Moderator: Grace Lee, MD Panelists: Julia Saraidaridis, MD (USA); Gonzalo Hargerman, MD (Mexico); Naomi Goldsmith, MD; Joseph Nunoo-Mensah, MD; Will Perry, MD; Gabriela Moeseline, MD; Liliana Bordeianou, MD; Rocco Ricciardi, MD; Lilias Maquire, MD; Thomas Peponis, MD; Carlo Ratto, MD; Holly Bonnette, MD
12:00pm
Anal Fissure: BLINQ, Please | Julia Saraidaridis, MD (USA)
12:10
Hemorrhoids : Anything New To Offer Since WWII | Gonzalo Hargerman, MD (Mexico)
12:20
Complex Pilonidal Diseases: My Favorite Flaps, How I Do Them, and Why | Margarita Murphy, MD (USA)
12:30
Panel Discussion
1:00
Lunch (complimentary) and Poster Walk Through
Afternoon Session I: The Evolution of Diverticulitis Treatment
Moderators: Christy Cauley, MD; William Kastrinakis, MD Panelists: Julia Saraidaridis, MD (USA); Thomas Peponis, MD (USA); William Kastrinakis, MD (USA); Tod Francone MD, Joel Goldberg MD; Maggie Cassidi, MD; Grace Lee MD, Lilian Chen, MD, Rocco Ricciardi MD, Olga Berezneva, MD ; Gonzalo Hagerman, MD: David Kleiman, MD; Jen Davids, MD; Rob Godlstone, MD
2:00
Why Did I Get Diverticulitis and Can I Prevent it From Coming Back? | Julia Saraidaridis, MD (USA)
2:10
Should We Stop Giving Antibiotics to Admitted Patients with Diverticulitis: Lessons from the STAND, AVOD and DIABOLO trials | Thomas Peponis, MD (USA)
2:20
How Long Can One Sit on a Stable Patient with Perforated Diverticulitis – and Does it Make Sense to Do It? | William Kastrinakis, MD (USA)
Debate: When To Operate on Patients With Recurrent Diverticulitis
2:30
Setting the Debate Scene: Patient Focused Decision Making in Diverticulitis. How to Decide Who Benefits from an Elective Sigmoid Colectomy? | Jason Hall, MD (USA)
2:45
Arguments for Prompt Surgery: “Enough Already! Just Take The Colon O-U-T OUT!” | Joseph Nunoo Mensah, MD (Great Britain)
3:00
Arguments for Medical Therapy: “ There are Many Effective Strategies to Prevent Recurrent Diverticulitis: First, Do No Harm” | Lilias Maquire, MD (USA)
3:15
Rebuttal | Joseph Nunoo Mensah, MD (Great Britain)
3:20
Rebuttal | Lilias Maquire, MD(USA)
3:25
Discussion, Vote, and Crowning of Winner
Afternoon Session II
3:30
Robotic Sigmoid Resection for Complicated Diverticulitis : Key Technical Points To Master As You Progress On Your Learning Curve | Mark Soliman, MD (USA)
3:50
Goodbye, Hartman or Not Quite Yet? | Gabriela Moeseline, MD (Germany)
4:00
Panel Discussion
5:00pm
Adjourn
Main Course: Saturday, April 5, 2025 | 7:00am - 5:00pm
7:00am
Breakfast
Morning Session I: Current Surgical Challenges in Inflammatory Bowel Disease Management
Moderators: Rob Goldstone, MD & Richard Hodin, MD Panelists: David Kleiman, MD (USA); Jennifer Davids, MD (USA); Gabriela Moseline, MD (Germany); Richard Hodin, MD (USA); Maggie Cassidy, MD (USA); Will Perry, MD; Joseph Nunoo Mensah, MD;Ronald Bleday, MD; Liliana Bordeianou, MD; Christy Cauley, MD; Tod Francone, MD; Joel Goldberg, MD; Grace Lee, MD; Thomas Peponis, MD; Rocco Ricciardi MD
8:00am
Primer on IBD Meds for the Surgeon: What to Hold and What to Keep Preop and Postop | David Kleiman, MD (USA)
8:10
Surgical Bailouts for a Technically Challenging IPAA: Know Your Options | Jennifer Davids, MD (USA)
8:30
Ernest Codman Lectureship Series: Is Continent Ileostomy In or Out of Fashion Again? Introduction by: Christy Cauley, MD Speaker: Gabriela Moseline, MD (Germany)
9:00
Segmental or Total Colectomy in UC patients with Dysplasia: Do We Have Any Data for a Rational Decision | Richard Hodin, MD (USA)
9:10
Ileocecal Resection with Various Anastomotic Techniques | Maggie Cassidy, MD (USA)
9:20
Does Diversion Have a Place in A Patient with Ileocecal Crohn’s? | Will Perry, MD
9:30
Approaching the Patient with Fistulizing Crohn’s Disease | Joel Goldberg, MD (USA)
9:40
Panel Discussion
10:15
Break
Morning Session II: Complications , Misadventures and Missed Opportunities
Moderator: Todd Francone, MD Panelists: Rob Goldstone, MD; Marc Soliman, MD (USA); Joseph Nunoo-Mensah, MD (Great Britain); Olga Berezneva, MD (USA); Rocco Ricciardi, MD (USA); Lucia Oliveira, MD (Brazil); Lilian Chen, MD (Germany); Grace Lee, MD (USA); Kyle Staller, MD (USA); Carlo Ratto, MD (Italy); Gonzalo Hagerman, MD (Mexico); Margarita Murphy, MD (USA); Ronald Bleday, MD; Liliana Bordeianou, MD; Christy Cauley, MD; Tod Francone, MD; Joel Goldberg, MD; Jennifer Irani, MD; Grace Lee, MD; Rocco Ricciardi, MD
10:30
Parastomal Hernia | Rob Goldstone, MD (USA)
10:40
My Colonic Conduit is Dead/Does Not Reach? | Marc Soliman, MD (USA)
10:50
Presacral Bleeding | Joseph Nunoo-Mensah, MD (Great Britain)
11:00
Stapler Does Not Fit or Pass Through a Kink | Olga Berezneva, MD (USA)
11:00
Anastomotic Leak | Rocco Ricciardi, MD (USA)
11:20
Challenging Stoma | Lucia Oliveira, MD (Brazil)
11:30
Ghost Ileostomy vs. Early Ileostomy Closure: Which Approach Makes More Sense To Me? | Lilian Chen, MD (Germany)
11:40
Postoperative Ileus | Grace Lee, MD (USA)
11:50
Is Surgery for Slow Transit Constipation Still A Thing? | Kyle Staller, MD (USA)
12:00pm
Obstetric Anal Sphincter Injury | Carlo Ratto, MD (Italy)
12:10
On Rectovaginal Fistula and Other Surgical Principles Re-Learned During My Missions in Africa | Gonzalo Hagerman, MD (Mexico)
12:20
Is There New Hope for Fecal Incontinence Patients? | Margarita Murphy, MD (USA)
12:30
Panel Discussion
1:00
Lunch (complimentary)
Afternoon Session: No More Data: Just Show Us What You Do!
Moderator: Rocco Ricciardi, MD
2:00
Anal Fistula: My Favorite Approach | Carlo Ratto, MD (Italy)
2:10
Anal Fistula: My Favorite Approach | Dhatchai Charoensilavath (Thailand)
2:20
Anal Fistula: My Favorite Approach | Joseph Nunoo Mensah, MD (Great Britain)
2:30
Anal Fistula: My Favorite Approach | Lucia Oliveira, MD (Brazil)
2:40
Pilonidal Cyst: My Favorite Approach | Thomas Peponis, MD (USA)
3:00
Pilonidal Cyst: My Favorite Approach | Will Perry, MD (USA)
3:10
Pilonidal Cyst: My Favorite Approach | Ayca Gultekin, MD (Turkey)
3:20
Useful Intra- Op Tricks: Using ICG to Your Patient’s Advantage | Olga Berezneva, MD (USA)
3:30
Rectal Prolapse: My Favorite Approach | Liliana Bordeianou, MD (USA)
ISUCRS members and Low-Income Country registrants will receive discounted tuition rates. Please use the appropriate code (listed below) at checkout:
ISUCRS Members will receive 15% off when the following code is used: ISUCRS15
Low-Income Country registrants will receive 30% off when the following code is used: LIC30
Thursday Hands On Workshops ONLY (In-Person):
Hands-On Workshop ONLY
Early Bird (ends March 1)
After March 1
(MD, NP, PA, Students, Fellows)
Robotic Cadaver Hands-On Lab
Laparoscopic Cadaver Hands-On Lab
Anal Fistula Masterclass Cadaver Lab
$1150.00
$1250.00
HRA Hands-On Workshop
MD
$125.00
$150.00
NP, PA
$80.00
$100.00
Students & Fellows
$5.00
$5.00
Friday & Saturday Main Course ONLY (In-Person or Virtual):
Tuition Type
Early Bird (ends March 1)
After March 1
MD
$400.00
$450.00
NP, PA
$300.00
$350.00
Students & Fellows (In-Person)
$35.00
$50.00
Students & Fellows (Virtual)
$5.00
$5.00
Thursday Workshop AND Friday/Saturday Main Course:
Tuition Type
Early Bird (ends March 1)
After March 1
Main Course AND Hands-On Workshop (Thu-Sat)
Robotic Cadaver Hands-On Lab
Laparoscopic Cadaver Hands-On Lab
Anal Fistula Masterclass Cadaver Lab
$1350.00
$1400.00
Main Course AND HRA Lab Combo (Thu-Sat) - MD
$450.00
$500.00
Main Course AND HRA Lab Combo (Thu-Sat) - NP, PA
$350.00
$400.00
Main Course AND HRA Lab Combo (Thu-Sat) - Students & Fellows
$35.00
$50.00
Cancellation Policy: Registrations cancelled on or before March 20, 2025 will be refunded, less a $50 administrative fee. Registrations cancelled after March 20, 2025 will not be refunded.
Contact mgbcpd@mgb.org if you require assistance in cancelling your online registration.
This activity is intended for general surgeons, colorectal surgeons, gastroenterologists, urogynecologists, nurse practitioners, physician assistants, nurses, and students.
Massachusetts General Hospital, a teaching affiliate of Harvard Medical School in collaboration with the International Society of University Colorectal Surgeons (ISUCRS) and Mass General Brigham
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Midlife Women’s Health 2024 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.
In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of gynecologic cancers, vascular disease, parathyroid disease and thyroid nodules, vulvovaginal disorders, lung cancer, cardiovascular health, attention deficit hyperactivity disorder, sexuality after cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients.
Jan L. Shifren, MD - Course Director Jan L. Shifren, MD is a reproductive endocrinologist at the Massachusetts General Hospital and Director of the MGH Midlife Women’s Health Center. She is the Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Dr. Shifren focuses her research on menopause, including the effects of estrogens, androgens and alternative therapies on menopausal symptoms and sexual function. She is a past President of the Menopause Society.
Allison Baker, MD Allison Baker, MD is a psychiatrist with the Perinatal and Reproductive Psychiatry Clinical Research Program at the Massachusetts General Hospital and an Instructor in Psychiatry at Harvard Medical School. Her current research focuses on the course and treatment of ADHD in women during pregnancy and postpartum.
Don Dizon, MD Don Dizon, MD is the Director of the Pelvic malignancies Program at Lifespan Cancer Institute, Head of Community Outreach & Engagement at Legorreta Cancer Center, and the Director of Medical Oncology at Rhode Island Hospital. Nationally, he is the Vice Chair for Diversity, Equity, Inclusion, and Professional Integrity at SWOG Cancer Research Network. He also is a founding member of the Collaboration for Outcomes using Social Media in Oncology. His research foci include novel treatment of ovarian, uterine, and cervical cancers; communication; survivorship after cancer especially in sexuality; professional social media use; and advocacy on behalf of the sexual and gender minoritized communities.
Anahita Dua, MD, MS, MBA Anahita Dua, MD, MS, MBA is a vascular surgeon at the Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School. At MGH, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program, associate director of the Wound Care Center, director of the Lymphedema Center, associate director of the Vascular Surgery Clerkship, and director of clinical research for the division of vascular surgery.
Rajshri Gartland, MD, MPH Rajshri Gartland, MD, MPH is an endocrine surgeon and surgical oncologist at the Massachusetts General Hospital with expertise in the surgical treatment of benign and malignant thyroid, parathyroid, and adrenal diseases. Dr. Gartland's clinical and research interests focus on the practice and advancement of endocrine surgery, particularly through innovative and minimally-invasive techniques. She co-founded and leads the Thyroid Radiofrequency Ablation Program at MGH and serves as Surgical Director of the NWH Thyroid Biopsy Clinic and Assistant Chief Quality Officer at MGH.
Allison Gockley, MD Allison Gockley, MD is a gynecologic oncologist in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Dr. Gockley’s research interests include the surgical treatment of gynecologic cancers, gestational trophoblastic neoplasia, advanced endometrial cancer and onco-fertility.
Linda Kelly, DNP, ANP-BC Linda Kelly, DNP, ANP-BC is an advanced practice provider at the Massachusetts General Hospital. She is the Nursing Director of the Midlife Women's Health Center in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital.
Deborah Kwolek, MD Deborah Kwolek, MD is a primary care physician at the Massachusetts General Hospital and the founding lead of the Women’s Health and Sex and Gender Medicine Program at the MGH and Harvard Medical School. Dr Kwolek is co-editor of the textbook, Sex- and Gender-Based Women’s Health: A Practical Guide for Primary Care. She is Chair of the Society of General Internal Medicine’s Women and Medicine Commission and serves as Co-Chair of the American Medical Women’s Association’s Sex and Gender Health Collaborative’s mentoring committee. Dr. Kwolek directs the HMS Primary Care Internal Medicine Course and the Women's Health Resident Rotation at MGH.
Varvara Mazina, MD Varvara Mazina, MD is a gynecologic oncologist in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Dr. Mazina’s research interests include multidisciplinary and translational collaboration for management of gynecologic malignancies, surgical innovation and education, and improvement of quality of life of cancer patients and survivors.
Alisa Pascale, DNP, WHNP-BC Alisa Pascale, DNP, WHNP-BC is a women's health nurse practitioner in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital. Her clinical interests include routine gynecologic care across the lifespan, contraceptive management, perimenopausal issues and LGBTQ health. She has clinical expertise in vulvar and vaginal disorders, including chronic vaginitis, and vulvar skin disorders such as lichen sclerosis. Dr. Pascale is a clinical instructor in the Women's Health program at the MGH Institute of Health Professions.
Isaac Schiff, MD Isaac Schiff, MD is the Chief, Department of Obstetrics and Gynecology, Emeritus, at the Massachusetts General Hospital and the Joe Vincent Meigs Distinguished Professor of Gynecology at Harvard Medical School. He is Co-Director of the MGH Midlife Women’s Health Center. Dr. Schiff is an internationally known expert in menopause, a founding member of the Menopause Society, and the Editor-in-Chief of the journal, Menopause.
Lecia Sequist, MD, MPH Lecia Sequist, MD, MPH is a medical oncologist in the Center for Thoracic Cancers at the Massachusetts General Hospital and Program Director, Cancer Early Detection and Diagnostics Clinic. She holds the Mary B Saltonstall Endowed Chair in Oncology at MGH and is the Landry Family Professor of Medicine at Harvard Medical School. Dr. Sequist's research focuses on studying novel targets and targeted agents for lung cancer treatment and in detecting and studying the significance of tumor cells circulating in the bloodstream.
Ahmed Tawakol, MD Ahmed Tawakol, MD is a cardiologist at the Massachusetts General Hospital. He is Co-Director of the Cardiac MR PET CT Program. Dr. Tawakol's research focuses on developing novel diagnostic approaches and treatment strategies for atherosclerosis. He leads several multi-center trials to evaluate interventions targeting plaque inflammation and is evaluating the potential clinical role of vascular PET imaging for improving the identification of patients at highest risk for atherothrombotic events.
Other Health Care Professionals & Physicians-in-Training
$125
AFTERMARCH 29, 2024
Registration Type
Tuition Fee
Physician
$295
Other Health Care Professionals & Physicians-in-Training
$150
Cancellation Policy: Registrations cancelled on or before March 29, 2024 will be refunded, less a $35 administrative fee. Registrations cancelled after March 29, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
Please contact our Course Coordinator at MGHMidlifeCenter@mgh.harvard.edu prior to the event to assist you with any special needs.
This educational activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Please note, access to symposium recordings is included with registration. Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.
Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma
P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School
Faculty:
Jeremy Abramson, MD Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center Associate Professor of Medicine, Harvard Medical School
Andrew Brunner, MD Assistant Professor of Medicine, Harvard Medical School Massachusetts General Hospital Cancer Center
Diana Cirstea, MD Attending Physician Multiple Myeloma Treatment Program Massachusetts General Hospital Cancer Center
Zach DeFilipp, MD Director, BMT Clinical Research, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Areej El-Jawahri, MD Associate Director, Cancer Outcomes Research and Education Program Director, Bone Marrow Transplant Survivorship Program, Massachusetts General Hospital Cancer Center Associate Professor of Medicine, Harvard Medical School
Matt Frigault, MD Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Gaby Hobbs, MD Clinical Director, Leukemia Service, Massachusetts General Hospital Cancer Center Assistant in Medicine, Harvard Medical School
Noopur Raje, MD Director, Center for Multiple Myeloma Massachusetts General Hospital Cancer Center
Jake Soumerai, MD Clinical Investigator in Lymphoma, Medicine, Massachusetts General Hospital Assistant Professor, Medicine, Harvard Medical School
Registrations cancelled on or before February 14, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after Februrary 14, 2023 will not be refunded.
This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequities. The goal of the Colloquium is to bring together individuals from healthcare, academia, private/public business sector, and the public at large to develop unique approaches to tackling these inequities. We know that impactful initiatives to promote cancer equity require the skills and experiences of individuals from all these sectors of society. The speakers will reflect a similar mixture of backgrounds. Attendees will have the opportunity to engage with each other and the Cancer Equity Colloquium faculty in hopes to develop novel partnerships.
Colin D. Weekes, MD, PhD Christopher D. Horner Endowed Chair in Pancreatic Cancer, Director, Pancreatic Cancer Research, Director, Cancer Center Grand Rounds, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Brenda Lormil, MSN, FNP-C Nurse Practitioner, Massachusetts General Hospital Cancer Center; Founder, Haitian American Medical Association (HAMA)
Speakers
Michele Barber, MS, GNP-BC, AOCNP Associate Director, Oncology Patient Engagement, Alkermes; Director-at-large, Boston Oncology Nursing Society (BONS)
A. William Blackstock Jr., MD Chair, Radiation Oncology, Interim Director, Comprehensive Cancer Center, Atrium Health Wake Forest Baptist
Karen Burns White Deputy Associate Director, Initiative to Eliminate Cancer Disparities, Dana-Farber / Harvard Cancer Center
Cesar Castro, MD Program Director, Gynecologic Oncology Massachusetts General Hospital Cancer Center
Taneshia Camillo-Sheffey Consultant, Founder & Director, The Haute House Design Studio MadelNcubator, Inc
Crystal Davis, RN Registered Nurse, Beth Israel Deaconess Medical Center
Neelima Denduluri, MD, FASCO Global Clinical Head, Late Phase Research & Development, AstraZeneca
Cesar Depaz Senior Pastor, Hispanic Community Church of Boston
Clifton David Fuller, MD, PhD Professor, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
S. Autumn Gaston, BSN, RN Infusion Nurse, Termeer Center, Massachusetts General Hospital Cancer Center
Rev. Deborah Hamilton, MDiv, BSN, RN, FCN Lecturer, Dept. of Health Sciences (part-time), Northeastern University; Staff Chaplain, Boston Medical Center (part-time)
Nora Hathaway, NP Inpatient Medical Oncology, Massachusetts General Hospital Cancer Center
Natasha Gross Jean, RN, BSN, OCN Hematology Clinic Infusion Center, Boston Medical Center
Christopher Lathan, MD, MS, MPH Chief Clinical Access and Equity Officer, Dana-Farber Cancer Institute; Christopher and Constance Hadley Family Chair at Dana Farber; Associate Chief Medical Officer, Director, Dana-Farber Cancer Institute Network; Associate Professor of Medicine, Harvard Medical School
Lisa Lewis, MPH Director, Diversity, Equity and Inclusion in Clinical Trials, Janssen Oncology
Rev. Jean J.M. Louis Senior Pastor, Free Pentecostal Church of God
Meghan McKenzie, MA Principal, Patient Inclusion & Health Equity, Chief Diversity Office, Genentech
Ruben A. Mesa, MD, FACP Senior Vice President, Atrium Health; President, Cancer Service Line, Atrium Health; Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center; Vice Dean for Cancer Programs, Wake Forest School of Medicine
Edith P. Mitchell, MD, MACP, FCPP, FRCP (London) Clinical Professor of Medicine and Medical Oncology, Department of Medical Oncology, Enterprise Vice President for Cancer Disparities, Director, Center to Eliminate Cancer Disparities, Associate Director, Diversity Affairs Sidney Kimmel Cancer Center at Jefferson
Mike Moise, MSA, CPA Director of Finances, Haitian America Medical Association; Associate Director, Life Sciences Practice, CrossCountry Consulting
Jean Claude Noel, MS, MA Atrium Consulting LLC - New York Kets de Vries Institute - London European Foundation for Management Development - Brussels Mount Sinai Hospital Tisch Cancer Institute - New York Boston Graduate School of Psychoanalysis - Boston
Olorunseun (Seun) Ogunwobi, MD, PhD Director, Hunter College Center for Cancer Health Disparities Research (CCHDR); Professor of Biological Sciences, Hunter College of The City University of New York
Raymond Osarogiagbon, MD, FACP Chief Scientist, Baptist Memorial Health Care Corporation; Director, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center
Electra D. Paskett, PhD Marion N. Rowley Professor of Cancer Research, Director, Division of Cancer Prevention and Control, College of Medicine; Professor, Division of Epidemiology, College of Public Health; Associate Director for Population Sciences and Community Outreach, Comprehensive Cancer Center The Ohio State University Founding Director, Center for Cancer Health Equity, James Cancer Hospital
Kenley Preval MD/PhD Student, UMass Medical School
Stanley Rameau Founder & CEO, Renavest; Founder & CEO, Paul Rameau
Jamie L. Studts, PhD Professor, Division of Medical Oncology, Scientific Director, Behavioral Oncology, University of Colorado School of Medicine; Program Co-Leader, Cancer Prevention and Control, Co-Director, Population Health Shared Resource, Member, Thoracic Oncology Research Initiative, University of Colorado Cancer Center
Charles Thomas, MD Professor and Chief of Radiation Oncology, Dartmouth-Hitchcock Norris Cotton Cancer Center; Deputy Editor, JAMA Oncology
Patrecia Valone, MS Global Head of Clinical Operations, Translational Clinical Oncology, Novartis Institutes for BioMedical Research (NIBR)
Rev. Gloria E. White-Hammond, MD, MDiv Co-Pastor, Bethel A.M.E. Church, Boston, MA; Swartz Resident Practitioner in Ministry Studies, Harvard Divinity School
Karen Winkfield, MD, PhD Executive Director, Meharry Vanderbilt Alliance; Ingram Professor of Cancer Research, Professor of Radiology Oncology, VUMC; Professor of Medicine, Meharry Medical College
Robert A. Winn, MD Director and Lipman Chair in Oncology, VCU Massey Cancer Center; Senior Associate Dean for Cancer Innovation, Professor of Pulmonary Disease and Critical Care Medicine, VCU School of Medicine
A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.
Upon completion of this activity, participants will be able to:
Recognize and understand existing inequities in cancer care.
Discuss solutions amongst the treatment team to address factors leading to cancer inequity.
Develop collaborative initiatives to promote equity in cancer care.
ACCOMMODATIONS:
A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.
Introduction | Colin D. Weekes, MD, PhD & Brenda Lormil, MSN, FNP-C
8:10
Keynote Address: Improving Cancer Equity through Precision Medicine | Karen Winkfield, MD, PhD
8:55
Sustained Mentorship: An Integral Component to Achieve Cancer Equity| Charles Thomas, MD
9:25
Diversity, Inclusion and Equity as Collective Competitive Advantage| Clifton David Fuller, MD, PhD
10:10
BREAK*
10:25
Importance of Early Mentorship for Minorities Pursuing Medicine | Kenley Preval
10:45
Mentorship: Supporting the Growth of the Next Generation | Moderator: Charles Thomas, MD Panelists: Cesar Castro, MD; Kenley Preval; Clifton David Fuller, MD, PhD
11:45am
LUNCH*
12:45pm
Prostate Cancer Community Engagement and the Male Patient | Jean Claude Noel, MS, MA
1:05
The Compounding Effects of Cancer: "My Voice, My Story, My Truth" Moderator: Brenda Lormil, MSN, FNP-C Panelists: Crystal Davis, RN; Mike Moise, MSA, CPA; Stanley Rameau; Taneshia Camillo-Sheffey
2:05
Improved Survival in Cancer but Continued Disparities: Planning the Future with Precision Medicine, but Assessing the Past through the Rear View Mirror | Edith Mitchell, MD
2:35
BREAK*
2:50
How Can I Help You? Navigating Barriers to Care | Moderator: Brenda Lormil, MSN, FNP-C Panelists: Michelle Barber, MS, GNP-BC, AOCNP; S. Autumn Gaston, BSN, RN; Nora Hathaway, NP; Natasha Gross Jean, RN, BSN, OCN
3:50
Democratization of Technology | Cesar Castro, MD
4:35
Overcoming Barriers to Representative Clinical Trial Enrollment | Jamie L. Studts, PhD
5:20
Closing Remarks
5:30pm
Adjourn
7:00pm – Welcome Reception @ Artists for Humanity (100 West 2nd Street, Boston, MA 02127) Complimentary transportation will be provided from meeting venue
*The exhibit hall will be open during breakfast, breaks, and lunch
Saturday, April 22, 2023 | 7:15am - 4:00pm
7:15am
Breakfast*
8:00
Welcome | Colin D. Weekes, MD, PhD & Brenda Lormil, MSN, FNP-C
8:05
The Role of Cancer Centers in Community Engagement | Moderator: Colin D. Weekes, MD, PhD Panelists: A. William Blackstock Jr., MD; Ruben A. Mesa, MD, FACP; Robert A. Winn, MD
9:05
Faith-Based Leadership, Support, and Advocacy Panel | Moderator: Karen Burns White Panelists: Cesar Depaz; Rev. Deborah Hamilton, MDiv, BSN, RN, FCN; Rev. Jean J.M. Louis; Rev. Gloria E. White-Hammond, MD, MDiv
10:05
BREAK*
10:20
Inequities in Cancer Health Outcomes: Can Strategies Leveraging Noncoding RNA Biology Helps? | Olorunseun (Seun) Ogunwobi, MD, PhD
11:05
Pharmaceutical Industry Initiatives to Approach Cancer Inequity | Panelists: Neelima Denduluri, MD, FASCO, Lisa Lewis, MPH; Megan McKenzie, MA; Patrecia Valone, MS
12:05pm
LUNCH*
12:50
Using Healthcare Delivery Systems to Improve Cancer Health Equity | Christopher Lathan, MD, MS, MPH
1:35
Community-Based Research to Understanding Lung Cancer | Raymond Osarogiagbon, MD, FACP
2:20
Cancer Equity Programs in Rural America | Electra A. Paskett, PhD
Professionals from healthcare and related industries must pay the registration fee to receive continuing education (CE) credit.
Cancellation Policy: Registrations cancelled on or before April 7, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after April 7, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
ACCOMMODATIONS:
A limited number of rooms have been reserved at the Boston Marriott Cambridge for the nights of April 20 and 21 at nightly rate of $199. Hotel room rates are subject to applicable state and local taxes (currently 14.45% and a 1.5% tourism fee) in effect at the time of check-out. To book your room, you may call Marriott reservations at 1 (800) 228-9290 or (617) 494-6600 and mention the “MGH Cancer Equity Colloquium” room block or CLICK HERE to reserve online. The reservation deadline is Thursday, March 30, 2023.
This activity is intended for Physicians, Nurses, Pharmacists, Psychologists, Physician Assistants, Social Workers, Other members of the healthcare team, General Public, and Patients & Caregivers.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 10.25 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity
This is a Hybrid Event. Registrants will be able to choose if they would like to attend in-person or virtually.
Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. For clinicians trying to keep current with advancing immuno-oncology principles and research, the pace of these developments has brought new challenges. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field.
Justin Gainor, MD Director, Center for Thoracic Cancers, Director of Targeted Immunotherapy, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Krista Rubin, MS, FNP-BC Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital Cancer Center
Ryan Sullivan, MD Physician Investigator, Cancer Center, Mass General Research Institute; Assistant In Medicine, Hematology-Oncology, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
Faculty
Jeremy Abramson, MD Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Hugh Auchincloss, MD Thoracic Surgery, Massachusetts General Hospital
Mark Awad, MD, PhD Clinical Director, Thoracic Oncology Treatment Center, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School
Steven Blum, MD Instructor in Medicine, Massachusetts General Hospital
Genevieve Boland, MD, PhD Vice Chair of Research, Department of Surgery, Director, Therapeutic Intralesional Program, Surgical Director, Termeer Center for Targeted Therapies, Massachusetts General Hospital
Riley Fadden, MSN, RN, FNP-C Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital Cancer Center
Florian Fintelmann, MD Radiologist, Thoracic Imaging and Intervention, Head, Thoracic Imaging Percutaneous Thermal Ablation, Massachusetts General Hospital; Associate Professor, Harvard Medical School
Ruth Foreman, MD Assistant Pathologist, Dermatopathology Service, Massachusetts General Hospital; Instructor, Harvard Medical School
Xin Gao, MD Assistant in Medicine, Massachusetts General Hospital Cancer Center; Assistant Professor, Harvard Medical School
Rakesh Jain, PhD Director, Steele Laboratory, Massachusetts General Hospital; A. Werk Cook Professor of Radiation Oncology, Harvard Medical School
Howard Kaufman, MD Assistant in Surgery, Surgery, Massachusetts General Hospital; Lecturer in Surgery, Harvard Medical School
Jason J. Luke, MD, FACP Director of the Cancer Immunotherapeutics Center, University of Pittsburgh
Mari Mino-Kenudson, MD Director, Pulmonary Pathology, Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Patrick Ott, MD, PhD Clinical Director, Melanoma Disease Center, Director, Clinical Sciences, Center for Immuno-Oncology, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School
Jong Chul Park, MD Assistant Professor of Medicine, Massachusetts General Hospital Cancer Center
Laura Petrillo, MD Palliative Care Physician, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School
Arlene Sharpe, MD, PhD Kolokotrones University Professor, Chair, Department of Immunology, Harvard Medical School
Alexandra-Chloe Villani, PhD Director, Single-Cell Genomics Program, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School; Associate Scientist, Broad Institute of MIT and Harvard
Leyre Zubiri, MD, PhD Immunotherapy Toxicity Fellow, Severe Immunotherapy Complications Service, Massachusetts General Hospital Cancer Center
A limited number of rooms have been reserved at The Westin Copley Place for the nights of April 30 and May 1 at nightly rate of $279. Hotel room rates are subject to applicable state and local taxes in effect at the time of check-out. To book your room, contact the hotel at (617) 262-9600 or CLICK HERE to reserve online. The reservation deadline is Friday, April 7, 2023.
Upon completion of this activity, participants will be able to:
Evaluate cancer immunotherapy principles and strategies and how they influence current treatment approaches.
Identify the emerging role of personalized cancer vaccination and other immunotherapy combinations in patients with solid tumor and hematologic malignancies.
Define currently approved and emerging predictive biomarkers for cancer immunotherapy.
Recognize and implement management strategies for immune-mediated side effects in patients treated with immunotherapy agents.
Recognize the importance of establishing a multidisciplinary approach in the immunotherapy era.
Cancellation Policy: Registrations cancelled on or before April 17, 2023 will be refunded, less a $25 administrative fee. Registrations cancelled after April 17, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
Accommodations:
A limited number of rooms have been reserved at The Westin Copley Place for the nights of April 30 and May 1 at nightly rate of $279. Hotel room rates are subject to applicable state and local taxes in effect at the time of check-out. To book your room, contact the hotel at (617) 262-9600. The reservation deadline is Friday, April 7, 2023.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Please note, access to symposium recordings is included with registration. Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.
Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma
P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School
Faculty:
Jeremy Abramson, MD Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center Associate Professor of Medicine, Harvard Medical School
Andrew Brunner, MD Assistant Professor of Medicine, Harvard Medical School Massachusetts General Hospital Cancer Center
Diana Cirstea, MD Attending Physician Multiple Myeloma Treatment Program Massachusetts General Hospital Cancer Center
Zach DeFilipp, MD Director, BMT Clinical Research, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Areej El-Jawahri, MD Associate Director, Cancer Outcomes Research and Education Program Director, Bone Marrow Transplant Survivorship Program, Massachusetts General Hospital Cancer Center Associate Professor of Medicine, Harvard Medical School
Matt Frigault, MD Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Gaby Hobbs, MD Clinical Director, Leukemia Service, Massachusetts General Hospital Cancer Center Assistant in Medicine, Harvard Medical School
Noopur Raje, MD Director, Center for Multiple Myeloma Massachusetts General Hospital Cancer Center
Jake Soumerai, MD Clinical Investigator in Lymphoma, Medicine, Massachusetts General Hospital Assistant Professor, Medicine, Harvard Medical School
Registrations cancelled on or before February 14, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after Februrary 14, 2023 will not be refunded.
This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 Credits™ Mass General Brigham designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 8 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 8 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This course provides education on acute and chronic aortic conditions to physicians and APPs who might encounter patients with these conditions in their practice but may not have sufficient familiarity with their management. The course will have two sessions – morning and afternoon. The morning session will focus on the fundamentals of aortic aneurysms and chronic aortic disease and will be targeted to PCPs, cardiologists and APPs. The afternoon session will focus on aortic dissection and other acute aortic syndromes, which will be more relevant to ER physicians and APPs.
Chief of Division of Vascular and Endovascular Surgery, Massachusetts General Hospital; Professor of Surgery in the Field of Vascular and Endovascular Surgery, Harvard Medical School
Chief, Division of Cardiac Surgery, Co-Director of the Corrigan Minehan Heart Center, Massachusetts General Hospital; Professor of Surgery, Harvard Medical School
Welcome and Introduction | Arminder Jassar, MBBS; Eric Isselbacher, MD; Matthew Eagleton, MD
Section I: Ascending Aortic Aneurysms
Arminder Jassar, MBBS & Eric Isselbacher, MD
8:00
Who gets aneurysms of the proximal aorta and what do we do about them? Lessons from the 2022 Guidelines | Eric Isselbacher, MD
8:25
The importance of medical management of aortic aneurysms, both pre-op and post-op | Amy Spooner, MD
8:40
Imaging of the Aorta: Which Modality to Choose, How to Interpret Reports? | Sandeep Hedgire, MD
9:00
Genetics of Aortic Disease: Who to Screen, How to Screen, and When? | Mark Lindsay, MD, PhD
9:20
BREAK
9:30
Bicuspid aortic valve disease and related aortopathy; A common clinical Conundrum | Jordan Bloom MD, MPH
9:50
Surgery for the Aortic Root / Ascending Aorta and the Aortic Arch: What is going on inside the surgeon’s head? | Duke Cameron, MD
10:10
Panel Discussion and Q&A: Ascending Aortic Aneurysms | Moderators: Eric Isselbacher, MD & Arminder Jassar, MBBS Panel: Duke Cameron, MD; Jordan Bloom, MD, MPH; Mark Lindsay, MD, PhD; Sandeep Hedgire, MD; Thoralf Sundt, MD
10:30
BREAK
Section II: Descending Aortic and Thoracoabdominal Aortic Aneurysms
Moderators: Duke Cameron, MD & Matthew Eagleton, MD
10:40
Aortic guidelines: When to intervene on the descending and the thoracoabdominal Aorta? | Eric Isselbacher, MD
10:50
Open and endovascular Strategies for Descending Aortic and Thoracoabdominal Aortic Aneurysms (TAAA): Who is a candidate for what? | Matthew Eagleton, MD
11:10
Management of Abdominal Aortic Aneurysms in the current era: When and how? | Sunita Srivastava, MD
11:30
Panel Discussion and Q&A: Descending Aortic and Thoracoabdominal Aortic Aneurysms | Moderators: Duke Cameron, MD & Matthew Eagleton, MD Panel: Eric Isselbacher, MD; Sunita Srivastava, MD; Amy Spooner, MD, MPH
11:50
Lunch Break
Session III: Aortic Dissection and other Acute Aortic Syndromes
Moderators: Jared Conley, MD, PhD, MPH and Arminder Jassar, MBBS
12:30
The most lethal aortic complication: Overview of Acute aortic dissection | Jahan Mohebali, MD, MPH
12:50
Does my patient have an aortic dissection? | Jared Conley, MD, PhD, MPH
1:10
My patient has an Aortic Dissection – what else should I look for? | Arminder Jassar, MBBS
1:30
Waiting for transfer – what can I do? Initial Management, Lines, and Drugs | Phillip Rice Jr., MD
1:50
Pack your Bags, Ready for Transfer | Michael Frakes, APRN, FCCM, FAEN, FACHE
2:10
Panel Discussion and Q&A | Moderators: Jared Conley, MD, PhD, MPH & Arminder Jassar, MBBS Panel: Eric Isselbacher, MD; Phillip Rice Jr., MD; Michael Frakes, APRN, FCCM, FAEN, FACHE; Jahan Mohebali MD, MPH
2:35
BREAK
Session IV: Aortic Dissection and other Acute Aortic Syndromes II
Moderators: Matthew Eagleton, MD & Eric Isselbacher, MD
2:50
The patient left my ER – I wonder what is happening to them now? | Arminder Jassar, MBBS
3:10
Surgery for Acute Type A Aortic Dissection: One Size Fits All | Thor Sundt, MD
3:30
Acute Type B Dissections: when to intervene? | Jahan Mohebali, MD, MPH
3:50
Ruptured Abdominal Aortic Aneurysm: From ER to OR | Anahita Dua, MD, MS, MBA
4:10
Lifetime management of aortic dissection: surveillance after initial repair | Motahar Hosseini, MD
Cancellation Policy: Registrations cancelled on or before November 17, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after November 17, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
This activity is intended for Physicians, Nurses, Physician Assistants in the following specialties Cardiology, Critical Care, Emergency Medicine, General Practice, Geriatric Medicine, Hematology/Oncology, Internal Medicine, Interventional Cardiology, Obstetrics/Gynecology, Peripheral Vascular Disease, Primary Care, Pulmonary Disease, and Sports Medicine.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 5 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This event will take place virtually, via Zoom. Details provided upon registration
Description
Mass General Brigham’s Virtual Care Speaker Series, led by our industry's most widely regarded stakeholders, thought leaders and policy experts, will feature a deep-dive into the evolving virtual care landscape and dig into how to build and optimize virtual care programs as a permanent modality in care delivery. Dynamic panels will lead in-depth discussions about advancing the reach of virtual and hybrid patient care at a critical time for hospitals and health care.
Lee Schwamm, MD Vice President, Virtual Care, Mass General Brigham
Dr. Schwamm is Professor of Neurology at Harvard Medical School and holds the C. Miller Fisher Chair in Vascular Neurology at MGH, where he serves as the Senior Clinical and Strategic Advisor to the Dept of Neurology and Director of the Center for TeleHealth. He leads all systemwide virtual care (telehealth) activities for the Mass General Brigham Health System as Vice President of Digital Patient Experience/Virtual Care (synchronous and synchronous virtual visits and consults, remote patient monitoring, virtual urgent care and online second opinions). During COVID, he led adoption efforts for 10,000 providers and 1.38 M visits, and introduced a suite of inpatient virtual solutions. He has spent 2 decades in telehealth, pioneering telestroke and leading advocacy efforts (e.g., FAST Act in Congress). He is a an internationally recognized expert in stroke diagnosis, treatment and prevention and a Fellow of the American Heart Association and American Neurological Association. He is the author of >450 peer-reviewed articles and has chaired many of the current practice guidelines for stroke and telehealth-enabled care delivery. He has received numerous awards for innovation, leadership and advocacy in the field of stroke and digital health. He serves as the section editor for digital health for Stroke, and on the international advisory board for Lancet Digital Health. His research has been funded by NIH, PCORI, AHRQ, HRSA, CDC, and others. He serves on the Board of Directors of the American Heart Association.
Upon completion of this course, participants will be able to:
Create, enhance, and extend the virtual care blueprint at their institution.
Apply best practices, interpersonal bedside skills, and multidisciplinary approaches to improve your virtual patient experience.
Identify necessary technology tools needed to successfully provide industry-leading virtual care services.
Integrate existing platforms in the virtual care space.
Demonstrate how to operationalize and engage with virtual care.
ABIM MOC Information
Maintenance of Certification (MOC) points can only be awarded if you attended the entire hour session.
Upon successful completion of this activity, if you wish to receive MOC II points you will need to enter your ABIM ID number, and Date of Birth (mm/dd) at the beginning of the evaluation.
The Mass General Brigham Office of Continuing Professional Development will verify completion of this activity and report to the ABIM.
Diplomates must check their ABIM Portfolio for confirmation of your MOC II points.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
September 16, 2022 11:00am - 12:00pm ET Session 1: Keeping Pace with Rapid Change: The Virtual Care Revolution
Virtual care has undoubtedly reshaped the future of health care. With a rapid growth in consumer expectations and consumption of virtual options from both patients and providers, we explore how the virtual care experience can be optimized as health care undergoes digital transformation. This session will delve into the history of virtual care, the current landscape and rapid expansion of emerging technologies expanding the reach of care.
Session Format: Didactic Lecture
Speaker Lee Schwamm, MD Vice President, Virtual Care, Mass General Brigham
October 14, 2022 11:00am - 12:00pm ET Session 2: Pushing the Arc Towards “Techquity”: Patient-Centric Virtual Care
Join patient experience experts in discussing ways to bring health equity in virtual care to the next level for patients. Experts will analyze interdisciplinary approaches to improve patient satisfaction. COVID exacerbated the preexisting inequities in care for vulnerable populations, and while virtual care restored access to care for many, in some cases it further deepened these disparities. This session will focus on the interaction between health equity, digital health and the patient experience, and how health systems can design for these challenges.
Session Format: Panel Discussion
Moderator Lee Park, MD, MPH Instructor in Medicine, Harvard Medical School; Internist, Brigham and Women's Hospital; Senior Medical Director, QPE Digital Health, Quality and Patient Experience, Mass General Brigham
Speakers Esteban Barreto, PhD Director, Evaluation of Equity and Community Health, Massachusetts General Hospital
Allison Bryant Mantha, MD, MPH Associate Professor of Obstetrics, Gynecology and Reproductive Sciences, Harvard Medical School; Maternal-Fetal Medicine Specialist, Frederic D. Frigoletto, MD Endowed Chair, Department of Obstetrics and Gynecology, Massachusetts General Hospital; Senior Medical Director for Health Equity, Mass General Brigham
Dan Noyes Co-CEO, Tech Goes Home
Aswita Tan-McGrory, MBA, MSPH Adjunct Faculty, Northeastern University; Director, the Disparities Solutions Center, Director, Equity in Care Implementation, Administrative Director of Research, Department of Medicine, Massachusetts General Hospital
November 10, 2022 11:00am - 12:00pm ET Session 3: The Human Experience of the Digital Patient
As virtual care has rapidly expanded; the role of telepresence is here to stay. This session will discuss the importance of developing a trust-based relationship between patient and provider to increase overall patient satisfaction and better health outcomes. Stakeholders will provide insights on how to foster a comfortable setting for the patient and how to upgrade their “webside” manner.
Session Format: Simulation and Panel Discussion
Moderator Lydia C Siegel, MD, MPH Internal Medicine, Brigham and Women’s Hospital; Medical Director, Ambulatory Services in Clinical Informatics, Mass General Brigham
Panelists Oscar Benavidez, MD Chief, Division of Pediatric Cardiology, Massachusetts General Hospital
David Binder, MD Medical Director, Spaulding Outpatient, Spaulding Rehabilitation Network
Susan Edgman-Levitan, PA Associate in Health Policy, Harvard Medical School; Executive Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital
Darlene Sawicki, MSN, NP-BC Director of Advanced Practice Providers, Massachusetts General Hospital
Shyam K. Tanguturi, MD Radiation Oncology, Dana-Farber Cancer Institute
December 9, 2022 11:00am - 12:00pm ET Session 4: Watch your Tech: Leveraging Technology for Care
In an era where Virtual Care is a core component of how care is delivered and will continue to grow as a core part of our healthcare system, designing and deploying technology solutions for providers and patients to use is critical. This session will cover intuitive Virtual Care deployment and how to provide existing virtual-based technologies for digital solutions. Experts will review strategies to increase technology adoption at their institution and provide demos of MGB-developed platforms that are currently in use at the bedside.
Session Format: Demo and Panel Discussion
Moderator Adam Landman, MD, MS, MIS, MHS Senior Vice President, Digital Chief Information Officer, Mass General Brigham
Panel Anne Bane, MSN, RN, BC Nurse Director, Nursing Informatics and Medication Safety, Center for Nursing Excellence, Brigham and Women's Hospital
Mike Carter Program Director, Health Information Systems, Mass General Brigham
Juan Estrada Senior Director, Center for TeleHealth, Massachusetts General Hospital
Benji Meller Program Director, Technology Operations and Inpatient Virtual Care, Massachusetts General Hospital
Daniel Meninger, MSPT, MBA Program Manager, Virtual Care Services, Spaulding Rehabilitation Network
Radhika Sangireddy Virtual Care Portfolio Manager, Mass General Brigham
Mark Zhang, DO, MMSc Medical Director, Brigham Digital Innovation Hub, Medical Director, Digital Health Implementation, Brigham and Women’s Hospital
January 13, 2023 11:00am - 12:00pm ET Session 5: The Rules of the Virtual Road: The Regulatory Landscape of Telehealth
Health care systems are increasing their use of virtual care in the setting of technology that is evolving at the speed of light. As a result, the regulatory and legal landscape in virtual care is constantly evolving. This expert panel will provide real-life examples from care settings and analyze state and federal regulations that govern the provision of virtual care.
Session Format: Simulation and Panel Discussion
Moderators Kate Connelly, CPA, MBA Corporate Director, Enterprise Risk Management, Mass General Brigham
Rosemary Gottlieb Senior Legal Counsel, Office of the General Counsel, Mass General Brigham
Panelists
Lindsey Reilly Director, Billing Compliance, Brigham and Women’s Hospital Massachusetts General Hospital
Marcy Simoni, MPH Mass General Brigham
Tim Willens, MD Chief, Division of Child and Adolescent Psychiatry, Co-Director for Center for Addiction Medicine, Massachusetts General Hospital
Alexis Williamson, MPH Executive Director of Central Credentialing, Mass General Brigham
This program is recommended for virtual care providers, healthcare professionals and organizations seeking to fine tune, develop or launch their Virtual Care programs.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 7.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity
PAs Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Please note, access to symposium recordings is included with registration. Access will be available for 30 days post event.
The Mass General Cancer Center Classical Hematology Review and ASH Highlights will be an interactive, virtual CME program highlighting state-of-the-art care for patients with hematologic diseases. This is a unique course, focused solely on classical hematology and the intricacies that come along with these diseases. Presentations will provide a combination of consultative case studies, approaches to patient care with various abnormalities, and the latest science and treatment paradigms from the 2022 ASH Meeting. There will be designated time in each section for a moderated Q&A, encouraging interaction between the audience and faculty.
Annemarie Fogerty, MD - Course Director Assistant Professor of Medicine, Harvard Medical School Massachusetts General Hospital Cancer Center
Hanny Al-Samkari, MD Classical Hematologist and Clinical Investigator Co-Director, Hereditary Hemorrhagic Telangiectasia Center Massachusetts General Hospital Assistant Professor of Medicine, Harvard Medical School
Sharl Azar, MD Medical Director, Comprehensive Sickle Cell Disease Treatment Center Massachusetts General Hospital Cancer Center
Pavan Bendapudi, MD MGH Division of Hematology and Blood Transfusion Service Assistant Professor of Medicine, Harvard Medical School
Larissa Bornikova, MD Instructor in Medicine, Hematology-Oncology, Harvard Medical School Massachusetts General Hospital Cancer Center
Jonathan Carlson, MD, PhD Physician Investigator (Cl), Mass General Cancer Center, Mass General Research Institute Instructor in Medicine, Harvard Medical School Assistant In Medicine, Hematology-Oncology, Massachusetts General Hospital
Sunny Dzik, MD Associate Pathologist, Massachusetts General Hospital Associate Professor of Pathology, Harvard Medical School
Katayoon Goodarzi, MD Physician Investigator, Mass General Research Institute Instructor in Medicine, Harvard Medical School Assistant In Medicine, Massachusetts General Hospital Cancer Center
Rebecca Karp, MD Co-Founder and Co-Director, Porphyria Center Assistant Professor, Harvard Medical School Division of Hematology, Massachusetts General Hospital Cancer Center
David Kuter, MD, DPhil Hematology Program Director, Massachusetts General Hospital Professor of Medicine, Harvard Medical School
Rachel Rosovsky, MD, MPH Director, Thrombosis Research - Division of Hematology, Massachusetts General Hospital Cancer Center Co-Chair of Thrombosis Committee, Massachusetts General Hospital Associate Professor, Harvard Medical School
David Sykes, MD, PhD Assistant Professor, Harvard Medical School Massachusetts General Hospital Cancer center
Anem Waheed, MD, MPH Instructor in Medicine, Massachusetts General Hospital Cancer Center
Registrations cancelled on or before January 31, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after January 31, 2023 will not be refunded.
The goal of this activity is to provide learners with a better understanding of immune mechanisms related to the pathogenesis of autoimmunity and rheumatoid arthritis. This module incorporates clinical scenarios and immunologic basic principles. In the module, learners acquire basic science knowledge, and then apply their understanding of JAK-kinase inhibition to the clinical management of patients. There is no fee for the online module.
We will provide collective feedback on module questions as value added to your participation.
The innovative adaptive learning platform used for this module will present content customized to each learner depending on baseline level of expertise. Depending on your baseline level of expertise, the module can be completed in as little as 30 minutes. The module may be completed in a single session or in small portions over time and may be accessed from any device.
Instructions to Complete the Module:
Click on the blue "Register/Take Course" tab above
You will be prompted to log in or register
After you log in or register, we will receive notification of your enrollment
We will email you a deidentified username, password and link to the adaptive learning module within 1 business day
Use the login information provided by email to select and complete the module
Provide any feedback
Target Audience
This activity is intended for physicians and advanced practice providers in the field of rheumatology. Dermatologists and gastroenterologists are a secondary target audience.
Additional Background Information:
This is an educational research project conducted by the Mass General Brigham Office of Professional Development Knowledge Translation Lab. Dr. Robert Birnbaum is the Principal Investigator, and Dr. Simon Helfgott is the Subject Matter Expert. All information derived from this study and data produced from your participation will be confidential. Data will be de-identified to protect healthcare provider information accessed by any constituencies. Data is collected for evaluating the efficacy of the learning methodology and to discern training needs — not to supervise or determine the level of your individual clinical acumen or skills. This educational research project is supported by funding from Eli Lilly. The content was solely developed by subject matter experts at Mass General Brigham.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 16.75 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Current treatment strategies for patients with complex digestive disorders continue to evolve. This is largely the result of growing technological advances in surgery and endoscopy. The goal of the Minimally Invasive and Novel Therapeutics (MINT) course is to inform physicians on how best to incorporate these technologies into their practice. Using a video-based format, our goal is technique transfer from world-renowned faculty to the community, hospital, endoscopy suite, and operating room. MINT offers an ideal mix of traditional standard-of-care principles with a balanced and unbiased view of new, cutting-edge information. This hybrid course (in-person and virtual) engages learners through video-based lectures with recordings of surgical and endoluminal therapies, along with lively multidisciplinary panel discussions.
Digestive disease management requires multidisciplinary care. This course intends to break the barriers of subspecialty medicine by bringing together gastroenterologists, surgeons, psychologists, APPs, nurses, and dietitians to learn from each other. Since many surgeons and endoscopists learn best by “doing”, this course offers hands-on skills sessions in both endoluminal therapies and surgical techniques taught by national and international experts.
Charu Paranjape, MBBS Faculty at Harvard Medical School Program Director, Robotic Education, Massachusetts General Hospital Associate Chair and Chief of General Surgery Mass General Brigham, Newton-Wellesley Hospital
Kumar Krishnan, MD Assistant professor of Medicine, Harvard Medical School; Director of Endoscopic Innovation, Technology and Education, Massachusetts General Hospital
Hany Takla, MD, FACS, FASMBS, DABS-FPMBS General & Bariatric Surgeon Medical Director of Surgical services Chair Department of Surgery General Surgery Dover I Center for Weight Management and Bariatric Surgery Wentworth Douglass Hospital Massachusetts General Hospital
Faculty
Abdelrahman Nimeri, MD, FACS Gastrointestinal and General Surgery, Director of Bariatric Surgery, Brigham and Women’s Hospital
Adham Saad, MD, FACS Assistant Professor, Surgery Fellow, Minimally Invasive Surgery University of South Florida Health
Alexandra Maltby, PA-C General Surgery Physician Assistant, Department of Surgery, Newton-Wellesley Hospital
Ali Tavakkoli, MD Associate Professor, Harvard Medical School; Chief, Division of General and GI Surgery, Co-Director, Center for Weight Management and Wellness, Program Director, Advanced Minimally Invasive Fellowship, Brigham and Women’s Hospital
Aman Ali, MD Bariatric Surgery, General Surgery, Department of Surgery, Houston Methodist
Ankit Patel, MD General and Bariatric surgeon, Associate professor of Surgery Emory University
Annaliessa Visco, RD
Ashraf Maghrabi, MD, FRCSC President, Saudi General Surgery Society Associate Professor of Surgery Thoracic, Foregut and Bariatric Surgeon King Abdulaziz University Hospital
Ashvind Bawa, MS, FACS Professor Surgery Dayanand Medical College and Hospital Ludhiana, Punjab, India
Ashwin Ananthakrishnan, MBBS, MPH Gastroenterologist, Massachusetts General Hospital
Brittany Mallette, RN
B. Ramana, MBSS, MS, FRCS, FACS, FIBC, FISA General and hernia surgery Goulburn Valley Health, Shepparton, Victoria, Australia Founder and President of AWR Surgeons Community
Dana Telem, MD Section Head of General Surgery, Associate Chair for Quality and Patient Safety, Lazar J. Greenfield Professor of Surgery, University of Michigan Health
David Lourié, MD Director of MIS program at Huntington Hospital
Deepak Subramanian, MD Clinical Lead, Dept of Laparoscopic and Bariatric Surgery MGM HEALTHCARE, Chennai
Denise Gee, MD Bariatric Surgeon Vice Chair of Clinical Operations, Department of Surgery, Surgical Director, Mass General Weight Center, Section Head, Swallowing, Heartburn and Esophageal Disease Program, Massachusetts General Hospital
Elan Witkowski, MD, MS Gastrointestinal Surgeon, Head, Hernia Center, Massachusetts General Hospital
Emily Letendre, PA-C Department of Surgery, Newton-Wellesley Hospital
Eran Brauner, MD General Surgery, Newton-Wellesley Hospital
Eric Pauli, MD, FACS, FASGE David L. Nahrwold Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery Vice Chair, Clinical Affairs Director of Abdominal Wall Surgery Program Director, Abdominal Wall Surgery Fellowship Department of Surgery Penn State Health
Firas El-Hanafi, MD, FACS, FRCSEd(Gen. Surg), FRCSEd(OG) Senior Upper GI and Bariatric Surgeon, Darlington Memorial Hospital; County Durham and Darlington NHS Foundation Trust, United Kingdom
George Velmahos, MD, PhD John F. Burke Professor of Surgery, Harvard Medical School; Division Chief of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital
Hassan Mashbari, MD Assistant professor in Surgery, General Surgery Residency Program Director, Director, Clinical Simulation & Life Support Center, Jazan University
Jennifer Lopes, RN Endoscopy Registered Nurse, Newton-Wellesley Hospital
John DeWitt, MD Professor of Medicine, Director of Endoscopic Ultrasound, Indiana University Health
John Pandolfino, MD Chief of Gastroenterology and Hepatology in the Department of Medicine, Hans Popper Professor, Professor of Medicine (Gastroenterology and Hepatology), Northwestern University Feinberg School of Medicine
Kathryn Schlosser, MD General Surgery, Beth Israel Deaconess Medical Center
Laura Shannon, RN
Lee Kaplan, MD, PhD Professor of Medicine, Dartmouth Geisel School of Medicine
Mario Gonçalves Abdominal wall surgeon Fellow of the European Board of Surgery - Abdominal Wall Fellow of the American College of Surgeons Hospital de Braga Braga, Portugal
Matthew Hutter, MD, MPH, MBA Professor in Surgery, Harvard Medical School; Gastrointestinal Surgeon | Bariatric Surgeon | Laparoscopic/Minimally Invasive Surgeon Director of the Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital
Michael DeWane, MD General Surgery, Massachusetts General Hospital
Mohit Bhandari, MS, DMAS, FICS, FIAGES, FALS Director Mohak Bariatrics and Robotics, Indore, India
Nari Sabeti, MD General and Gastrointestinal Surgery, Weight Loss (Bariatric) Surgery Medical Director, Surgical Weight Loss Program Salem Hospital
Nora Fullington, MD Partner, Boston Hernia Newton-Wellesley Hospital
Omar Ghanem, MD Chair, Division of Metabolic and abdominal wall reconstructive surgery Associate professor of Surgery Mayo Clinic, Rochester, MN
Pawanindra Lal, MD Department of Surgery, Maulana Azad Medical College
Peter Fagenholz, MD Associate Professor of Surgery, Harvard Medical School; Pancreatic and General Surgeon, Surgical Director, MGH Pancreatitis Treatment Center, Massachusetts General Hospital
Pramod Shinde, MD Bariatric Surgeon, General Surgeon, Laparoscopic Surgeon, Kaushalya Hospital & Research Centre | Nashik
Prakash Gatta, MD Texas Christian University, Brunette School of Medicine, Fort Worth, TX
Premkumar Balachandran, MD Clinical Lead, Apollo Institutes of Hernia Surgery and Abdominal Wall Reconstruction Apollo Hospitals
Priyanca Waghmarae, PA-C Outpatient Gastroenterology, Massachusetts General Hospital
Ralph Weissleder, MD, PhD Thrall Family Professor of Radiology, Professor of Systems Biology, Harvard Medical School; Center for Systems Biology, Radiologist, Interventional Radiology, Massachusetts General Hospital
Rana Pullat, MD, FACS, FASMBS Professor of Surgery, Director of Bariatrics and Robotic Surgery Division Chief of Foregut and Metabolic Surgery, Medical University of South Carolina
Reem Sharaiha, MD, MSc Gastroenterology, Weill Cornell Medicine
Rocco Ricciardi, MD Colorectal Surgeon | Gastrointestinal Surgeon Chief, Section of Colon and Rectal Surgery, Massachusetts General Hospital
Roy Patankar, MD Director and Administrative Head, Zen Multispeciality Hospital
Sanjay Sonar, MD General Surgeon, Godrej Memorial Hospital | Mumbai
Sheila Partridge, MD General Surgery, Bariatric Surgery, Newton-Wellesley Hospital
Suha K. Kaaki, MD, FRCSC FACS Assistant Professor of Surgery Program Director, Thoracic Surgery Fellowship Thoracic and Foregut Surgeon King Saud University Medical City
Susana Wishnia, MD General Surgery, Bariatric Surgery, Newton-Wellesley Hospital
Uzma Siddiqui, MD Professor of Medicine Director, Endoscopic Ultrasound and Advanced Endoscopy Training Director, Center for Endoscopic Research & Therapeutics University of Chicago Medicine
Vivek Bindal, MD Director & Head, Max Institute of Minimal Access, Bariatric & Robotic Surgery
Yalini Vigneswaran, MD Advanced GI and Bariatric Surgery Surgical Director of Education Institute Program Director of Esophageal Diseases University of Chicago Medicine
Yusef Kudsi, MD, MBA, FACS, Gastrointestinal and General Surgery, Brigham and Women’s Hospital
Upon completion of this activity, participants will be able to:
Apply new knowledge in the management of patients with foregut disease, abdominal wall hernias, and pancreaticobiliary disease.
Develop treatment strategies based on current evidence and expert opinion.
Compare and contrast standard-of-care management with cutting-edge treatments.
Recognize the unique roles and contributions of various healthcare professionals within the multidisciplinary foregut team.
Collaborate effectively among multidisciplinary team members to improve patient outcomes.
Maintenance of Certification (MOC)
American Board of Surgery (ABS) MOC Recognition Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
American Board of Internal Medicine (ABIM) MOC Recognition Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.75 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Station 1: ESD | Uzma Siddiqui Station 2: POEM | Elan Witkowski Station 3: Overstitch | Reem Sharaiha Station 4: EUS Axios | John DeWitt Station 5: EMR and Ablation | Industry Station 6: LAP CBDE | Eric Pauli & Susana Wishnia Station 7: TIF | Charu Paranjape Station 8: ZPOEM | Kumar Krishnan Station 9: endoFLIP | John Pandolfino
APP/RN Session: MINT Multidisiplinary Team 1:30pm - 4:15pm
Co-Directors: Alexandra Maltby & Priyanca Waghmarae
1:30
Complex Esophageal Case/Barrett's Esophagus | Adham Saad; Jennifer Lopes-DeCarvalho; Priyanca Waghmarae; Laura Shannon, Brittany Mallette
2:00
Complex Biliary Case | Hany Takla; Kendal Towle; Priyanca Waghmarae; Laura Shannon, Brittany Mallette
Stones in the Postoperative Patient | Uzma Siddiqui
10:45
EUS Biliary Drainage: How To | John DeWitt
11:05
All in One Approach: Lap CBDE to the Rescue? | Eric Pauli
11:25
Percutaneous Management of Strictures and Stones | Ralph Weisslader
11:45
Multidisciplinary Management of Complex Pancreatitis | Peter Fagenholz
12:15pm
LUNCH
MINT Hernia and Abdominal Wall
Co-Directors: Hany Takla & Elan Witkowski
12:45
Know Your Anatomy for the Attending Surgeon | Speaker: David Lourié
Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
1:05
New Robotic Platforms: Comparisons, Advantages, and Challenges | Speaker: Vivek Bindal Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
1:20
How to Navigate Complex Hernia as a New Attending? | Speaker: Kathryn Schlosser Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
1:35
AWR in 2024: What’s out there to know? Speaker: Yusef Kudsi Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
1:50
E-TEP Inguinal Hernia Repair - Troubleshooting Speaker: Jignesh Gandhi Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
2:05
Abdominal Fistula in the IBD Patient | Speakers: Ashwin Ananthakrishnan & Rocco Ricciardi Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
2:25
Measuring Individual Performance and Quality Data to Better Your Hernia Practice | Speaker: Yalini Vigneswaran Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington; Ramesh Punjani
2:35
TAR gone wrong; can I fix it? | Speaker: Michael DeWane Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington
2:50
Lateral Hernias: Ten Things You Should Know | Speaker: Pramod Shinde Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington
3:00
Surgeon’s Edge: AI Tool for the Modern Surgeon | Speaker: Ashvind Bawa Panelists: Matthew Hutter; Dana Telem; B. Ramana; Nora Fullington
3:10
BREAK
MINT Hernia
3:20
Weight loss and AWR: too idealistic? | Speaker: Sharad Sharma Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
3:30
Eliminating chronic pain after inguinal hernia surgery | Speaker: Nora Fullington Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
3:45
Mesh Infections: Does Experience Match with Evidence? | Speaker: Deepak Subramanian Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
3:55
The abdominal catastrophe | Speaker: B. Ramana Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
4:10
RIF Hernias: Many Ways to Skin It | Speaker: Sanjay Sonar Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
4:20
Hernia centers of excellence: a marketing gimmick or useful quality initiative? | Speaker: Elan Witkowski Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
4:30
Parastomal Hernias: A Short Ride | Speaker: Premkumar Balachandran Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
4:40
The most useful tools for the MIS hernia surgeon | Speaker: Rahul Mahadar Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
4:50
Post liver transplant hernias: surgical considerations | Speaker: Rajesh Shrivastava Panelists: George Velmahos; Nari Sabeti; Pramod Shinde
Didactic MINT course ONLY (Monday 9/9 & Tuesday 9/10)
$100.00
$150.00
Industry
Registration Type
Early Bird Tuition Fees (until June 1, 2024)
Regular Tuition Fees
Didactic MINT course ONLY (Monday 9/9 & Tuesday 9/10)
N/A
$400.00
Cancellation Policy: Registrations cancelled on or before August 26, 2024 will be refunded, less a $50 administrative fee. Registrations cancelled after August 26, 2024 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For more than 40 years, “Advances in Rheumatology” has been influential in educating generations of clinicians on over 100 rheumatic conditions, which now encompass the specialty. A collaboration between Harvard Medical School’s two largest teaching hospitals, the Massachusetts General Hospital and Brigham and Women’s Hospital, the course not only focuses on rheumatic diseases, but offers additional perspectives from other medical disciplines, such as pulmonology, dermatology, oncology, ophthalmology, and endocrinology. “Advances in Rheumatology” targets the practicing clinician seeking to enhance their clinical skills and increase their knowledge with the latest breakthroughs in the diagnosis, treatment, and pathophysiology of rheumatic diseases.
This three day livestream course will be a combination of sessions formatted with lectures by leading experts on topics pertaining to their special areas of interest, curbside consultations and panel discussions. Topics include The Year in Rheumatology, updates on Giant Cell Arteritis, Orbital Inflammatory Disease, Systemic Sclerosis, Hemophagocytic Syndrome, the New England Journal of Medicine Clinicopathological Conference (CPC) and various disease focused afternoon sessions such as Lupus, Psoriatic Arthritis and Rheumatoid Arthritis. The full range of rheumatic disease is covered every year over the span of this course.
John H. Stone, MD, MPH Professor of Medicine, Harvard Medical School; The Edward A. Fox Chair in Medicine, Massachusetts General Hospital
Michael Weinblatt, MD John R. Riedman Professor of Medicine, Harvard Medical School; Co-Director, Clinical Rheumatology, Associate Director, Center for Arthritis and Joint Diseases, Brigham and Women’s Hospital
Advances in Rheumatology Speakers
Rohit Aggarwal MD, MS University of Pittsburgh
Luke Chen, MD BC Cancer | Vancouver, BC
Stanley Cohen, MD
Christian Dejaco, MD Brunico Hospital
Atul Deodhar, MD Oregon Health & Science University
Thomas Dorner, MD Charite University Hospital
David Dudzinski, MD, JD Massachusetts General Hospital
Paul Emery, MD University of Leeds
Judith Ferry, MD Massachusetts General Hospital
Ambrose Huang, MD Massachusetts General Hospital
Laura Hummers, MD Johns Hopkins University
David Isenberg, MD, FRCP, FAMS University College London
Michael Jordan, MD Cincinnati Children’s Hospital
Andreas Kronbichler, MD Medical University Innsbruck
Katherine Liao, MD Brigham and Women’s Hospital
Andrew Mammen, MD, PhD National Institute of Health
Iain B McInnes, CBE, PhD, FRCP, FRSE, FMedSci. University of Glasgow
Joseph Merola, MD Brigham and Women’s Hospital
Alexis Ogdie, MD, MSCE University of Pennsylvania
Julie Paik, MD Johns Hopkins University
Michelle Petri, MD, MPH Johns Hopkins University
Brad Rovin, MD Ohio State University
Ami Shah, MD Johns Hopkins University
Allen Steere, MD Massachusetts General Hospital
Ronald van Vollenhofen, MD University of Amsterdam
Upon completion of Advances in Rheumatology, participants will be able to:
Evaluate the latest scientific advances in the field of rheumatology.
Analyze insights from pathology, immunology, and pharmacology that pertain to specific rheumatologic issues.
Translate the latest developments in the field of rheumatology to clinical practice.
Integrate new treatment approaches for patients with rheumatic disease.
Apply new diagnostic techniques in their patient population.
MOC Completion Criteria
Participant completion for MOC points will be reported to the boards at the conclusion of the course.
Please have your ABIM ID available when completing the evaluation at the end of the course.
Instructions: Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program
Upon successful completion of this activity, if you wish to receive MOC Part 2 points you will need to enter your ABIM ID number in the post-course evaluation. The Mass General Brigham Office of Continuing Professional Development will verify completion of your activity and report to the ABIM. Diplomates must check their ABIM Portfolio for confirmation of your MOC Part 2 points.
MOC Recognition Statement Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 22.25 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Funding
Advances in Rheumatology 2023 has received support in the form of an educational grant from the following companies:
The Year in Clinical Rheumatology | John H. Stone, MD, MPH
8:30
Giant Cell Arteritis & Polymyalgia Rheumatica: Answering the Currently Critical Questions | Christian Dejaco, MD, PhD, MBA
9:30
Morning Break
9:45
ANCA-Associated Vasculitis: The Nephrologist’s Perspective | Andreas Kronbichler, MD
10:45
New England Journal of Medicine Clinicopathologic Conference | Luke Chen, MD; John H. Stone, MD, MPH; Ambrose Huang, MD; Judith Ferry, MD; David Dudzinski, MD, JD
Other Allied Healthcare Professionals (Pharmacists, Physician Assistants, PhD)
$300.00
Industry
$800.00
Cancellation Policy: Registrations cancelled on or before September 29, 2023 will be refunded, less a $60 administrative fee. Registrations cancelled after September 29, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Pharmacy This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-P
Pharmacy Technicians This activity provides 1.5 contact hours (1.5 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-24-001-L01-T
Please note, access to symposium recordings is included with registration. Access will be available for 30 days post event.
With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices, and how those are evolving based on major updates in the biology, diagnosis, and management of hematologic malignancies. Attendee interaction is encouraged and promoted through the designated time for audience questions at the end of each webinar. Each 90-minute webinar will have two talks followed by discussion and audience Q&A. Presenters will include internationally-known disease experts from Mass General Cancer Center covering high-yield practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.
P. Connor Johnson, MD Hematology/Oncology, Massachusetts General Hospital Cancer Center Instructor in Medicine, Harvard Medical School
Faculty:
Andrew Brunner, MD Assistant in Medicine, Center for Leukemia, Massachusetts General Hospital; Assistant Professor, Medicine, Harvard Medical School
Diana Cirstea, MD Attending Physician, Center for Multiple Myeloma Massachusetts General Hospital Cancer Center
Zach DeFilipp, MD Director, BMT Clinical Research, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Matt Frigault, MD Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center Assistant Professor of Medicine, Harvard Medical School
Erika Haydu, MD, PhD Assistant in Medicine, Massachusetts General Hospital Instructor in Medicine, Harvard Medical School
Gaby Hobbs, MD Clinical Director, Leukemia Service, Massachusetts General Hospital Cancer Center Assistant in Medicine, Harvard Medical School
Richard Newcomb, MD Instructor of Medicine, Harvard Medical School Assistant Physician, Massachusetts General Hospital
Jake Soumerai, MD Clinical Investigator in Lymphoma, Medicine, Massachusetts General Hospital Assistant Professor, Medicine, Harvard Medical School
Andrew Yee, MD Clinical Director, Center for Multiple Myeloma Massachusetts General Hospital Cancer Center
Upon completion of this activity, participants will be able to:
Describe new therapies available for hematologic malignancies.
Discuss practice-changing updates in the management of hematologic malignancies Consider new concepts in palliative care and survivorship.
Determine appropriate timing to consider transplant evaluation and cellular therapy referral for hematologic malignancies.
Discuss latest and most promising disease-specific treatment options amongst the team to improve patient outcomes.
FUNDING
Mass General Cancer Center Practice-Changing Updates in Hematologic Malignancies 2024 has received support in the form of an educational grant from the following companies:
AbbVie Inc. AstraZeneca Pharmaceuticals Bristol Myers Squibb Incyte Corporation
Registrations cancelled on or before February 12, 2024 will be refunded, less a $20 administrative fee. Registrations cancelled after February 12, 2024 will not be refunded.
This activity is intended for physicians, nurses, pharmacists, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
Nursing Mass General Brigham designates this activity for 6.75 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.75 AAPA Category 1 CME credits. Approval is valid until June 2025. PAs should only claim credit commensurate with the extent of their participation.
Becoming an Asthma Educator is an on-line program with current information on asthma diagnosis, assessment, and treatment. It consists of a series of 9 video recordings, each approximately 40-45 minutes in length, and each followed by self-assessment multiple -choice questions with discussion of correct answers. It is designed to help allied health professionals to become qualified asthma educators.
Module #1 Understanding & Teaching the Mechanisms of Asthma
Module #2 Diagnosis & Assessment of Asthma
Module #3 Introduction to Pulmonary Function Testing
Module #4 Ambulatory Management of Asthma in the Adult
Elizabeth Klements, MS, RN, PPCNP-BC, AE-C Boston Children's Hospital (retired)
Disclosure Summary of Relevant Financial Relationships
MITIGATION STRATEGIES Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners have no reported relevant financial relationships with an ineligible company:
Christopher H. Fanta, MD Victoria Forth, PA-C Elizabeth Klements, MS, RN, PPCNP-BC, AE-C
The following speakers have reported no relevant financial relationships with an ineligible company:
Christopher H. Fanta, MD Kenan Haver, MD Elizabeth Klements, MS, RN, PPCNP-BC, AE-C
Upon completion of this activity, participants will be able to:
Describe to patients and their families about asthma; allergy testing; proper medication use; and peak flow monitoring.
Demonstrate a basic understanding of the use of pulmonary function testing in the diagnosis and assessment of asthma.
Specify the distinction between asthma severity and asthma control, and employ techniques to help patients develop a strategy to achieve good asthma control.
Acquire and demonstrate a willingness to collaborate across disciplines in asthma education. Both nurses and respiratory therapists are asked to administer inhaled medications to patients with asthma and teach skills (like peak flow monitoring) useful in preventing asthma attacks. Attendees are encouraged to recognize the unique set of skills brought to bear by each discipline.
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Midlife Women’s Health 2025 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.
In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of osteoporosis, gastrointestinal malignancy, stress, obesity, substance use disorder, anxiety, sexual dysfunction, breast cancer, and menopausal hormone therapy to assist clinicians in caring for their midlife patients.
Jan Shifren, MD - Course Director Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Massachusetts General Hospital
Dr. Shifren is a reproductive endocrinologist at the Massachusetts General Hospital and Director of the MGH Midlife Women’s Health Center. She focuses her research on menopause, including the effects of estrogens, androgens and alternative therapies on menopausal symptoms and sexual function. She is a past President of the Menopause Society.
Isaac Schiff, MD Chief, Department of Obstetrics and Gynecology, Emeritus, Massachusetts General Hospital
Dr. Isaac Schiff is the Chief, Department of Obstetrics and Gynecology, Emeritus, at the Massachusetts General Hospital and the Joe Vincent Meigs Distinguished Professor of Gynecology at Harvard Medical School. He is Co-Director of the MGH Midlife Women’s Health Center. Dr. Schiff is an internationally known expert in menopause, a founding member of the Menopause Society, and the Editor-in-Chief of the journal, Menopause.
Daniel Chung, MD Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital
Dr. Daniel Chung is a gastroenterologist at the Massachusetts General Hospital and Director of the High-Risk GI Cancer Clinic. He is also Medical Co-Director of the Center for Cancer Risk Assessment. His research aims to gain new insights into the molecular pathogenesis of GI malignancies, with a focus on colon cancer, angiogenesis, hereditary cancers, and genetic instability.
John Denninger, MD, PhD Department of Psychiatry, Massachusetts General Hospital
Dr. John Denninger is a psychiatrist at the Massachusetts General Hospital and Director of Integrative Science and Clinical Training at the Benson-Henry Institute for Mind Body Medicine. His research focuses on how mind-body interventions can promote wellness and resilience. He also investigates how these interventions work by exploring genes, biochemistry, and brain activity.
Tara Iyer, MD Department of Medicine, Brigham & Women's Hospital
Dr. Tara Iyer is a family medicine and obesity specialist and Medical Director of the Menopause and Midlife Clinic in the Division of Women's Health at the Brigham and Women’s Hospital. Her clinical and research interests include weight management in women, bone health, and menopause care of the cancer survivor.
Linda Kelly, DNP, ANP-BC Department of Obstetrics and Gynecology, Massachusetts General Hospital
Dr. Linda Kelly is an advanced practice provider at the Massachusetts General Hospital. She is the Nursing Director of the Midlife Women's Health Center in the Department of Obstetrics and Gynecology at MGH.
Noreen Reilly Harrington, PhD Department of Psychiatry, Massachusetts General Hospital
Dr. Noreen Harrington is a psychologist at the Massachusetts General Hospital. She is an internationally-recognized expert in the cognitive-behavioral treatment of mood and anxiety disorders, with a special focus on bipolar disorder.
Kathryn Rexrode, MD, MPH Chief, Division of Women's Health, Department of Medicine, Brigham & Women's Hospital
Dr. Kathryn Rexrode is an internist and Chief of the Division of Women's Health in the Department of Medicine at the Brigham and Women’s Hospital. She leads efforts to advance women’s health through research, clinical care, medical education and advocacy. He work focuses on metabolic factors, hormonal exposures and sex-specific risk factors for cardiovascular disease.
James Sawalla Guseh, II, MD Department of Cardiology, Massachusetts General Hospital
Dr. Sawalla Guseh is a cardiologist at the Massachusetts General Hospital and Director of the Cardiovascular Performance Program. His principal clinical interests include the treatment of patients, professionals, and athletes with varied forms of heart disease. His research focuses on understanding the molecular basis of human aerobic fitness.
Joy Tsai, MD Department of Medicine, Division of Endocrinology, Massachusetts General Hospital
Dr. Joy Tsai is an endocrinologist and osteoporosis specialist in the Division of Endocrinology in the Department of Medicine at the Massachusetts General Hospital. Her research interests include optimizing postmenopausal osteoporosis therapy and bone health, with a focus on the evaluation of bone quality through advanced imaging techniques.
Francys Verdial, MD Department of Surgery, Massachusetts General Hospital
Dr. Francys Verdial is a surgical oncologist at the Massachusetts General Hospital with special expertise in the management of breast cancer.
Sarah Wakeman, MD Department of Medicine, Massachusetts General Hospital
Dr. Sarah Wakeman is the Medical Director for the Massachusetts General Hospital Substance Use Disorder Initiative and the Senior Medical Director for Substance Use Disorder at Mass General Brigham. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care.
Other Health Care Professionals & Physicians-in-Training
$125
AFTERMARCH 28, 2025
Registration Type
Tuition Fee
Physician
$295
Other Health Care Professionals & Physicians-in-Training
$150
Cancellation Policy: Registrations cancelled on or before March 28, 2025 will be refunded, less a $35 administrative fee. Registrations cancelled after March 28, 2025 will not be refunded.
Contact mgbcpd@mgb.org if you require assistance in cancelling your online registration.
Please contact our Course Coordinator at MGHMidlifeCenter@mgh.harvard.edu prior to the event to assist you with any special needs.
This activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.